Presented at #ctad26 from @JAMA_current: A plasma immunoassay for eMTBR-tau identified advanced insoluble tau pathology in #alzheimerdisease across autopsy and tau #pet cohorts.
jamanetwork.com/journals/jama/fullarticle/2856953?guestAc…
@CTADconference
JAMA Neurology
JAMA Neurology is a monthly peer-reviewed medical journal published by the American Medical Association. It was established in 1960 as Archives of Neurology and obtained its current name in 2013. The journal publishes research on the nervous system as well as the various mechanisms of neurological disease. Its editor-in-chief is S. Andrew Josephson. More on Wikipedia
-
JAMA Neurology
@JAMANeuro
-
JAMA Neurology
@JAMANeuro
📝 Editorial: Evidence linking #agentorange and #parkinsondisease provides clarity for exposed veterans and highlights a public health concern, as a major component of the defoliant is still used on farms, golf courses, and around homes. jamanetwork.com/journals/jamaneurology/fullarticle/10.100…
-
JAMA Neurology
@JAMANeuro
📈 Among US veterans, #agentorange exposure was associated with higher risk of #parkinsondisease, rapid eye movement sleep behavior disorder, and dementia with Lewy bodies, with stronger associations among those with more direct exposure. jamanetwork.com/journals/jamaneurology/fullarticle/10.100…
-
JAMA Neurology
@JAMANeuro
💬 Viewpoint: The role of #leftatrialappendageclosure in #atrialfibrillation may depend on patient phenotype, and more evidence is needed in patients who cannot take long-term direct oral anticoagulants. jamanetwork.com/journals/jamaneurology/fullarticle/10.100…
-
JAMA Neurology
@JAMANeuro
📢 Applications are open for the 2027 @JAMANeuro Editorial Fellowship.
The 1-year fellowship begins February 1, 2027, and offers hands-on training in editorial processes and policies.
📅 Apply by December 15, 2026: jamanetwork.com/pages/jama-neurology-editorial-fellowship… -
JAMA Neurology
@JAMANeuro
📊🧠 A harmonized #taupet visual reading framework for #alzheimerdisease with five classes showed high agreement across raters and tracers, and identified more early-stage tau pathology than the regulatory-approved binary approach. jamanetwork.com/journals/jamaneurology/fullarticle/10.100…
-
JAMA Neurology
@JAMANeuro
Presented at #jcdp2026 from @JAMA_current:
Plasma eMTBR-tau243 increased with advancing #cte stage and showed strong discrimination for stage III and IV disease vs cognitively unimpaired controls, but not for stage I disease.
jamanetwork.com/journals/jama/fullarticle/10.1001/jama.20… -
JAMA Neurology
@JAMANeuro
Among patients with relapsing #multiplesclerosis, earlier and continuous ocrelizumab treatment was associated with better long-term relapse and disability control than delayed initiation after interferon beta-1a. jamanetwork.com/journals/jamaneurology/fullarticle/10.100…
-
JAMA Neurology
@JAMANeuro
📝 #jamareview: #acuteischemicstroke requires rapid brain imaging and urgent evaluation for reperfusion therapy.
Learn more in this Review from @JAMA_current: jamanetwork.com/journals/jama/fullarticle/2856706?guestAc… -
JAMA Neurology
@JAMANeuro
Among older adults with #mildcognitiveimpairment and hearing loss, hearing aid intervention did not significantly reduce dementia-level impairment over 24 months vs hearing care education. jamanetwork.com/journals/jamaneurology/fullarticle/10.100…
-
JAMA Neurology
@JAMANeuro
Among adults with newly diagnosed #idiopathicinflammatorymyopathies, add-on intravenous immunoglobulin plus high-dose prednisone led to greater and faster improvement than high-dose prednisone alone. jamanetwork.com/journals/jamaneurology/fullarticle/10.100…
-
JAMA Neurology
@JAMANeuro
Interested in medical editing and publishing? The @JAMANeuro Editorial Fellowship offers early-career neurologists hands-on experience in peer review, editorial decision-making, and the processes of a medical journal.
🔗 Learn more and apply: jamanetwork.com/pages/jama-neurology-editorial-fellowship… -
JAMA Neurology
@JAMANeuro
Regular smoking was associated with lower risk of #parkinsondisease, and among individuals who never smoked, higher exhaled #carbonmonoxide levels were also associated with lower Parkinson disease risk. jamanetwork.com/journals/jamaneurology/fullarticle/10.100…
-
JAMA Neurology
@JAMANeuro
💡 In adults with focal epilepsy who continued to have #focalseizures despite treatment with 1 to 3 antiseizure medications, azetukalner reduced seizure frequency vs placebo, with rapid and durable benefit during the 12-week double-blind period.
jamanetwork.com/journals/jamaneurology/fullarticle/285638… -
JAMA Neurology
@JAMANeuro
📊 #rimkla-IgG was identified as a new biomarker of paraneoplastic neurological syndrome associated with cerebellar ataxia, hindbrain encephalitis, inflammatory cerebrospinal fluid, and frequent #smallcelllungcancer. jamanetwork.com/journals/jamaneurology/fullarticle/285639…
-
JAMA Neurology
@JAMANeuro
📊 A single dose of CD19 #chimericantigenreceptor T-cell therapy for #stiffpersonsyndrome was associated with clinically meaningful mobility improvement and changes supportive of immune reset, with a manageable safety profile. jamanetwork.com/journals/jamaneurology/fullarticle/285638…
-
JAMA Neurology
@JAMANeuro
📝 Editorial: In patients with #stiffpersonsyndrome and inadequate response to prior immune therapy, anti-CD19 #chimericantigenreceptor T-cell therapy was associated with improved walking, stiffness, and heightened sensitivity at 16 weeks.
jamanetwork.com/journals/jamaneurology/fullarticle/285639… -
JAMA Neurology
@JAMANeuro
Early detection of cognitive impairment is critical. New findings in JAMA Neurology suggest #ai could help screen for #cognitiveimpairment by listening to primary care visit conversations. #neurology
📌 Learn more: jamanetwork.com/journals/jamaneurology/fullarticle/10.100… -
JAMA Neurology
@JAMANeuro
📢 Calling all early-career neurologists
Apply for the @JAMANeuro Editorial Fellowship, a 1-year opportunity beginning February 1, 2027. Gain hands-on editorial experience, serve as a Reviewing Editor, & work closely with the journal’s editorial team.
🔗 jamanetwork.com/pages/jama-neurology-editorial-fellowship… -
JAMA Neurology
@JAMANeuro
In 2027, JAMA will convene leaders across #medicine, research, #technology, industry, and #policy to address how #ai will reshape health care and biomedical science.
Learn more: jamanetwork.com/pages/jama-summit-health-after-ai?linkId=…
#healthafterai #jamasummit -
JAMA Neurology
@JAMANeuro
📊 #epilepsy in the first 2 years of life represents a substantial global burden, driven largely by developmental and epileptic encephalopathies, especially infantile epileptic spasms syndrome, with major data gaps outside high-income regions. jamanetwork.com/journals/jamaneurology/fullarticle/10.100…
-
JAMA Neurology
@JAMANeuro
📢 Applications are open for the 2027 JAMA Neurology Editorial Fellowship.
The 1-year fellowship begins February 1, 2027, and offers hands-on training in editorial processes and policies.
📅 Apply by December 15, 2026: jamanetwork.com/pages/jama-neurology-editorial-fellowship… -
JAMA Neurology
@JAMANeuro
📝 Editorial: JAMA Neurology is accepting applications for a 1-year editorial fellowship starting February 1, 2027, with training in peer review, editorial decisions, and medical publishing. Applications are due December 15, 2026. jamanetwork.com/journals/jamaneurology/fullarticle/10.100…
-
JAMA Neurology
@JAMANeuro
📝 Viewpoint: In care for #alzheimersdisease and related diseases that cause dementia, clinicians should ask who will take part in a patient’s care, because care partners may support assessment, daily function, emotional well-being, and decision-making. jamanetwork.com/journals/jamaneurology/fullarticle/10.100…
-
JAMA Neurology
@JAMANeuro
🧠 Viewpoint: Integrating #neurology and #physiatry in early post-#stroke care may improve #strokerecovery by combining lesion-based diagnosis with function-focused rehabilitation during a period of heightened neuroplasticity. jamanetwork.com/journals/jamaneurology/fullarticle/10.100…
-
JAMA Neurology
@JAMANeuro
A recent JAMA #neurology study found that ecopipam maintained clinically meaningful improvement in #tourettesyndrome symptoms and was generally well tolerated for up to 24 weeks.
📌 Learn more: jamanetwork.com/journals/jamaneurology/fullarticle/10.100…This media couldn't be displayed. See it on the original post. -
JAMA Neurology
@JAMANeuro
This cohort study examines data for a large population-based cohort to identify and characterize any cases of primary Epstein-Barr virus infection that occurred after the onset of multiple sclerosis. jamanetwork.com/journals/jamaneurology/fullarticle/10.100…
-
JAMA Neurology
@JAMANeuro
Pressure-induced paroxysmal dystonia was diagnosed using clinical observation and video EEG, with symptoms abolished by low-dose clonazepam. Brief episodes and sensorimotor hypersensitivity distinguished it from other #movementdisorders. jamanetwork.com/journals/jamaneurology/fullarticle/10.100…
-
JAMA Neurology
@JAMANeuro
A patient with cavin-4 IgG-positive immune-mediated rippling muscle disease achieved complete clinical and serological remission following B-cell-targeted therapy with rituximab. jamanetwork.com/journals/jamaneurology/fullarticle/10.100…
-
JAMA Neurology
@JAMANeuro
This Review proposes #tdp43-associated neurodegenerative disease as a staging framework that links presymptomatic biology with later clinical phenotypes and could support earlier mechanism-based treatment development. jamanetwork.com/journals/jamaneurology/fullarticle/10.100…
-
JAMA Neurology
@JAMANeuro
Among adults with #epilepsy receiving direct oral anticoagulants, antiseizure medication selection was associated with different risks of thromboembolic events, major bleeding, and all-cause mortality. jamanetwork.com/journals/jamaneurology/fullarticle/10.100…
-
JAMA Neurology
@JAMANeuro
Among amyloid-positive individuals, a 7-protein plasma panel improved identification of advanced neocortical #tau pathology compared with phosphorylated tau-217 alone. jamanetwork.com/journals/jamaneurology/fullarticle/10.100…
-
JAMA Neurology
@JAMANeuro
📣 JAMA and the JAMA Network journals are issuing a call for papers on Women's Health.
➡️ Manuscripts submitted by November 15, 2026, will have the best chance for consideration for simultaneous publication on International Women’s Day.
🔗 Learn more: jamanetwork.com/journals/jama/fullarticle/2855130?guestAc… -
JAMA Neurology
@JAMANeuro
Common MC1R loss-of-function variants may define a large genetic subgroup in #parkinsondisease with accelerated motor progression and potential relevance for clinical trial enrichment. jamanetwork.com/journals/jamaneurology/fullarticle/10.100…
-
JAMA Neurology
@JAMANeuro
💬 Editorial: A shared #tdp43 disease framework could improve cross-specialty research, but heterogeneity in pathology, phenotype, and coexisting proteinopathies may limit how broadly it can be applied. jamanetwork.com/journals/jamaneurology/fullarticle/10.100…
-
JAMA Neurology
@JAMANeuro
📝 Editorial: Common MC1R loss-of-function variants may be associated with faster motor progression in #parkinsondisease, indicating a potential role for common inherited variation in disease tempo. jamanetwork.com/journals/jamaneurology/fullarticle/10.100…
-
JAMA Neurology
@JAMANeuro
💬 Editorial: Among patients with #branchatheromatousdisease-related #ischemicstroke, the trial did not show an overall benefit of tirofiban plus aspirin. jamanetwork.com/journals/jamaneurology/fullarticle/10.100…
-
JAMA Neurology
@JAMANeuro
📊 Among older adults, current smoking, #hypertension, #diabetes, chronic kidney disease, and history of stroke were associated with higher risk of #lateonsetepilepsy, indicating a link with underlying vascular disease.
jamanetwork.com/journals/jamaneurology/fullarticle/285527… -
JAMA Neurology
@JAMANeuro
💬 Editorial: In the DOT-MS trial, discontinuation of disease-modifying therapy in stable #multiplesclerosis led to increased relapse rates, challenging the safety of stopping treatment even after years of disease stability. jamanetwork.com/journals/jamaneurology/fullarticle/10.100…
-
JAMA Neurology
@JAMANeuro
💬 Viewpoint: For inflight #epilepsy emergencies, nasal and buccal benzodiazepines may provide practical rescue options, supporting updated airline medical kit requirements and standardized crew training. jamanetwork.com/journals/jamaneurology/fullarticle/10.100…
-
JAMA Neurology
@JAMANeuro
💬Viewpoint: As biomarker testing expands, clinicians will increasingly observe #alzheimerdisease pathology and copathologies, indicating a need for individualized treatment decisions and more evidence on #amyloidtargetingtreatments. jamanetwork.com/journals/jamaneurology/fullarticle/10.100…
-
JAMA Neurology
@JAMANeuro
Female sex, smoking, and family history were independent risk factors for de novo #intracranialaneurysm formation after #aneurysmalsubarachnoidhemorrhage, and #smokingcessation was associated with lower risk.
jamanetwork.com/journals/jamaneurology/fullarticle/10.100… -
JAMA Neurology reposted
JAMA
@JAMA_current
The JAMA Network announces @JAMA_AI_, a new peer-reviewed online journal dedicated to the science of artificial intelligence, digital health, and emerging technologies that are transforming medicine and health care.
Led by inaugural Editor in Chief Roy H. Perlis, MD, MSc, JAMA AI will publish research spanning the full spectrum of AI in health care, from advances in AI capabilities and clinical applications to rigorous evaluation and real-world implementation.
The journal will begin accepting submissions in early 2027.
➡️ Learn more and sign up for updates: jama-ai.com?linkId=1021777473 -
JAMA Neurology
@JAMANeuro
In generalized #myastheniagravis, inebilizumab was associated with fewer exacerbations during corticosteroid tapering, including less use of intravenous immunoglobulin or plasma exchange. jamanetwork.com/journals/jamaneurology/fullarticle/10.100…
-
JAMA Neurology
@JAMANeuro
Among patients with #branchatheromatousdisease-related #ischemicstroke, intravenous #tirofiban plus aspirin did not reduce early neurological deterioration or new stroke compared with aspirin alone. jamanetwork.com/journals/jamaneurology/fullarticle/10.100…
-
JAMA Neurology
@JAMANeuro
📄 This case report describes an optic embolism in a 30-year-old woman with sudden, painless vision loss in the left eye.
jamanetwork.com/journals/jamaneurology/fullarticle/10.100… -
JAMA Neurology
@JAMANeuro
🎙️ In the latest episode of the JAMA Neurology Author Interviews podcast, Anick Bérard, PhD, and Cynthia Armand, MD, discussed how these findings may inform treatment decisions for patients who become pregnant while using preventive migraine therapy.
edhub.ama-assn.org/jn-learning/audio-player/19100014?link… -
JAMA Neurology
@JAMANeuro
Among pregnant individuals with #migraine, early pregnancy exposure to anti-calcitonin gene-related peptide monoclonal antibodies was associated with higher spontaneous abortion risk, while propranolol was not.
jamanetwork.com/journals/jamaneurology/fullarticle/10.100… -
JAMA Neurology
@JAMANeuro
Meta-analysis: Global #dementia incidence was estimated at 9.7 per 1000 person-years, with higher incidence in women and in low- and middle-income countries vs high-income countries.
jamanetwork.com/journals/jamaneurology/fullarticle/10.100… -
JAMA Neurology
@JAMANeuro
In preclinical #alzheimerdisease screening, higher plasma phosphorylated tau 217 percentage was associated with higher amyloid #pet across racial groups.
jamanetwork.com/journals/jamaneurology/fullarticle/10.100… -
JAMA Neurology
@JAMANeuro
Among patients with relapsing #multiplesclerosis, earlier and continuous ocrelizumab treatment was associated with better long-term relapse and disability control than delayed initiation after interferon beta-1a.
jamanetwork.com/journals/jamaneurology/fullarticle/285479… -
JAMA Neurology
@JAMANeuro
Among pediatric inpatients with unexplained #neurologic presentations, rapid #wholegenomesequencing diagnosed nearly half of patients and changed management in about 2-thirds of diagnosed cases.
jamanetwork.com/journals/jamaneurology/fullarticle/285479… -
JAMA Neurology reposted
JAMA
@JAMA_current
📣 @JAMA_current and the @JAMANetwork journals are issuing a call for papers on Women's Health.
Last year, we launched @JAMAWomenHealth, an initiative that offers expertly curated research and insights from work published in JAMA and the JAMA Network. An important goal of JAMA+ Women's Health is to shift the conversation about women’s health beyond the “usual” categories of #reproductive #health, #pregnancy, #menopause, and certain #cancers.
To align with the 2027 International Women’s Day, JAMA and the JAMA Network journals will publish women’s health articles across the full spectrum of health care on March 8, 2027.
This call for papers will prioritize timely and novel research articles and opinion manuscripts. Manuscripts submitted by November 15, 2026, will have the best chance for consideration for simultaneous publication on International Women’s Day.
🔗 Click on the link to read the full editorial: jamanetwork.com/journals/jama/fullarticle/10.1001/jama.20… -
JAMA Neurology reposted
JAMA
@JAMA_current
🧵 Among patients with early #parkinsondisease, treatment with nicotinamide riboside for 52 weeks did not improve clinical outcomes vs placebo and was associated with worse change in overall Movement Disorder Society Unified Parkinson Disease Rating Scale scores.
These findings do not support nicotinamide riboside as a disease-modifying treatment for Parkinson disease.
jamanetwork.com/journals/jama/fullarticle/2855023?guestAc… -
JAMA Neurology reposted
Mass General Brigham Research
@MGBResearchNews
A new study published in @JAMANeuro shows that a common genetic variant may help explain why #parkinson’s disease progresses faster in some people⤵️
-
JAMA Neurology reposted
AMA Ed Hub™
@AMAEdHub
A 61-year-old man presented with chronic progressive weakness and gait dysfunction. Neurological examination revealed impaired short-term recall and a pseudobulbar affect. Share your diagnosis. @JAMANeuro edhub.ama-assn.org/jn-learning/module/2828933
-
JAMA Neurology reposted
Eric Topol
@EricTopol
Should the left atrial appendage be closed (LAAC) with an implantable device to prevent stroke with atrial fibrillation and need for long-term blood thinners (DOACs)?
This @JAMANeuro editorial argues against the procedure
jamanetwork.com/journals/jamaneurology/article-abstract/2… -
JAMA Neurology reposted
David Seiffge
@DavidSeiffge
Our (neurologists’) viewpoint in @JAMANeuro on recent trial results of RCTs assessing Left Atrial Appendage Closure in patients with atrial fibrillation
@StrokeBern @MedFacultyUniBE
jamanetwork.com/journals/jamaneurology/article-abstract/2… -
JAMA Neurology
@JAMANeuro
Among patients with relapsing #multiplesclerosis, earlier and continuous ocrelizumab treatment was associated with better long-term relapse and disability control than delayed initiation after interferon beta-1a.
jamanetwork.com/journals/jamaneurology/fullarticle/285479… -
JAMA Neurology
@JAMANeuro
Among patients evaluated for cognitive symptoms, earlier disclosure of blood-based biomarkers increased diagnostic certainty without worsening anxiety, depressive symptoms, perceived stress, or quality of life.
jamanetwork.com/journals/jamaneurology/fullarticle/285479… -
JAMA Neurology
@JAMANeuro
💬 Editorial: In children with #neurologicdisease, rapid #wholegenomesequencing may support earlier diagnosis and management changes, with increasing relevance as precision therapies emerge.
jamanetwork.com/journals/jamaneurology/fullarticle/285479… -
JAMA Neurology
@JAMANeuro
Among pediatric inpatients with unexplained #neurologic presentations, rapid #wholegenomesequencing diagnosed nearly half of patients and changed management in about 2-thirds of diagnosed cases.
jamanetwork.com/journals/jamaneurology/fullarticle/285479… -
JAMA Neurology
@JAMANeuro
Can anesthesia choice during #stroketreatment affect recovery?
#sedation #anesthesia
📌Learn more: jamanetwork.com/journals/jamaneurology/fullarticle/10.100… -
JAMA Neurology
@JAMANeuro
IL-6 receptor blockers provided favorable recovery and visual improvement after acute attacks in #mogad and #aqp4nmosd, but controlled trials are needed to determine effects on long-term disability. jamanetwork.com/journals/jamaneurology/fullarticle/10.100…
-
JAMA Neurology
@JAMANeuro
Self-reported seizure durations in a large outpatient sample were often longer than laboratory-recorded values, with 90% of seizures lasting ≤4 minutes and substantial variation by seizure type and age group in #epilepsy. jamanetwork.com/journals/jamaneurology/fullarticle/10.100…
-
JAMA Neurology
@JAMANeuro
In #mogad, MRI lesions often resolve over time and asymptomatic radiological activity is rare, limiting the clinical utility of surveillance MRI compared with multiple sclerosis.
jamanetwork.com/journals/jamaneurology/fullarticle/10.100… -
JAMA Neurology
@JAMANeuro
An unusual congenital fusion of the left and right oculomotor nerves was identified in a child with complex #strabismus and ptosis, demonstrating a rare variant of cranial nerve dysgenesis on neuroimaging.
jamanetwork.com/journals/jamaneurology/fullarticle/10.100… -
JAMA Neurology
@JAMANeuro
💬 Viewpoint: The role of #leftatrialappendageclosure in #atrialfibrillation may depend on patient phenotype, and more evidence is needed in patients who cannot take long-term direct oral anticoagulants.
jamanetwork.com/journals/jamaneurology/fullarticle/10.100… -
JAMA Neurology
@JAMANeuro
Among older adults with #mildcognitiveimpairment and hearing loss, hearing aid intervention did not significantly reduce dementia-level impairment over 24 months vs hearing care education.
jamanetwork.com/journals/jamaneurology/fullarticle/10.100… -
JAMA Neurology
@JAMANeuro
Playing or singing music reliably relieved benign essential #blepharospasm in a professional oboist, while nonmusical mimics did not, demonstrating a complex sensory trick. jamanetwork.com/journals/jamaneurology/fullarticle/10.100…
-
JAMA Neurology
@JAMANeuro
📑 JAMA Neurology #review: Neurological manifestations of #hantavirus infection include encephalopathy, pituitary apoplexy, hemorrhage, and neuropathy; most are secondary to systemic illness but can be severe. jamanetwork.com/journals/jamaneurology/fullarticle/10.100…
-
JAMA Neurology
@JAMANeuro
International consensus developed a football-specific on-pitch concussion protocol (FOCUS) for rapid assessment, bridging a gap in player health and safety, but feasibility and diagnostic performance await further evaluation. jamanetwork.com/journals/jamaneurology/fullarticle/10.100…
-
JAMA Neurology
@JAMANeuro
Dementia prevalence increased over 2 decades in Mexico, Peru, and Puerto Rico, while rates remained stable in Cuba and the Dominican Republic, indicating an uneven and rising burden compared with high-income countries. #aaic26 jamanetwork.com/journals/jamaneurology/fullarticle/10.100…
-
JAMA Neurology
@JAMANeuro
In #multiplesclerosis, higher serum glial fibrillary acidic protein was associated with greater risk of progression independent of relapse activity, while neurofilament light chain was more closely associated with relapse risk. jamanetwork.com/journals/jamaneurology/fullarticle/10.100…
-
JAMA Neurology
@JAMANeuro
In autopsy tissue from patients with #sod1als, intrathecal tofersen achieved predicted central nervous system distribution and substantially reduced SOD1 protein levels in somatic motor system tissues. jamanetwork.com/journals/jamaneurology/fullarticle/10.100…
-
JAMA Neurology
@JAMANeuro
🧠 Portable low-field #mri of the brain showed strong agreement with conventional MRI for key volumetric measures and may expand access to brain health assessment outside traditional radiology settings. jamanetwork.com/journals/jamaneurology/fullarticle/10.100…
-
JAMA Neurology
@JAMANeuro
This case report describes 11.7-T in vivo human brain magnetic resonance imaging (MRI) of the basal ganglia in 2 healthy volunteers. jamanetwork.com/journals/jamaneurology/fullarticle/10.100…
-
JAMA Neurology
@JAMANeuro
In #primaryprogressiveaphasia, automated #speechanalysis of a brief picture description task distinguished nonfluent, logopenic, and semantic variants and produced interpretable speech profiles. jamanetwork.com/journals/jamaneurology/fullarticle/10.100…
-
JAMA Neurology
@JAMANeuro
📝 The #hints examination is most effective in patients with continuous dizziness and spontaneous nystagmus at rest.
This Review indicates that outside this population , HINTS can reduce stroke diagnostic accuracy and lead to unnecessary imaging.
jamanetwork.com/journals/jamaneurology/fullarticle/10.100… -
JAMA Neurology
@JAMANeuro
A harmonized #taupet visual reading framework for #alzheimerdisease with five classes showed high agreement across raters and tracers, and identified more early-stage tau pathology than the regulatory-approved binary approach.
jamanetwork.com/journals/jamaneurology/fullarticle/10.100… -
JAMA Neurology
@JAMANeuro
IL-6 receptor blockade was associated with low relapse rates and a favorable safety profile in #mogad, performing better than low-dose #ivig and comparably to higher-dose IVIG regimens. jamanetwork.com/journals/jamaneurology/fullarticle/10.100…
-
JAMA Neurology
@JAMANeuro
Among residents exposed to higher traffic noise, a quieter residential side was associated with lower #parkinsondisease risk, suggesting a possible role for noise mitigation in housing and urban design. jamanetwork.com/journals/jamaneurology/fullarticle/10.100…
-
JAMA Neurology
@JAMANeuro
Gefurulimab, a complement component 5–blocking nanobody, provided early and sustained benefit in generalized #myastheniagravis and was well tolerated with once-weekly self-administered subcutaneous dosing. jamanetwork.com/journals/jamaneurology/fullarticle/10.100…
-
JAMA Neurology
@JAMANeuro
💬 Editorial: Road traffic noise may be a novel place-based risk factor for #parkinsondisease, adding to evidence linking environmental toxicants and pollution exposures to disease risk. jamanetwork.com/journals/jamaneurology/fullarticle/10.100…
-
JAMA Neurology
@JAMANeuro
💬 Editorial: In anti–acetylcholine receptor antibody–positive generalized #myastheniagravis, gefurulimab improved activities of daily living and quantitative disease scores over 26 weeks. jamanetwork.com/journals/jamaneurology/fullarticle/10.100…
-
JAMA Neurology
@JAMANeuro
💬 Viewpoint: Medicolegal advocacy from neurologists can support patients with neurologic illness in securing rehabilitation, disability benefits, and housing stability, with implications for individual and population health. jamanetwork.com/journals/jamaneurology/fullarticle/10.100…
-
JAMA Neurology
@JAMANeuro
📝 #jamareview: #idiopathic normal pressure hydrocephalus is a progressive neurologic disorder in older adults associated with gait impairment and often urinary dysfunction and cognitive decline.
🔗 Learn more: jamanetwork.com/journals/jama/fullarticle/10.1001/jama.20…
JAMA Neurology
@JAMANeuro
📝 This #jamareview indicates that early recognition matters because shorter symptom duration and less advanced disease are associated with more favorable outcomes, and symptoms improve in most patients after shunt surgery.
🔗 jamanetwork.com/journals/jama/fullarticle/10.1001/jama.20… -
JAMA Neurology
@JAMANeuro
Interview with Prof Zheng-Ming Chen, DPhil author Smoking, Exhaled Carbon Monoxide, and Risk of Parkinson Disease. Hosted by Cynthia E. Armand, MD. edhub.ama-assn.org/jn-learning/audio-player/10.1001/jaman…
-
JAMA Neurology
@JAMANeuro
📝 Editorial: Higher exhaled #carbonmonoxide levels among individuals who never smoked were associated with lower risk of #parkinsondisease, offering a potential clue to Parkinson disease etiology. jamanetwork.com/journals/jamaneurology/fullarticle/10.100…
-
JAMA Neurology
@JAMANeuro
📝 Editorial: Common MC1R loss-of-function variants may be associated with faster motor progression in #parkinsondisease, indicating a potential role for common inherited variation in disease tempo. jamanetwork.com/journals/jamaneurology/fullarticle/10.100…
-
JAMA Neurology
@JAMANeuro
Regular smoking was associated with lower risk of #parkinsondisease, and among individuals who never smoked, higher exhaled #carbonmonoxide levels were also associated with lower Parkinson disease risk. jamanetwork.com/journals/jamaneurology/fullarticle/10.100…
-
JAMA Neurology
@JAMANeuro
Common MC1R loss-of-function variants may define a large genetic subgroup in #parkinsondisease with accelerated motor progression and potential relevance for clinical trial enrichment. jamanetwork.com/journals/jamaneurology/fullarticle/10.100…
-
JAMA Neurology
@JAMANeuro
Among patients with #branchatheromatousdisease-related #ischemicstroke, intravenous #tirofiban plus aspirin did not reduce early neurological deterioration or new stroke compared with aspirin alone.
jamanetwork.com/journals/jamaneurology/fullarticle/10.100… -
JAMA Neurology
@JAMANeuro
💬 Editorial: Among patients with #branchatheromatousdisease-related #ischemicstroke, the trial did not show an overall benefit of tirofiban plus aspirin.
jamanetwork.com/journals/jamaneurology/fullarticle/10.100… -
JAMA Neurology
@JAMANeuro
💬Viewpoint: As biomarker testing expands, clinicians will increasingly observe #alzheimerdisease pathology and copathologies, indicating a need for individualized treatment decisions and more evidence on #amyloidtargetingtreatments. jamanetwork.com/journals/jamaneurology/fullarticle/10.100…
-
JAMA Neurology
@JAMANeuro
In 2 clinical trials, once-daily #tevapadon improved symptoms in patients with #parkinsondisease, increasing daily good on time in those taking levodopa and improving motor scores in early disease vs placebo.
📖 Read the full article to learn more: jamanetwork.com/journals/jamaneurology/fullarticle/10.100…This media couldn't be displayed. See it on the original post. -
JAMA Neurology
@JAMANeuro
Female sex, smoking, and family history were independent risk factors for de novo #intracranialaneurysm formation after #aneurysmalsubarachnoidhemorrhage, and #smokingcessation was associated with lower risk.
jamanetwork.com/journals/jamaneurology/fullarticle/10.100… -
JAMA Neurology
@JAMANeuro
💬 Editorial: A shared #tdp43 disease framework could improve cross-specialty research, but heterogeneity in pathology, phenotype, and coexisting proteinopathies may limit how broadly it can be applied. jamanetwork.com/journals/jamaneurology/fullarticle/10.100…
-
JAMA Neurology
@JAMANeuro
This JAMA Neurology #review proposes #tdp43-associated #neurodegenerative disease as a staging framework that links presymptomatic biology with later clinical phenotypes and could support earlier mechanism-based treatment development.
jamanetwork.com/journals/jamaneurology/fullarticle/10.100… -
JAMA Neurology
@JAMANeuro
Performance of the FDA-cleared Lumipulse plasma #biomarker for amyloid pathology detection in #alzheimerdisease varied by site and reagent lots, highlighting need for local assay verification and ongoing quality control. jamanetwork.com/journals/jamaneurology/fullarticle/10.100…
-
JAMA Neurology
@JAMANeuro
Quantile aggregation may artificially inflate amyloid-cognition associations in #alzheimerdisease trials, highlighting need for causally interpretable methods when assessing surrogate endpoints. jamanetwork.com/journals/jamaneurology/fullarticle/10.100…
-
JAMA Neurology
@JAMANeuro
Delayed onset of hemichorea and dystonia can occur after cortical temporal #stroke, even when imaging reveals small acute ischemic lesions and routine blood tests are normal. jamanetwork.com/journals/jamaneurology/fullarticle/10.100…
-
JAMA Neurology
@JAMANeuro
#cavernoussinus dural arteriovenous fistula can present with proptosis, conjunctival injection, and ophthalmoplegia; endovascular embolization achieved complete occlusion and rapid symptom resolution in this case. jamanetwork.com/journals/jamaneurology/fullarticle/10.100…
-
JAMA Neurology
@JAMANeuro
📑 JAMA Neurology #review: Gene delivery platforms for #glioblastoma include viral vectors, lipid nanoparticles, and nanocarriers, with oncolytic HSV gaining approval and new nonviral approaches entering early clinical trials in #neurooncology. jamanetwork.com/journals/jamaneurology/fullarticle/10.100…
-
JAMA Neurology
@JAMANeuro
Integrating genetic and pathological data increased diagnostic accuracy and identified ancestry-related differences in #parkinsondisease, supporting biologically informed diagnostic tools and future pathology-targeted therapeutic trials. jamanetwork.com/journals/jamaneurology/fullarticle/10.100…
-
JAMA Neurology
@JAMANeuro
💬 Viewpoint: For inflight #epilepsy emergencies, nasal and buccal benzodiazepines may provide practical rescue options, supporting updated airline medical kit requirements and standardized crew training. jamanetwork.com/journals/jamaneurology/fullarticle/10.100…
-
JAMA Neurology
@JAMANeuro
A reperfusion-guided systolic blood pressure strategy improved functional outcomes and reduced hemorrhagic transformation for patients with acute #stroke after endovascular therapy compared with guideline-recommended management. jamanetwork.com/journals/jamaneurology/fullarticle/10.100…
-
JAMA Neurology
@JAMANeuro
Among patients with idiopathic #myelopathy, screening for anti-CD320 antibodies with metabolic confirmation of central nervous system–restricted #vitaminb12 deficiency may help clarify diagnosis and guide treatment evaluation.
jamanetwork.com/journals/jamaneurology/fullarticle/10.100… -
JAMA Neurology
@JAMANeuro
Among adults with #epilepsy receiving direct oral anticoagulants, antiseizure medication selection was associated with different risks of thromboembolic events, major bleeding, and all-cause mortality.
jamanetwork.com/journals/jamaneurology/fullarticle/10.100… -
JAMA Neurology
@JAMANeuro
Among patients with familial or sporadic #frontotemporaldementia, cerebrospinal fluid TMEM106B levels were lower with greater disease severity, progression, smaller brain volumes, and in carriers of the protective rs1990622 genotype. jamanetwork.com/journals/jamaneurology/fullarticle/10.100…
-
JAMA Neurology
@JAMANeuro
Among patients with acute ischemic stroke due to large-vessel occlusion, standard-dose tenecteplase resulted in greater early reperfusion vs low-dose alteplase, with comparable functional and safety outcomes. jamanetwork.com/journals/jamaneurology/fullarticle/10.100…
-
JAMA Neurology
@JAMANeuro
Among veterans with prior #traumaticbraininjury, the plasma p-tau217/Aβ42 blood test for #alzheimerdisease missed over half of brain amyloid-positive cases, indicating reduced diagnostic accuracy in this population. jamanetwork.com/journals/jamaneurology/fullarticle/10.100…
-
JAMA Neurology
@JAMANeuro
Randomized clinical trial indicates middle meningeal artery embolization with n-butyl cyanoacrylate plus standard care reduced #subduralhematoma recurrence and need for surgery vs standard care alone, with comparable safety profile. jamanetwork.com/journals/jamaneurology/fullarticle/10.100…
-
JAMA Neurology
@JAMANeuro
Among adult #ebola survivors, neurological symptoms such as memory loss, headaches, and depression remained common even 7 years post-infection, although most improved over time.
jamanetwork.com/journals/jamaneurology/fullarticle/10.100… -
JAMA Neurology
@JAMANeuro
A patient with isolated peripheral nerve vasculitis developed reversible bilateral hypoglossal palsy and tongue atrophy, with resolution of bulbar symptoms following immunosuppressive therapy and reinnervation, a rare neurological outcome.
jamanetwork.com/journals/jamaneurology/fullarticle/10.100… -
JAMA Neurology
@JAMANeuro
Machine learning analysis of patient-clinician conversations identified cognitive impairment with sensitivity 68% and specificity 64%, supporting passive speech-based screening in routine #primarycare. jamanetwork.com/journals/jamaneurology/fullarticle/10.100…
-
JAMA Neurology
@JAMANeuro
📝 A young adult with thoracic myelopathy developed worsening #spasticparaparesis after lumbar puncture, and flexion #mri revealed dynamic thoracic cord compression consistent with a Hirayama-like mechanism.
jamanetwork.com/journals/jamaneurology/fullarticle/10.100… -
JAMA Neurology
@JAMANeuro
Among amyloid-positive individuals, a 7-protein plasma panel improved identification of advanced neocortical #tau pathology compared with phosphorylated tau-217 alone. jamanetwork.com/journals/jamaneurology/fullarticle/10.100…
-
JAMA Neurology
@JAMANeuro
In generalized #myastheniagravis, inebilizumab was associated with fewer exacerbations during corticosteroid tapering, including less use of intravenous immunoglobulin or plasma exchange. jamanetwork.com/journals/jamaneurology/fullarticle/10.100…
-
JAMA Neurology
@JAMANeuro
In #primaryprogressiveaphasia, automated #speechanalysis of a brief picture description task distinguished nonfluent, logopenic, and semantic variants and produced interpretable speech profiles.
jamanetwork.com/journals/jamaneurology/fullarticle/10.100… -
JAMA Neurology
@JAMANeuro
In #multiplesclerosis, higher serum glial fibrillary acidic protein was associated with greater risk of progression independent of relapse activity, while neurofilament light chain was more closely associated with relapse risk.
jamanetwork.com/journals/jamaneurology/fullarticle/10.100… -
JAMA Neurology
@JAMANeuro
This cohort study examines data for a large population-based cohort to identify and characterize any cases of primary Epstein-Barr virus infection that occurred after the onset of multiple sclerosis. jamanetwork.com/journals/jamaneurology/fullarticle/10.100…
-
JAMA Neurology
@JAMANeuro
This case report describes a 60-year-old woman presenting with sudden loss of muscle tone with preserved consciousness and severe daytime sleepiness.
jamanetwork.com/journals/jamaneurology/fullarticle/10.100… -
JAMA Neurology
@JAMANeuro
In #primaryprogressiveaphasia, automated #speechanalysis of a brief picture description task distinguished nonfluent, logopenic, and semantic variants and produced interpretable speech profiles.
jamanetwork.com/journals/jamaneurology/fullarticle/10.100… -
JAMA Neurology
@JAMANeuro
In #multiplesclerosis, higher serum glial fibrillary acidic protein was associated with greater risk of progression independent of relapse activity, while neurofilament light chain was more closely associated with relapse risk.
jamanetwork.com/journals/jamaneurology/fullarticle/10.100… -
JAMA Neurology
@JAMANeuro
In a RCT published in JAMA Neurology, stopping first-line disease-modifying therapy led to more inflammatory disease activity vs continuing treatment for patients with stable #multiplesclerosis (MS) for at least 5 years,
📖 Read the trial:
jamanetwork.com/journals/jamaneurology/fullarticle/10.100…This media couldn't be displayed. See it on the original post.
JAMA Neurology
@JAMANeuro
JAMA Neurology EIC S. Andrew Josephson, MD, selected this as his 2025 Editor's Choice: Clinical Trial of the Year for its important findings on relapse risk after discontinuing disease-modifying therapy in stable MS.
🔗 Read the Editorial: jamanetwork.com/journals/jamaneurology/fullarticle/10.100…
JAMA Neurology
@JAMANeuro
📌 How can clinicians and researchers stay up to date on the most clinically relevant trials?
Follow @JAMAplusTrials to get curated access to the best of the JAMA Network’s trial research, commentaries, and educational resources: jamanetwork.com/channels/trials?linkId=989020754 -
JAMA Neurology
@JAMANeuro
Patients with functional #neurological disorder exhibit frequent psychiatric and neurological comorbidities, worse functional outcomes, higher health care use, and increased mortality compared with multiple sclerosis.
jamanetwork.com/journals/jamaneurology/fullarticle/10.100… -
JAMA Neurology
@JAMANeuro
Interview with Kelly G. Gwathmey, MD, author of Efficacy and Safety of Gefurulimab in Generalized Myasthenia Gravis: The PREVAIL Phase 3 Randomized Clinical Trial. Hosted by Cynthia E. Armand, MD. edhub.ama-assn.org/jn-learning/audio-player/10.1001/jaman…
-
JAMA Neurology
@JAMANeuro
💬 Editorial: Road traffic noise may be a novel place-based risk factor for #parkinsondisease, adding to evidence linking environmental toxicants and pollution exposures to disease risk. jamanetwork.com/journals/jamaneurology/fullarticle/10.100…
-
JAMA Neurology
@JAMANeuro
Among residents exposed to higher traffic noise, a quieter residential side was associated with lower #parkinsondisease risk, suggesting a possible role for noise mitigation in housing and urban design. jamanetwork.com/journals/jamaneurology/fullarticle/10.100…
-
JAMA Neurology
@JAMANeuro
💬 Editorial: In anti–acetylcholine receptor antibody–positive generalized #myastheniagravis, gefurulimab improved activities of daily living and quantitative disease scores over 26 weeks.
jamanetwork.com/journals/jamaneurology/fullarticle/10.100… -
JAMA Neurology
@JAMANeuro
Gefurulimab, a complement component 5–blocking nanobody, provided early and sustained benefit in generalized #myastheniagravis and was well tolerated with once-weekly self-administered subcutaneous dosing. jamanetwork.com/journals/jamaneurology/fullarticle/10.100…
-
JAMA Neurology
@JAMANeuro
💬 Viewpoint: Medicolegal advocacy from neurologists can support patients with neurologic illness in securing rehabilitation, disability benefits, and housing stability, with implications for individual and population health. jamanetwork.com/journals/jamaneurology/fullarticle/10.100…
-
JAMA Neurology
@JAMANeuro
Limiting #parkinsondisease genetic testing to onset ≤50 years misses most carriers of pathogenic variants, including many eligible for gene-targeted therapies; broader, age-inclusive strategies may improve diagnostic yield.
jamanetwork.com/journals/jamaneurology/fullarticle/10.100… -
JAMA Neurology
@JAMANeuro
Patients with #functionalneurologicaldisorder exhibit frequent psychiatric and neurological comorbidities, worse functional outcomes, higher health care use, and increased mortality compared with multiple sclerosis. jamanetwork.com/journals/jamaneurology/fullarticle/10.100…
-
JAMA Neurology
@JAMANeuro
PET imaging in a patient with #mma and dystonia revealed reduced dopamine transporter binding, supporting dopaminergic system involvement and potential for targeted therapies. jamanetwork.com/journals/jamaneurology/fullarticle/10.100…
-
JAMA Neurology
@JAMANeuro
Abdominal clonus can occur in patients with thoracic spinal cord injury, expanding recognized patterns of upper motor neuron lesion-induced rhythmic contractions. jamanetwork.com/journals/jamaneurology/fullarticle/10.100…
-
JAMA Neurology
@JAMANeuro
Accelerometer-derived #sleepwakecycle metrics moderately improved dementia risk prediction in large cohort studies, performing similarly to genetic and plasma biomarkers. jamanetwork.com/journals/jamaneurology/fullarticle/10.100…
-
JAMA Neurology
@JAMANeuro
#dlb incidence and prevalence rise steeply with age and are higher in men, but diagnostic variability and underrecognition limit global estimates, highlighting the need for standardized, population-based assessment. jamanetwork.com/journals/jamaneurology/fullarticle/10.100…
-
JAMA Neurology
@JAMANeuro
Neurological teleconsultations in rural German #primarycare shifted referrals from ambulatory neurologists to other specialists and hospitals, but did not increase sole management within general practice. jamanetwork.com/journals/jamaneurology/fullarticle/10.100…
-
JAMA Neurology
@JAMANeuro
In patients with #postherpeticneuralgia, 4 weeks of electroacupuncture led to a greater reduction in pain severity and higher responder rates compared with sham, with effects persisting at 1 month. jamanetwork.com/journals/jamaneurology/fullarticle/10.100…
-
JAMA Neurology
@JAMANeuro
A plasma staging model using #emtbrtau243 and %p-tau217 demonstrated strong concordance with PET-based staging and clinical severity, supporting scalable, minimally invasive #alzheimerdisease stratification. jamanetwork.com/journals/jamaneurology/fullarticle/10.100…
-
JAMA Neurology
@JAMANeuro
Among patients with #tourettesyndrome, ecopipam maintained tic suppression and was well tolerated for up to 24 weeks, without clinically significant metabolic or movement disorder adverse effects. jamanetwork.com/journals/jamaneurology/fullarticle/10.100…
-
JAMA Neurology
@JAMANeuro
Among amateur soccer players, real-life heading was associated with acute increases in blood-based biomarkers p-tau217 and S100B, with dose-response relationships. These elevations normalized within 48 hours. jamanetwork.com/journals/jamaneurology/fullarticle/10.100…
-
JAMA Neurology
@JAMANeuro
Intra-arterial alteplase after successful thrombectomy for posterior circulation #ais was safe but did not improve 90-day functional outcomes or reduce mortality compared to thrombectomy alone.
jamanetwork.com/journals/jamaneurology/fullarticle/10.100… -
JAMA Neurology
@JAMANeuro
#dementia prevalence increased over 2 decades in Mexico, Peru, and Puerto Rico, while rates remained stable in Cuba and the Dominican Republic, indicating an uneven and rising burden compared with high-income countries.
jamanetwork.com/journals/jamaneurology/fullarticle/10.100… -
JAMA Neurology reposted
NM Neurology
@NMNeurology
New in @JAMANeuro: Patients with new onset refractory status epilepticus showed substantially elevated neurofilament light chain levels, reflecting acute neuroaxonal injury early in the disease course.
Co authored by Elizabeth E. Gerard, MD (@EEG_MD).
Read the publication: jamanetwork.com/journals/jamaneurology/article-abstract/2…
#neurology #jamaneurology #statusepilepticus #neurocriticalcare #norse -
JAMA Neurology reposted
AMA Ed Hub™
@AMAEdHub
Do these symptoms suggest adult-onset Alexander disease? A 61-year-old man presented with chronic progressive weakness, gait dysfunction, impaired short-term recall and spastic dysarthria. Give your diagnosis on this @JAMANeuro Clinical Challenge. #cme amaedhub.org/4wdmbp5
-
JAMA Neurology reposted
Divyanshu Dubey
@Div_Dubey
In this @JAMANeuro Viewpoint, we discuss why continued autoantibody discovery matters. Today's seronegative patient may become tomorrow's newly recognized disease. Discovery advances diagnosis, reveals disease mechanisms & guides targeted therapies.
jamanetwork.com/journals/jamaneurology/fullarticle/2850849 -
JAMA Neurology reposted
Medical Xpress
@medical_xpress
A full soccer concussion check was completed in 2 minutes 52 seconds on the pitch, using a new protocol that rules out concussion during matches but still requires substitution after a single warning sign. @jamaneuro medicalxpress.com/news/2026-07-soccer-concussion-protocol…
-
JAMA Neurology reposted
Andreu Vilaseca
@andreuvilaseca7
Big step forward for #mogad treatment!🚨
Our multicenter @JAMANeuro study shows that IL-6 receptor blockade (90% in Tocilizumab) markedly reduces relapses, achieving relapse-free outcomes comparable to high-dose IVIG (≥1g/kg/month).
If satralizumab gains approval for MOGAD, these data support #tocilizumab as a widely available, lower-cost option thanks to biosimilars!
A great example of collaboration across the Americas🌎
#neurology #mog #neurotwitter -
JAMA Neurology reposted
Michael Okun
@MichaelOkun
Are you checking out all the ‘heading’ of the ball in the World Cup? What happens to p-tau after a header? What is p-tau217? p-tau217 is a blood biomarker linked to the tau protein, which plays an important role in brain cells. It has attracted attention because it can reflect brain injury and is also being studied in neurodegenerative diseases such as Alzheimer's disease. Hoppen and colleagues describe in a new paper in JAMA Neurology how heading a soccer ball during real-world amateur matches was associated w/ short-term increases in blood biomarkers linked to neural injury.
Key points:
- Amateur soccer players who headed the ball showed greater immediate increases in the blood biomarker S100B compared to players who did not head the ball.
- More headers, and especially high-impact headers, were associated w/ greater increases in both p-tau217 and S100B, suggesting a dose-response relationship.
- These biomarker elevations returned to baseline within 24 to 48 hours, however the long-term implications remain unknown.
My take: This is an important study because it moves the discussion beyond speculation. The investigators carefully accounted for the effects of exercise itself and still observed measurable changes in blood biomarkers after real-world soccer heading. That does not mean that every header causes permanent brain damage or that soccer is unsafe. It does mean that repetitive heading leaves a measurable biological fingerprint that deserves further study. The biggest unanswered question is whether these temporary changes accumulate over years and contribute to later neurodegeneration. We simply do not know yet. Studies like this help us ask better questions, identify who may be at greatest risk, and hopefully develop smarter strategies that preserve both the joy of the game and long-term brain health.
Here are 5 points that resonated w/ me:
1- Repetitive heading appears capable of producing measurable short-term biological changes in the brain, even during amateur competition.
2- The number and force of headers matter. This study supports the idea that cumulative exposure is important.
3- Blood biomarkers such as p-tau217 may become useful tools for studying brain health in athletes, though they are not ready for routine clinical decision making.
4- Temporary normalization of a blood test does not necessarily mean the brain has completely recovered. More research is needed to understand repeated exposures.
5- The future should focus on making sports safer through better science, smarter coaching, improved techniques and thoughtful policies that protect athletes while preserving the many benefits of participation.
jamanetwork.com/journals/jamaneurology/fullarticle/2849324 -
JAMA Neurology reposted
JAMA
@JAMA_current
🧵#aaic26 attendees, check out these findings from JAMA, @JAMANeuro, and @JAMANetworkOpen:
This clinicopathologic case report examined a patient with #alzheimer disease and a p.R47H TREM2 variant who received long-term #aducanumab therapy.
Postmortem analysis revealed that brain regions with extensive #amyloid clearance, particularly in gyral crests, displayed less #tau #pathology and slower atrophy on serial #mri compared with regions where amyloid persisted.
In contrast, regions with persistent amyloid, mostly in sulcal depths and deep cortical layers, showed typical tau burden and #neurodegeneration.
🔗 jamanetwork.com/journals/jama/fullarticle/10.1001/jama.20… -
JAMA Neurology
@JAMANeuro
🔖 #aaic attendees, save this for your citations:
Among patients with #cognitive symptoms examined in primary and secondary care, #plasma-based blood #biomarkers demonstrated high #diagnostic accuracy (88%-92%) for detecting #alzheimerdisease pathology. jamanetwork.com/journals/jama/fullarticle/10.1001/jama.20…
JAMA Neurology
@JAMANeuro
Both APS2 and percentage of p-tau217 alone outperformed standard #clinical assessments by physicians in identifying #alzheimer disease, providing reliable diagnostic information even in the presence of significant medical comorbidities.
🔗 Cite this: jamanetwork.com/journals/jama/fullarticle/10.1001/jama.20… -
JAMA Neurology
@JAMANeuro
From @JAMA_current: Among cognitively unimpaired older adults, very high plasma #ptau217 levels were associated with a 38% risk of progression to #cognitiveimpairment within five years.
#aaic26
jamanetwork.com/journals/jama/fullarticle/10.1001/jama.20… -
JAMA Neurology
@JAMANeuro
📚 Check out all the papers presented at #aaic26 from JAMA, JAMA Neurology, and JAMA Network Open, plus additional #alzheimer disease research just published in JAMA.
jamanetwork.com/pages/conferences-aaic?linkId=978673282 -
JAMA Neurology
@JAMANeuro
#pureautonomicfailure carries an annual phenoconversion rate of 5% to central a-synucleinopathies including #parkinsondisease, #msa, and #dlb; subtle motor signs and REM sleep behavior disorder consistently predict conversion risk. jamanetwork.com/journals/jamaneurology/fullarticle/10.100…
-
JAMA Neurology
@JAMANeuro
📑 JAMA Neurology #review: Neurological manifestations of #hantavirus infection include encephalopathy, pituitary apoplexy, hemorrhage, and neuropathy; most are secondary to systemic illness but can be severe. jamanetwork.com/journals/jamaneurology/fullarticle/10.100…
-
JAMA Neurology
@JAMANeuro
💬 Editorial: #pureautonomicfailure is firmly established as prodromal for central a-synucleinopathies, with mild motor signs, REM sleep behavior disorder, and bladder symptoms reliably predicting conversion to #parkinsondisease, #msa, or #dlb. jamanetwork.com/journals/jamaneurology/fullarticle/10.100…
-
JAMA Neurology
@JAMANeuro
IL-6 receptor blockade was associated with low relapse rates and a favorable safety profile in #mogad, performing better than low-dose #ivig and comparably to higher-dose IVIG regimens.
jamanetwork.com/journals/jamaneurology/fullarticle/10.100… -
JAMA Neurology
@JAMANeuro
📑 JAMA Neurology #review: Gene delivery platforms for #glioblastoma include viral vectors, lipid nanoparticles, and nanocarriers, with oncolytic HSV gaining approval and new nonviral approaches entering early clinical trials in #neurooncology.
jamanetwork.com/journals/jamaneurology/fullarticle/10.100… -
JAMA Neurology
@JAMANeuro
Presented today at #aaic26:
#dementia prevalence increased over 2 decades in Mexico, Peru, and Puerto Rico, while rates remained stable in Cuba and the Dominican Republic, indicating an uneven and rising burden compared with high-income countries.
jamanetwork.com/journals/jamaneurology/fullarticle/10.100… -
JAMA Neurology
@JAMANeuro
Presented at #aaic26 from @JAMA_current:
#amyloid clearance was most efficient in gyral crests, not sulcal depths, and correlated locally with reduced #tau #pathology and #neurodegeneration after aducanumab therapy in #alzheimerdisease.
jamanetwork.com/journals/jama/fullarticle/10.1001/jama.20… -
JAMA Neurology
@JAMANeuro
In autopsy tissue from patients with #sod1als, intrathecal tofersen achieved predicted central nervous system distribution and substantially reduced SOD1 protein levels in somatic motor system tissues.
jamanetwork.com/journals/jamaneurology/fullarticle/10.100… -
JAMA Neurology
@JAMANeuro
This case report describes a 71-year-old woman presenting with altered speech, gait difficulties, and hearing loss diagnosed with infratentorial superficial siderosis and a thoracic spinal cord cleft.
jamanetwork.com/journals/jamaneurology/fullarticle/10.100… -
JAMA Neurology
@JAMANeuro
Among veterans with prior #traumaticbraininjury, the plasma p-tau217/Aβ42 blood test for #alzheimerdisease missed over half of brain amyloid-positive cases, indicating reduced diagnostic accuracy in this population.
jamanetwork.com/journals/jamaneurology/fullarticle/10.100… -
JAMA Neurology
@JAMANeuro
An international consensus process established a football-specific standardized on-pitch concussion assessment protocol (#focus) to address the need for rapid, evidence-informed evaluation of suspected concussion during match play.
jamanetwork.com/journals/jamaneurology/fullarticle/285104…
JAMA Neurology
@JAMANeuro
FOCUS comprises 45 items across 11 domains, including player history, mechanism of #injury, level of consciousness, #cervical #spine assessment, symptoms, orientation, balance, proprioception, #oculomotor function, and activity-based assessment.
jamanetwork.com/journals/jamaneurology/fullarticle/285104… -
JAMA Neurology
@JAMANeuro
Among patients with familial or sporadic #frontotemporal #dementia, cerebrospinal fluid TMEM106B levels were lower with greater disease severity, progression, smaller brain volumes, and in carriers of the protective rs1990622 genotype.
jamanetwork.com/journals/jamaneurology/fullarticle/10.100… -
JAMA Neurology
@JAMANeuro
Among patients with familial or sporadic #frontotemporaldementia, cerebrospinal fluid TMEM106B levels were lower with greater disease severity, progression, smaller brain volumes, and in carriers of the protective rs1990622 genotype.
jamanetwork.com/journals/jamaneurology/fullarticle/10.100… -
JAMA Neurology
@JAMANeuro
Among patients with familial or sporadic #frontotemporal #dementia, cerebrospinal fluid TMEM106B levels were lower with greater disease severity, progression, smaller brain volumes, and in carriers of the protective rs1990622 genotype.
jamanetwork.com/journals/jamaneurology/fullarticle/10.100… -
JAMA Neurology
@JAMANeuro
A patient with isolated peripheral nerve vasculitis developed reversible bilateral hypoglossal palsy and tongue atrophy, with resolution of bulbar symptoms following immunosuppressive therapy and reinnervation, a rare neurological outcome.
jamanetwork.com/journals/jamaneurology/fullarticle/10.100… -
JAMA Neurology
@JAMANeuro
💬 Perspective from JAMA: Monoclonal antibodies for #alzheimerdisease clear brain amyloid-β and modestly slow cognitive decline in early stages, supporting a causal role but with clinically limited impact and risk for imaging abnormalities.
jamanetwork.com/journals/jama/fullarticle/10.1001/jama.20… -
JAMA Neurology
@JAMANeuro
Among patients with familial or sporadic #frontotemporaldementia, cerebrospinal fluid TMEM106B levels were lower with greater disease severity, progression, smaller brain volumes, and in carriers of the protective rs1990622 genotype.
jamanetwork.com/journals/jamaneurology/fullarticle/10.100… -
JAMA Neurology
@JAMANeuro
Machine learning analysis of patient-clinician conversations identified cognitive impairment with sensitivity 68% and specificity 64%, supporting passive speech-based screening in routine #primarycare.
jamanetwork.com/journals/jamaneurology/fullarticle/10.100… -
JAMA Neurology
@JAMANeuro
Machine learning analysis of patient-clinician conversations identified cognitive impairment with sensitivity 68% and specificity 64%, supporting passive speech-based screening in routine #primarycare.
jamanetwork.com/journals/jamaneurology/fullarticle/10.100… -
JAMA Neurology
@JAMANeuro
💬 Editorial: Routine clinical conversations in #primarycare contain acoustic signals that machine learning models can use for passive cognitive impairment screening, but risks and potential biases must be evaluated before clinical adoption.
jamanetwork.com/journals/jamaneurology/fullarticle/10.100… -
JAMA Neurology
@JAMANeuro
Among adult #ebola survivors, neurological symptoms such as memory loss, headaches, and depression remained common even 7 years post-infection, although most improved over time.
jamanetwork.com/journals/jamaneurology/fullarticle/10.100… -
JAMA Neurology
@JAMANeuro
IL-6 receptor blockers provided favorable recovery and visual improvement after acute attacks in #mogad and #aqp4nmosd, but controlled trials are needed to determine effects on long-term disability. jamanetwork.com/journals/jamaneurology/fullarticle/10.100…
-
JAMA Neurology
@JAMANeuro
Machine learning analysis of patient-clinician conversations identified cognitive impairment with sensitivity 68% and specificity 64%, supporting passive speech-based screening in routine #primarycare.
jamanetwork.com/journals/jamaneurology/fullarticle/10.100… -
JAMA Neurology
@JAMANeuro
Pressure-induced paroxysmal dystonia was diagnosed using clinical observation and video EEG, with symptoms abolished by low-dose clonazepam. Brief episodes and sensorimotor hypersensitivity distinguished it from other #movementdisorders.
jamanetwork.com/journals/jamaneurology/fullarticle/10.100… -
JAMA Neurology
@JAMANeuro
Machine learning analysis of patient-clinician conversations identified cognitive impairment with sensitivity 68% and specificity 64%, supporting passive speech-based screening in routine #primarycare.
jamanetwork.com/journals/jamaneurology/fullarticle/10.100… -
JAMA Neurology
@JAMANeuro
Among adult #ebola survivors, neurological symptoms such as memory loss, headaches, and depression remained common even 7 years post-infection, although most improved over time.
jamanetwork.com/journals/jamaneurology/fullarticle/10.100… -
JAMA Neurology
@JAMANeuro
Cynthia Armand, MD, spoke with Joseph Colonel, PhD, of the Icahn School of Medicine at Mount Sinai, about a study applying acoustic analysis and machine learning to audio recordings of routine primary care encounters among older adults.
🎧 Listen now: edhub.ama-assn.org/jn-learning/audio-player/19071335?link… -
JAMA Neurology
@JAMANeuro
Randomized clinical trial indicates middle meningeal artery embolization with n-butyl cyanoacrylate plus standard care reduced #subduralhematoma recurrence and need for surgery vs standard care alone, with comparable safety profile.
jamanetwork.com/journals/jamaneurology/fullarticle/10.100… -
JAMA Neurology
@JAMANeuro
Integrating genetic and pathological data increased diagnostic accuracy and identified ancestry-related differences in #parkinsondisease, supporting biologically informed diagnostic tools and future pathology-targeted therapeutic trials. jamanetwork.com/journals/jamaneurology/fullarticle/10.100…
-
JAMA Neurology
@JAMANeuro
Among adult #ebola survivors, neurological symptoms such as memory loss, headaches, and depression remained common even 7 years post-infection, although most improved over time.
jamanetwork.com/journals/jamaneurology/fullarticle/10.100… -
JAMA Neurology
@JAMANeuro
Integrating genetic and pathological data increased diagnostic accuracy and identified ancestry-related differences in #parkinsondisease, supporting biologically informed diagnostic tools and future pathology-targeted therapeutic trials. jamanetwork.com/journals/jamaneurology/fullarticle/10.100…
-
JAMA Neurology
@JAMANeuro
Among adult #ebola survivors, neurological symptoms such as memory loss, headaches, and depression remained common even 7 years post-infection, although most improved over time.
jamanetwork.com/journals/jamaneurology/fullarticle/10.100… -
JAMA Neurology
@JAMANeuro
Self-reported seizure durations in a large outpatient sample were often longer than laboratory-recorded values, with 90% of seizures lasting ≤4 minutes and substantial variation by seizure type and age group in #epilepsy. jamanetwork.com/journals/jamaneurology/fullarticle/10.100…
-
JAMA Neurology
@JAMANeuro
Integrating genetic and pathological data increased diagnostic accuracy and identified ancestry-related differences in #parkinsondisease, supporting biologically informed diagnostic tools and future pathology-targeted therapeutic trials.
jamanetwork.com/journals/jamaneurology/fullarticle/10.100… -
JAMA Neurology
@JAMANeuro
A reperfusion-guided systolic blood pressure strategy improved functional outcomes and reduced hemorrhagic transformation for patients with acute #stroke after endovascular therapy compared with guideline-recommended management. jamanetwork.com/journals/jamaneurology/fullarticle/10.100…
-
JAMA Neurology
@JAMANeuro
Among patients with acute ischemic #stroke due to large-vessel occlusion, standard-dose tenecteplase resulted in greater early reperfusion vs low-dose #alteplase, with comparable functional and safety outcomes.
jamanetwork.com/journals/jamaneurology/fullarticle/10.100… -
JAMA Neurology
@JAMANeuro
Integrating genetic and pathological data increased diagnostic accuracy and identified ancestry-related differences in #parkinsondisease, supporting biologically informed diagnostic tools and future pathology-targeted therapeutic trials. jamanetwork.com/journals/jamaneurology/fullarticle/10.100…
-
JAMA Neurology
@JAMANeuro
Performance of the FDA-cleared Lumipulse plasma #biomarker for amyloid pathology detection in #alzheimerdisease varied by site and reagent lots, highlighting need for local assay verification and ongoing quality control.
jamanetwork.com/journals/jamaneurology/fullarticle/10.100… -
JAMA Neurology
@JAMANeuro
An unusual congenital fusion of the left and right oculomotor nerves was identified in a child with complex #strabismus and ptosis, demonstrating a rare variant of cranial nerve dysgenesis on neuroimaging.
jamanetwork.com/journals/jamaneurology/fullarticle/10.100… -
JAMA Neurology
@JAMANeuro
A patient with cavin-4 IgG-positive immune-mediated rippling muscle disease achieved complete clinical and serological remission following B-cell-targeted therapy with rituximab. jamanetwork.com/journals/jamaneurology/fullarticle/10.100…
-
JAMA Neurology
@JAMANeuro
Peripheral neuropathy involves nerve damage that can cause numbness, tingling, pain, and mild muscle weakness in the legs and, sometimes, the arms.
📄 Learn more in this JAMA Patient Page.
jamanetwork.com/journals/jama/fullarticle/10.1001/jama.20… -
JAMA Neurology
@JAMANeuro
Among patients with acute ischemic #stroke due to large-vessel occlusion, standard-dose tenecteplase resulted in greater early reperfusion vs low-dose #alteplase, with comparable functional and safety outcomes.
jamanetwork.com/journals/jamaneurology/fullarticle/10.100… -
JAMA Neurology
@JAMANeuro
A plasma staging model using #emtbrtau243 and %p-tau217 demonstrated strong concordance with PET-based staging and clinical severity, supporting scalable, minimally invasive #alzheimerdisease stratification.
jamanetwork.com/journals/jamaneurology/fullarticle/10.100… -
JAMA Neurology
@JAMANeuro
An unusual congenital fusion of the left and right oculomotor nerves was identified in a child with complex #strabismus and ptosis, demonstrating a rare variant of cranial nerve dysgenesis on neuroimaging. jamanetwork.com/journals/jamaneurology/fullarticle/10.100…
-
JAMA Neurology
@JAMANeuro
Neurological teleconsultations in rural German #primarycare shifted referrals from ambulatory neurologists to other specialists and hospitals, but did not increase sole management within general practice. jamanetwork.com/journals/jamaneurology/fullarticle/10.100…
-
JAMA Neurology
@JAMANeuro
In patients with #postherpeticneuralgia, 4 weeks of electroacupuncture led to a greater reduction in pain severity and higher responder rates compared with sham, with effects persisting at 1 month. jamanetwork.com/journals/jamaneurology/fullarticle/10.100…
-
JAMA Neurology
@JAMANeuro
Among patients with multiple sclerosis treated long-term with ocrelizumab, interstitial lung disease developed after a mean of 10.5 years, mainly as organizing pneumonia with variable outcomes; prompt recognition and corticosteroid treatment are important. jamanetwork.com/journals/jamaneurology/fullarticle/10.100…
-
JAMA Neurology
@JAMANeuro
Among patients with #tourettesyndrome, ecopipam maintained tic suppression and was well tolerated for up to 24 weeks, without clinically significant metabolic or movement disorder adverse effects. jamanetwork.com/journals/jamaneurology/fullarticle/10.100…
-
JAMA Neurology
@JAMANeuro
Among adult patients with #mogad, discontinuation of oral immunosuppressants or rituximab was associated with a low 1-year relapse risk, especially after ≥1 year of treatment and ≥2 years since last relapse. jamanetwork.com/journals/jamaneurology/fullarticle/10.100…
-
JAMA Neurology
@JAMANeuro
A plasma staging model using #emtbrtau243 and %p-tau217 demonstrated strong concordance with PET-based staging and clinical severity, supporting scalable, minimally invasive #alzheimerdisease stratification. jamanetwork.com/journals/jamaneurology/fullarticle/10.100…
-
JAMA Neurology
@JAMANeuro
#multiplesclerosis prevalence in England more than doubled in 30 years as survival improved, but abnormal weight, tobacco use, and deprivation gradients persisted and were associated with increased mortality risk. jamanetwork.com/journals/jamaneurology/fullarticle/10.100…
-
JAMA Neurology
@JAMANeuro
Among patients undergoing endovascular #thrombectomy for acute #stroke, early (<6 hours) vs delayed (6–12 hours) extubation did not improve 90-day functional independence, hospital stay, complication rates, or mortality. jamanetwork.com/journals/jamaneurology/fullarticle/10.100…
-
JAMA Neurology
@JAMANeuro
Delayed onset of hemichorea and dystonia can occur after cortical temporal #stroke, even when imaging reveals small acute ischemic lesions and routine blood tests are normal.
jamanetwork.com/journals/jamaneurology/fullarticle/10.100… -
JAMA Neurology
@JAMANeuro
Among amateur soccer players, real-life heading was associated with acute increases in blood-based biomarkers p-tau217 and S100B, with dose-response relationships. These elevations normalized within 48 hours.
jamanetwork.com/journals/jamaneurology/fullarticle/10.100… -
JAMA Neurology
@JAMANeuro
This case report describes a patient with left-sided weakness following transient ischemic attacks who underwent external carotid angioplasty based on findings from ultrahigh-resolution photon-counting computed tomographic angiography (CTA). jamanetwork.com/journals/jamaneurology/fullarticle/10.100…
-
JAMA Neurology
@JAMANeuro
PrimeC demonstrated comparable safety to placebo and showed slowed functional decline, reduced ALS-related complications, and modulation of iron-regulatory and microRNA biomarkers in adults with #als over 18 months of treatment. jamanetwork.com/journals/jamaneurology/fullarticle/10.100…
-
JAMA Neurology
@JAMANeuro
Among amateur soccer players, real-life heading was associated with acute increases in blood-based biomarkers p-tau217 and S100B, with dose-response relationships. These elevations normalized within 48 hours.
jamanetwork.com/journals/jamaneurology/fullarticle/10.100… -
JAMA Neurology
@JAMANeuro
Editorial: Current evidence supports iatrogenic transmission of cerebral amyloid angiopathy but not #alzheimerdisease; a definitive causal link between contaminated growth hormone exposure and AD remains speculative. jamanetwork.com/journals/jamaneurology/fullarticle/10.100…
-
JAMA Neurology
@JAMANeuro
Quantile aggregation may artificially inflate amyloid-cognition associations in #alzheimerdisease trials, highlighting need for causally interpretable methods when assessing surrogate endpoints. jamanetwork.com/journals/jamaneurology/fullarticle/10.100…
-
JAMA Neurology
@JAMANeuro
Persistently high Epstein-Barr nuclear antigen 1 antibody titers distinguished #multiplesclerosis from #mogad and #nmosd, supporting use as a noninvasive diagnostic biomarker. jamanetwork.com/journals/jamaneurology/fullarticle/10.100…
-
JAMA Neurology
@JAMANeuro
Playing or singing music reliably relieved benign essential #blepharospasm in a professional oboist, while nonmusical mimics did not, demonstrating a complex sensory trick. jamanetwork.com/journals/jamaneurology/fullarticle/10.100…
-
JAMA Neurology
@JAMANeuro
Among amateur soccer players, real-life heading was associated with acute increases in blood-based biomarkers p-tau217 and S100B, with dose-response relationships. These elevations normalized within 48 hours.
jamanetwork.com/journals/jamaneurology/fullarticle/10.100… -
JAMA Neurology
@JAMANeuro
Editorial: In a randomized trial, aerobic exercise and intensive vascular risk reduction for older adults at risk of dementia led to only modest cognitive improvement, with no significant group differences in global cognitive function. jamanetwork.com/journals/jamaneurology/fullarticle/10.100…
-
JAMA Neurology
@JAMANeuro
Accelerometer-derived #sleepwakecycle metrics moderately improved dementia risk prediction in large cohort studies, performing similarly to genetic and plasma biomarkers. jamanetwork.com/journals/jamaneurology/fullarticle/10.100…
-
JAMA Neurology
@JAMANeuro
Among adults with early #parkinsondisease, fixed-dose tavapadon (5 or 15 mg once daily) improved motor function over 26 weeks versus placebo, with most adverse events mild or moderate in severity. jamanetwork.com/journals/jamaneurology/fullarticle/10.100…
-
JAMA Neurology
@JAMANeuro
Among amateur soccer players, real-life heading was associated with acute increases in blood-based biomarkers p-tau217 and S100B, with dose-response relationships. These elevations normalized within 48 hours.
jamanetwork.com/journals/jamaneurology/fullarticle/10.100… -
JAMA Neurology
@JAMANeuro
In adults with #parkinsondisease experiencing motor fluctuations on levodopa, adjunctive tavapadon increased daily good-on-time and decreased daily off-time compared to placebo, with a favorable safety profile. jamanetwork.com/journals/jamaneurology/fullarticle/10.100…
-
JAMA Neurology
@JAMANeuro
In 2025, JAMA Neurology saw a >15% increase in submissions, an Impact Factor of 21.4, >11.3 million article views/downloads, and >5,800 media mentions. Read the full “JAMA Neurology Year in Review, 2025,” by S. Andrew Josephson, MD.
jamanetwork.com/journals/jamaneurology/fullarticle/10.100… -
JAMA Neurology
@JAMANeuro
Limiting #parkinsondisease genetic testing to onset ≤50 years misses most carriers of pathogenic variants, including many eligible for gene-targeted therapies; broader, age-inclusive strategies may improve diagnostic yield. jamanetwork.com/journals/jamaneurology/fullarticle/10.100…
-
JAMA Neurology
@JAMANeuro
This case report describes a patient with a back-and-forth interhemispheric migration along a bullet’s own trajectory.
jamanetwork.com/journals/jamaneurology/fullarticle/10.100… -
JAMA Neurology
@JAMANeuro
Patients treated with cadaveric pituitary-derived human growth hormone contaminated with amyloid-β developed early-onset #alzheimerdisease with prominent language deficits and histopathological features consistent with AD. jamanetwork.com/journals/jamaneurology/fullarticle/10.100…
-
JAMA Neurology
@JAMANeuro
Delayed onset of hemichorea and dystonia can occur after cortical temporal #stroke, even when imaging reveals small acute ischemic lesions and routine blood tests are normal.
jamanetwork.com/journals/jamaneurology/fullarticle/10.100… -
JAMA Neurology
@JAMANeuro
Aerobic exercise, intensive blood pressure and cholesterol reduction, or both did not show differences in cognitive function improvement over 24 months among older adults with family history of dementia or subjective cognitive decline. jamanetwork.com/journals/jamaneurology/fullarticle/10.100…
-
JAMA Neurology
@JAMANeuro
Limiting #parkinsondisease genetic testing to onset ≤50 years misses most carriers of pathogenic variants, including many eligible for gene-targeted therapies; broader, age-inclusive strategies may improve diagnostic yield. jamanetwork.com/journals/jamaneurology/fullarticle/10.100…
-
JAMA Neurology
@JAMANeuro
Patients with #functionalneurologicaldisorder exhibit frequent psychiatric and neurological comorbidities, worse functional outcomes, higher health care use, and increased mortality compared with multiple sclerosis. jamanetwork.com/journals/jamaneurology/fullarticle/10.100…
-
JAMA Neurology
@JAMANeuro
#dlb incidence and prevalence rise steeply with age and are higher in men, but diagnostic variability and underrecognition limit global estimates, highlighting the need for standardized, population-based assessment. jamanetwork.com/journals/jamaneurology/fullarticle/10.100…
-
JAMA Neurology
@JAMANeuro
From JAMA: Amyotrophic lateral sclerosis (#als) is an adult-onset neurodegenerative disorder characterized by progressive muscle weakness due to degeneration of upper motor neurons in the brain and lower motor neurons in the brainstem and spinal cord.
jamanetwork.com/journals/jama/fullarticle/10.1001/jama.20… -
JAMA Neurology
@JAMANeuro
Among infants with genetic #epilepsy, 16% had variants amenable to #antisenseoligonucleotide therapies; most could be considered for precision treatment currently or at seizure onset. jamanetwork.com/journals/jamaneurology/fullarticle/10.100…
-
JAMA Neurology
@JAMANeuro
Delayed onset of hemichorea and dystonia can occur after cortical temporal #stroke, even when imaging reveals small acute ischemic lesions and routine blood tests are normal.
jamanetwork.com/journals/jamaneurology/fullarticle/10.100… -
JAMA Neurology
@JAMANeuro
#pureautonomicfailure carries an annual phenoconversion rate of 5% to central a-synucleinopathies including #parkinsondisease, #msa, and #dlb; subtle motor signs and REM sleep behavior disorder consistently predict conversion risk. jamanetwork.com/journals/jamaneurology/fullarticle/10.100…
-
JAMA Neurology
@JAMANeuro
📊 JAMA Research Summary: In acute #ischemicstroke without large or medium vessel occlusion, adjunctive #tirofiban after poor tenecteplase response increased excellent 90-day outcomes without excess bleeding or mortality.
#esoc2026 @ESOstroke
jamanetwork.com/journals/jama/fullarticle/10.1001/jama.20… -
JAMA Neurology
@JAMANeuro
From @JAMA_current: Among adults with acute #ischemic #stroke treated 4.5 to 24 hours after onset, intravenous #tenecteplase prior to EVT did not increase functional independence or reduce disability compared with EVT alone.
#esoc2026 @ESOstroke
jamanetwork.com/journals/jama/fullarticle/10.1001/jama.20… -
JAMA Neurology
@JAMANeuro
Phenoconversion in #pureautonomicfailure is associated with risk for progression to #multiplesystematrophy, #parkinsondisease, or #lewybodydementia.
🎧 Learn more in this podcast episode: edhub.ama-assn.org/jn-learning/audio-player/19059948?link… -
JAMA Neurology
@JAMANeuro
#pureautonomicfailure carries an annual phenoconversion rate of 5% to central a-synucleinopathies including #parkinsondisease, #msa, and #dlb; subtle motor signs and REM sleep behavior disorder consistently predict conversion risk. jamanetwork.com/journals/jamaneurology/fullarticle/10.100…
-
JAMA Neurology
@JAMANeuro
Among infants with genetic #epilepsy, 16% had variants amenable to #antisenseoligonucleotide therapies; most could be considered for precision treatment currently or at seizure onset. jamanetwork.com/journals/jamaneurology/fullarticle/10.100…
-
JAMA Neurology
@JAMANeuro
Delayed onset of hemichorea and dystonia can occur after cortical temporal #stroke, even when imaging reveals small acute ischemic lesions and routine blood tests are normal. jamanetwork.com/journals/jamaneurology/fullarticle/10.100…
-
JAMA Neurology
@JAMANeuro
Among patients younger than 55 years, recurrent #stroke rates declined prior to 2000 but have remained stable since, indicating that further reductions in stroke recurrence may require new preventive strategies. jamanetwork.com/journals/jamaneurology/fullarticle/10.100…
-
JAMA Neurology
@JAMANeuro
💬 Editorial: #pureautonomicfailure is firmly established as prodromal for central a-synucleinopathies, with mild motor signs, REM sleep behavior disorder, and bladder symptoms reliably predicting conversion to #parkinsondisease, #msa, or #dlb. jamanetwork.com/journals/jamaneurology/fullarticle/10.100…
-
JAMA Neurology
@JAMANeuro
#pureautonomicfailure carries an annual phenoconversion rate of 5% to central a-synucleinopathies including #parkinsondisease, #msa, and #dlb; subtle motor signs and REM sleep behavior disorder consistently predict conversion risk. jamanetwork.com/journals/jamaneurology/fullarticle/10.100…
-
JAMA Neurology
@JAMANeuro
Among patients younger than 55 years, recurrent #stroke rates declined prior to 2000 but have remained stable since, indicating that further reductions in stroke recurrence may require new preventive strategies. jamanetwork.com/journals/jamaneurology/fullarticle/10.100…
-
JAMA Neurology
@JAMANeuro
Vemircopan, an oral selective factor D inhibitor, did not demonstrate greater efficacy than placebo for #myastheniagravis symptom improvement over 8 weeks; most adverse events were mild or moderate and did not differ from placebo. jamanetwork.com/journals/jamaneurology/fullarticle/10.100…
-
JAMA Neurology
@JAMANeuro
In a nationwide cohort, adults with a first-time seizure had a markedly increased risk of both neurological and nonneurological #cancer within 1 year, with slightly higher long-term risk, supporting broader diagnostic assessment in select patients. jamanetwork.com/journals/jamaneurology/fullarticle/10.100…
-
JAMA Neurology
@JAMANeuro
In cryptogenic new-onset refractory status epilepticus, serum #neurofilamentlightchain levels indicated greater and faster neuronal injury than in etiology-defined status epilepticus or chronic #epilepsy. jamanetwork.com/journals/jamaneurology/fullarticle/10.100…
-
JAMA Neurology
@JAMANeuro
In #alzheimerdisease risk, a high-intensity multidomain lifestyle intervention did not alter brain biomarker trajectories, but older adults with lower baseline hippocampal volume derived greater cognitive benefit from structured intervention. jamanetwork.com/journals/jamaneurology/fullarticle/10.100…
-
JAMA Neurology
@JAMANeuro
This case report describes a 73-year-old man with a type B aortic dissection and quadriplegia. jamanetwork.com/journals/jamaneurology/fullarticle/10.100…
-
JAMA Neurology
@JAMANeuro
This case report discusses a patient with vertebral pseudoaneurysm that spontaneously ruptured and led to vertebro-vertebral arteriovenous fistula requiring endovascular therapy. jamanetwork.com/journals/jamaneurology/fullarticle/10.100…
-
JAMA Neurology
@JAMANeuro
Female sex, APOE ε4 allele, race, and African ancestry were jointly associated with amyloid pathology severity, supporting the need for sex- and ancestry-informed approaches in #alzheimerdisease biomarker thresholds and clinical trial design. jamanetwork.com/journals/jamaneurology/fullarticle/10.100…
-
JAMA Neurology
@JAMANeuro
Greater adherence to the #dash diet, plant-based dietary patterns, or diets with lower hyperinsulinemia and inflammation was associated with lower risk of subjective cognitive decline and better cognitive function in adults. jamanetwork.com/journals/jamaneurology/fullarticle/10.100…
-
JAMA Neurology
@JAMANeuro
In an exploratory analysis of the ARCADIA randomized clinical trial, hypertension with high‑risk features was associated with modification of antithrombotic treatment effects after cryptogenic stroke. jamanetwork.com/journals/jamaneurology/fullarticle/10.100…
-
JAMA Neurology
@JAMANeuro
In preclinical #alzheimerdisease, women exhibited higher plasma phosphorylated tau 217 at greater amyloid-β burden and faster tau accumulation and cognitive decline compared with men. jamanetwork.com/journals/jamaneurology/fullarticle/10.100…
-
JAMA Neurology
@JAMANeuro
📚Thinking about submitting your #aan2026 research to the JAMA Network?
🎥This video walks you through the submission & review process:
www.youtube.com/watch?linkId=931286042&v=YQhpKdSfc_g -
JAMA Neurology
@JAMANeuro
Attending #aan2026?
📖 Digital Detection of Dementia in Primary Care — a Randomized Clinical Trial from @JAMANetworkOpen
🔓 It’s free to read online
jamanetwork.com/pages/conferences-aan?linkId=931285844 -
JAMA Neurology
@JAMANeuro
🎉Final day of exhibits at #aan2026
📍Stop by booth 1927
📚Grab articles for your trip home
✨Ask about submitting your meeting research to the JAMA Network -
JAMA Neurology
@JAMANeuro
Among adults with newly diagnosed focal #epilepsy, suicidality at diagnosis was associated with more than double the risk of future drug resistance vs mood or anxiety disorders alone.
jamanetwork.com/journals/jamaneurology/fullarticle/10.100… -
JAMA Neurology
@JAMANeuro
In #stroke due to medium or distal vessel occlusion, endovascular treatment plus best medical treatment preserved more brain tissue and was linked to improved imaging outcomes and better clinical recovery compared with medical treatment alone. jamanetwork.com/journals/jamaneurology/fullarticle/10.100…
-
JAMA Neurology
@JAMANeuro
✨Attending #aan2026?
📖Catheter Ablation and Oral Anticoagulation for Secondary Stroke Prevention in Atrial Fibrillation
The STABLED Randomized Clinical Trial from @JAMANeuro
🔓 Free to read online during the meeting
jamanetwork.com/pages/conferences-aan?linkId=930600111 -
JAMA Neurology
@JAMANeuro
✨ Attending #aan2026?
📖 Low‑Dose Lithium for Mild Cognitive Impairment A Pilot Randomized Clinical Trial from @JAMANeuro
🔓 Free to read online during the meeting
jamanetwork.com/pages/conferences-aan?linkId=930600078 -
JAMA Neurology
@JAMANeuro
Interview with Susan M. Landau, PhD, author of Brain Imaging Biomarkers and Cognitive Outcomes in a Multidomain Lifestyle Intervention:The POINTER Imaging Ancillary Study. Hosted by Cynthia E. Armand, MD. edhub.ama-assn.org/jn-learning/audio-player/10.1001/jaman…
-
JAMA Neurology
@JAMANeuro
👋 Meet S. Andrew Josephson, MD, Editor of @JAMANeuro, today at #aan2026
📅 April 20
⏰ 11:30 AM – 12:30 PM
📍 Booth 1927
✨ Learn about publishing with the JAMA Network -
JAMA Neurology
@JAMANeuro
In #alzheimerdisease risk, a high-intensity multidomain lifestyle intervention did not alter brain biomarker trajectories, but older adults with lower baseline hippocampal volume derived greater cognitive benefit from structured intervention. jamanetwork.com/journals/jamaneurology/fullarticle/10.100…
-
JAMA Neurology
@JAMANeuro
Among adults with #chronicsubduralhematoma, long-term survival was lower than in the general population, and survivors experienced persistent cognitive and functional impairments despite preserved global quality of life, even after surgical treatment.
jamanetwork.com/journals/jamaneurology/fullarticle/10.100… -
JAMA Neurology
@JAMANeuro
Five years of ublituximab treatment in #multiplesclerosis demonstrated sustained reduction in relapse rates and confirmed disability progression, with safety profile consistent over time. jamanetwork.com/journals/jamaneurology/fullarticle/10.100…
-
JAMA Neurology
@JAMANeuro
📊Effects of Exercise and Intensive Vascular Risk Reduction on Cognitive Function in Older Adults: A Randomized Clinical Trial from @JAMANeuro
🔓Free to read online during #aan2026
jamanetwork.com/pages/conferences-aan?linkId=930417033 -
JAMA Neurology
@JAMANeuro
👋Meet S. Andrew Josephson, MD, Editor of @JAMANeuro, today at #aan2026
📅 April 19
⏰ 2:00 PM – 3:00 PM
📍 Booth 1927
✨Learn about publishing with the JAMA Network -
JAMA Neurology
@JAMANeuro
🎉Exhibits at #aan2026 are open!
📍Find @JAMA_current, @JAMANeuro & @JAMANetworkOpen at booth 1927
✨Explore recently published research & publishing opportunities
jamanetwork.com/pages/conferences-aan?linkId=930416540 -
JAMA Neurology
@JAMANeuro
Following out-of-hospital cardiac arrest, targeted hypothermia did not affect societal participation or cognitive function at 24 months compared with normothermia; most recovery occurred within 6 months. jamanetwork.com/journals/jamaneurology/fullarticle/10.100…
-
JAMA Neurology
@JAMANeuro
In patients with atrial fibrillation and recent stroke, adding catheter ablation to oral anticoagulation did not significantly reduce recurrent stroke, systemic embolism, death, or hospitalization for heart failure compared to standard therapy. jamanetwork.com/journals/jamaneurology/fullarticle/10.100…
-
JAMA Neurology
@JAMANeuro
✨Attending #aan2026? Visit our attendee page to:
📚 Read recent articles
🎧 Listen to podcasts
👋 Find out when you can meet our editors
📝 Explore author resources
jamanetwork.com/pages/conferences-aan?linkId=929843016 -
JAMA Neurology
@JAMANeuro
In adults with drug-resistant #focalepilepsy, cenobamate was associated with greater seizure reduction and seizure freedom vs brivaracetam, lacosamide, and perampanel, but with more adverse effects. jamanetwork.com/journals/jamaneurology/fullarticle/10.100…
-
JAMA Neurology
@JAMANeuro
PrimeC demonstrated comparable safety to placebo and showed slowed functional decline, reduced ALS-related complications, and modulation of iron-regulatory and microRNA biomarkers in adults with #als over 18 months of treatment.
jamanetwork.com/journals/jamaneurology/fullarticle/10.100… -
JAMA Neurology
@JAMANeuro
Among older adults with mild cognitive impairment, low-dose lithium did not significantly delay cognitive decline or affect neuroimaging and plasma biomarker outcomes over 2 years. Treatment was safe and well tolerated. jamanetwork.com/journals/jamaneurology/fullarticle/10.100…
-
JAMA Neurology reposted
JAMA
@JAMA_current
Today, the JAMA Network launches @JAMAplusTrials, a new online platform that highlights the vision, innovation, and resilience of clinical trial research.
Designed for clinicians, investigators, trainees, and others engaged in clinical research worldwide, JAMA+ Trials is an interdisciplinary resource for enhancing insights and promoting dialogue in clinical trial research. 🧵 -
JAMA Neurology reposted
Michael Okun
@MichaelOkun
A new drug 'on the block' for Parkinson’s: Tavapadon, a D1/D5 selective dopamine agonist. Randomized trial results are in and positive. Randomized means participants were assigned by chance to different groups. Pahwa and colleagues describe in their new paper in JAMA Neurology the results of a phase 3 randomized trial of Tavapadon in EARLY Parkinson’s disease.
Key Points:
- Tavapadon significantly improved motor symptoms as measured by MDS-UPDRS II and III scores compared to placebo over 26 weeks.
- Clinical benefit emerged as early as week 5 and was sustained through the duration of the study.
- The drug demonstrated a favorable safety profile, w/ most adverse events mild to moderate including nausea, headache and dizziness.
My take: This is an important study that brings a D1/D5 selective dopamine agonist into the spotlight. The idea of targeting D1 pathways while potentially avoiding some of the D2/D3 related side effects is compelling. However, we should be cautious as longer term data will be critical to understand durability, safety and real world impact.
Here are 5 points that resonated w/ me:
1- Early Parkinson’s disease remains a window where smarter therapies could meaningfully alter trajectories.
2- Selective D1/D5 agonism represents a different pharmacologic strategy compared to traditional dopamine agonists.
3- The magnitude of motor improvement in this trial appears clinically meaningful and not just statistically significant.
4- Side effects were frequent, however mostly manageable, and this balance will matter in early disease decision making.
5- The future will hinge on long term safety, comparative effectiveness and identifying which folks benefit the most.
jamanetwork.com/journals/jamaneurology/fullarticle/2846846 @JAMA_current @JAMANeuro -
JAMA Neurology reposted
Michael Okun
@MichaelOkun
Who doesn't love a scientific 'double feature?' A second paper also just came out in JAMA Neurology and this one featuring Tavapadon as an 'add on therapy' to your current Parkinson's drug regimen? The drug is a new D1/D5 agonist and the authors were hoping when they conducted the study it would have less worrisome side effects vs. conventional dopamine agonists. The folks in the study were experiencing motor fluctuations. This is a different paper on the same drug and the first author on this one was Hubert Fernandez. The other paper by Pahwa was focused on using the drug in early Parkinson's.
Key points:
- Tavapadon increased daily 'good on time' by about 1 hour compared to placebo, meaning more time w/ smoother movement and fewer symptoms.
- Tavapadon reduced daily off time by nearly 1 hour more than placebo, meaning fewer periods when symptoms return between doses.
- Most side effects were mild to moderate, w/ nausea, dyskinesia and dizziness being the most common.
My take: We have been stuck in a D2/D3 world for a long time and this study opens the door to a different dopamine agonist strategy. Will there be less impulse control disorders (ICDs) in clinical practice? We shall see as this drug will soon be in use.
jamanetwork.com/journals/jamaneurology/fullarticle/2846847 @JAMA_current @JAMANeuro #parkinson -
JAMA Neurology reposted
Michael Okun
@MichaelOkun
A new combination therapy in ALS: Did PrimeC move the needle? Combination therapy means using two medications together to target multiple disease pathways at the same time. Cudkowicz and colleagues describe in a new paper in JAMA Neurology the results of the PARADIGM randomized clinical trial testing PrimeC in ALS. The results were encouraging, however the trial was not powered for efficacy.
Key Points:
- PrimeC, a combination of celecoxib and ciprofloxacin, was safe and well tolerated over 18 months w/ side effects mostly mild to moderate.
- Continuous treatment showed signals of slower functional decline and reduced risk of major ALS complications such as hospitalization, respiratory failure or death.
- Biomarker changes suggested engagement of key ALS pathways including iron regulation, inflammation and microRNA biology.
My take: This is an encouraging and thoughtful study. ALS is a complex disease and targeting multiple pathways simultaneously makes biological sense. The results do not yet provide definitive proof of benefit, however the signals across function, complications and biomarkers suggest we may be moving in the right direction. Can they get to meaningful clinical change?
Here are 5 take home points that resonated w/ me:
1- ALS may likely requires multi target approaches rather than single pathway therapies.
2- Safety matters and this study supports that combination strategies can be tested carefully in this population.
3- Slowing progression even modestly could translate into meaningful time and function for folks living w/ ALS.
4- Biomarkers such as microRNAs and iron markers may help us understand whether a therapy is truly engaging disease biology.
5- The future of ALS treatment may depend on combining therapies, timing them correctly and matching them to the right folks.
jamanetwork.com/journals/jamaneurology/fullarticle/2846474 @ParkinsonDotOrg @JAMANetwork @JAMANeuro #parkinson -
JAMA Neurology reposted
Michael Okun
@MichaelOkun
Can exercise and aggressive risk factor control protect your brain as you age? A new randomized trial provides important data. In a randomized clinical trial participants are assigned by chance to different treatments to in a 'more fair way' test what works. Rong Zhang and colleagues describe in a new paper in JAMA Neurology the effects of exercise and intensive vascular risk reduction on cognitive function in older adults at risk for dementia.
Key Points:
- Over 24 months, aerobic exercise, intensive blood pressure and cholesterol lowering, or both did not significantly improve overall cognitive scores compared to usual care.
- Cognitive scores improved slightly across all groups, suggesting possible practice or participation effects rather than a true treatment benefit.
- Intensive vascular treatment successfully lowered blood pressure and cholesterol, however this did not translate into measurable cognitive gains over the study period.
My take: This is an important and humbling study. We all want a clear signal that exercise or aggressive risk reduction will sharpen cognition in the short term. However, biology is complex. Brain health may require longer timelines, earlier intervention, or more comprehensive strategies. This does not mean these approaches are not valuable. It means we need to better understand how and when they work.
Here are 5 points that resonated w/ me:
1- Exercise remains critical for overall brain and body health, even if short term cognitive gains are not obvious.
2- Lowering blood pressure and cholesterol is essential for preventing stroke and vascular disease and likely still matters for long term brain health.
3- Not seeing a signal at 2 years does not mean there is no benefit over 5 or 10 years.
4- Brain health may require combining exercise w/ diet, cognitive training and social engagement rather than a single approach.
5- Folks should not stop healthy habits based on one study, instead this work should guide smarter and more personalized prevention strategies moving forward.
jamanetwork.com/journals/jamaneurology/fullarticle/2846826 @ParkinsonDotOrg @JAMANetwork @JAMANeuro -
JAMA Neurology reposted
AMA Ed Hub™
@AMAEdHub
A 61-year-old man presented with chronic progressive weakness and gait dysfunction. Neurological examination revealed impaired short-term recall and a pseudobulbar affect. Let us know your diagnosis in the comments. @JAMANeuro
amaedhub.org/41XITUS -
JAMA Neurology
@JAMANeuro
#cavernoussinus dural arteriovenous fistula can present with proptosis, conjunctival injection, and ophthalmoplegia; endovascular embolization achieved complete occlusion and rapid symptom resolution in this case.
jamanetwork.com/journals/jamaneurology/fullarticle/10.100… -
JAMA Neurology
@JAMANeuro
Aerobic exercise, intensive blood pressure and cholesterol reduction, or both did not show differences in cognitive function improvement over 24 months among older adults with family history of #dementia or subjective #cognitive decline.
jamanetwork.com/journals/jamaneurology/fullarticle/10.100… -
JAMA Neurology
@JAMANeuro
💬Editorial: Decade-long follow-up highlights that patients with surgically treated #chronicsubduralhematoma have persistent excess mortality and long-term cognitive and functional impairment, even when overall quality of life appears preserved. jamanetwork.com/journals/jamaneurology/fullarticle/10.100…
-
JAMA Neurology
@JAMANeuro
#multiplesclerosis prevalence in England more than doubled in 30 years as survival improved, but abnormal weight, tobacco use, and deprivation gradients persisted and were associated with increased mortality risk.
jamanetwork.com/journals/jamaneurology/fullarticle/10.100… -
JAMA Neurology
@JAMANeuro
#multiplesclerosis prevalence in England more than doubled in 30 years as survival improved, but abnormal weight, tobacco use, and deprivation gradients persisted and were associated with increased mortality risk.
jamanetwork.com/journals/jamaneurology/fullarticle/10.100… -
JAMA Neurology
@JAMANeuro
PrimeC demonstrated comparable safety to placebo and showed slowed functional decline, reduced ALS-related complications, and modulation of iron-regulatory and microRNA biomarkers in adults with #als over 18 months of treatment.
jamanetwork.com/journals/jamaneurology/fullarticle/10.100… -
JAMA Neurology
@JAMANeuro
Among patients with multiple sclerosis treated long-term with ocrelizumab, interstitial lung disease developed after a mean of 10.5 years, mainly as organizing pneumonia with variable outcomes.
jamanetwork.com/journals/jamaneurology/fullarticle/10.100… -
JAMA Neurology
@JAMANeuro
Aerobic exercise, intensive blood pressure and cholesterol reduction, or both did not show differences in cognitive function improvement over 24 months among older adults with family history of #dementia or subjective #cognitive decline.
jamanetwork.com/journals/jamaneurology/fullarticle/10.100… -
JAMA Neurology
@JAMANeuro
In a multicenter German study, teleneurological ward rounds in subacute #stroke care were noninferior and showed greater guideline adherence across all quality domains compared with on-site ward rounds, especially in secondary prevention.
jamanetwork.com/journals/jamaneurology/fullarticle/10.100… -
JAMA Neurology
@JAMANeuro
Aerobic exercise, intensive blood pressure and cholesterol reduction, or both did not show differences in cognitive function improvement over 24 months among older adults with family history of #dementia or subjective #cognitive decline.
jamanetwork.com/journals/jamaneurology/fullarticle/10.100… -
JAMA Neurology
@JAMANeuro
#multiplesclerosis prevalence in England more than doubled in 30 years as survival improved, but abnormal weight, tobacco use, and deprivation gradients persisted and were associated with increased mortality risk.
jamanetwork.com/journals/jamaneurology/fullarticle/10.100… -
JAMA Neurology
@JAMANeuro
Among patients undergoing endovascular #thrombectomy for acute #stroke, early (<6 hours) vs delayed (6–12 hours) extubation did not improve 90-day functional independence, hospital stay, complication rates, or mortality.
jamanetwork.com/journals/jamaneurology/fullarticle/10.100… -
JAMA Neurology
@JAMANeuro
Among patients undergoing endovascular #thrombectomy for acute #stroke, early (<6 hours) vs delayed (6–12 hours) extubation did not improve 90-day functional independence, hospital stay, complication rates, or mortality. jamanetwork.com/journals/jamaneurology/fullarticle/10.100…
-
JAMA Neurology
@JAMANeuro
PrimeC demonstrated comparable safety to placebo and showed slowed functional decline, reduced ALS-related complications, and modulation of iron-regulatory and microRNA biomarkers in adults with #als over 18 months of treatment.
jamanetwork.com/journals/jamaneurology/fullarticle/10.100… -
JAMA Neurology
@JAMANeuro
💬 Editorial: Current evidence supports iatrogenic transmission of cerebral amyloid angiopathy but not #alzheimerdisease; a definitive causal link between contaminated growth hormone exposure and AD remains speculative. jamanetwork.com/journals/jamaneurology/fullarticle/10.100…
-
JAMA Neurology
@JAMANeuro
Patients treated with cadaveric pituitary-derived human growth hormone contaminated with amyloid-β developed early-onset #alzheimerdisease with prominent language deficits and histopathological features consistent with AD.
jamanetwork.com/journals/jamaneurology/fullarticle/10.100… -
JAMA Neurology
@JAMANeuro
#multiplesclerosis prevalence in England more than doubled in 30 years as survival improved, but abnormal weight, tobacco use, and deprivation gradients persisted and were associated with increased mortality risk.
jamanetwork.com/journals/jamaneurology/fullarticle/10.100… -
JAMA Neurology
@JAMANeuro
💬 Editorial: In a randomized trial, aerobic exercise and intensive vascular risk reduction for older adults at risk of #dementia led to only modest cognitive improvement, with no significant group differences in global cognitive function.
jamanetwork.com/journals/jamaneurology/fullarticle/10.100… -
JAMA Neurology
@JAMANeuro
Aerobic exercise, intensive blood pressure and cholesterol reduction, or both did not show differences in cognitive function improvement over 24 months among older adults with family history of #dementia or subjective #cognitive decline.
jamanetwork.com/journals/jamaneurology/fullarticle/10.100… -
JAMA Neurology
@JAMANeuro
In adults with #parkinsondisease experiencing motor fluctuations on levodopa, adjunctive tavapadon increased daily good-on-time and decreased daily off-time compared to placebo, with a favorable safety profile.
jamanetwork.com/journals/jamaneurology/fullarticle/10.100… -
JAMA Neurology
@JAMANeuro
Among adults with early #parkinsondisease, fixed-dose tavapadon (5 or 15 mg once daily) improved motor function over 26 weeks versus placebo, with most adverse events mild or moderate in severity.
jamanetwork.com/journals/jamaneurology/fullarticle/10.100… -
JAMA Neurology
@JAMANeuro
Among adult patients with #mogad, discontinuation of oral immunosuppressants or rituximab was associated with a low 1-year relapse risk, especially after ≥1 year of treatment and ≥2 years since last relapse.
jamanetwork.com/journals/jamaneurology/fullarticle/10.100… -
JAMA Neurology
@JAMANeuro
💬 Editorial: In a randomized trial, aerobic exercise and intensive vascular risk reduction for older adults at risk of #dementia led to only modest cognitive improvement, with no significant group differences in global cognitive function.
jamanetwork.com/journals/jamaneurology/fullarticle/10.100… -
JAMA Neurology
@JAMANeuro
Aerobic exercise, intensive blood pressure and cholesterol reduction, or both did not show differences in cognitive function improvement over 24 months among older adults with family history of #dementia or subjective #cognitive decline.
jamanetwork.com/journals/jamaneurology/fullarticle/10.100… -
JAMA Neurology
@JAMANeuro
#multiplesclerosis prevalence in England more than doubled in 30 years as survival improved, but abnormal weight, tobacco use, and deprivation gradients persisted and were associated with increased mortality risk.
jamanetwork.com/journals/jamaneurology/fullarticle/10.100… -
JAMA Neurology
@JAMANeuro
Among adult patients with #mogad, discontinuation of oral immunosuppressants or rituximab was associated with a low 1-year relapse risk, especially after ≥1 year of treatment and ≥2 years since last relapse.
jamanetwork.com/journals/jamaneurology/fullarticle/10.100… -
JAMA Neurology
@JAMANeuro
In adults with #parkinsondisease experiencing motor fluctuations on levodopa, adjunctive tavapadon increased daily good-on-time and decreased daily off-time compared to placebo, with a favorable safety profile.
jamanetwork.com/journals/jamaneurology/fullarticle/10.100… -
JAMA Neurology
@JAMANeuro
💬 Editorial: In a randomized trial, aerobic exercise and intensive vascular risk reduction for older adults at risk of #dementia led to only modest cognitive improvement, with no significant group differences in global cognitive function.
jamanetwork.com/journals/jamaneurology/fullarticle/10.100… -
JAMA Neurology
@JAMANeuro
Aerobic exercise, intensive blood pressure and cholesterol reduction, or both did not show differences in cognitive function improvement over 24 months among older adults with family history of #dementia or subjective #cognitive decline.
jamanetwork.com/journals/jamaneurology/fullarticle/10.100… -
JAMA Neurology
@JAMANeuro
Among adults with early #parkinsondisease, fixed-dose tavapadon (5 or 15 mg once daily) improved motor function over 26 weeks versus placebo, with most adverse events mild or moderate in severity.
jamanetwork.com/journals/jamaneurology/fullarticle/10.100… -
JAMA Neurology
@JAMANeuro
Among adults with early #parkinsondisease, fixed-dose tavapadon (5 or 15 mg once daily) improved motor function over 26 weeks versus placebo, with most adverse events mild or moderate in severity.
jamanetwork.com/journals/jamaneurology/fullarticle/10.100… -
JAMA Neurology
@JAMANeuro
In adults with #parkinsondisease experiencing motor fluctuations on levodopa, adjunctive tavapadon increased daily good-on-time and decreased daily off-time compared to placebo, with a favorable safety profile.
jamanetwork.com/journals/jamaneurology/fullarticle/10.100… -
JAMA Neurology
@JAMANeuro
Uniform amyloid PET cutoffs are supported for diverse older adult populations in #alzheimerdisease clinical practice. jamanetwork.com/journals/jamaneurology/fullarticle/10.100…
-
JAMA Neurology
@JAMANeuro
Patients with detectable virus-specific T cells before checkpoint inhibitor therapy in #pml demonstrated better survival rates and functional recovery than those without. jamanetwork.com/journals/jamaneurology/fullarticle/10.100…
-
JAMA Neurology
@JAMANeuro
Biologically informed plasma #ptau217 thresholds improved diagnostic accuracy for amyloid PET positivity in patients with #ckd and #anemia vs a standard single cutoff, supporting cost-efficient biomarker implementation in #alzheimerdisease screening. jamanetwork.com/journals/jamaneurology/fullarticle/10.100…
-
JAMA Neurology
@JAMANeuro
Adults with #downsyndrome and amyloid-positive #alzheimerdisease had higher alignment between clinical and biological staging compared to sporadic cases. jamanetwork.com/journals/jamaneurology/fullarticle/10.100…
-
JAMA Neurology
@JAMANeuro
In 2025, JAMA Neurology saw a >15% increase in submissions, an Impact Factor of 21.4, >11.3 million article views/downloads, and >5,800 media mentions.
📄 Read the full “JAMA Neurology Year in Review, 2025,” by S. Andrew Josephson, MD.
jamanetwork.com/journals/jamaneurology/fullarticle/10.100… -
JAMA Neurology
@JAMANeuro
Higher circulating serum #klotho concentrations moderated the adverse association between brain atrophy and cognition in older adults at risk for #alzheimerdisease but not in younger individuals. jamanetwork.com/journals/jamaneurology/fullarticle/10.100…
-
JAMA Neurology
@JAMANeuro
This case report describes a patient who presented with a 2-day history of dizziness, unsteady gait, and confusion. In the past month, he had experienced 2 cerebral infarctions and fungal infection in his left armpit. jamanetwork.com/journals/jamaneurology/fullarticle/10.100…
-
JAMA Neurology
@JAMANeuro
PrimeC demonstrated comparable safety to placebo and showed slowed functional decline, reduced ALS-related complications, and modulation of iron-regulatory and microRNA biomarkers in adults with #als over 18 months of treatment.
jamanetwork.com/journals/jamaneurology/fullarticle/10.100… -
JAMA Neurology
@JAMANeuro
In #radiologicallyisolatedsyndrome, greater paramagnetic rim lesion burden on MRI was associated with increased risk and earlier development of clinical #multiplesclerosis.
jamanetwork.com/journals/jamaneurology/fullarticle/10.100… -
JAMA Neurology
@JAMANeuro
Among patients with #stroke and #patentforamenovale, the PASCAL classification system identified those likely to benefit from closure and those at risk of increased atrial fibrillation. jamanetwork.com/journals/jamaneurology/fullarticle/10.100…
-
JAMA Neurology
@JAMANeuro
HHV-6 was identified as a rare cause of fulminant acute hemorrhagic leukoencephalitis in an immunocompetent adult. jamanetwork.com/journals/jamaneurology/fullarticle/10.100…
-
JAMA Neurology
@JAMANeuro
Autopsy findings in individuals with chronic traumatic encephalopathy (#cte) show frequent spinal tau and protein pathologies after repetitive head impacts, indicating spinal involvement in neurodegeneration.
jamanetwork.com/journals/jamaneurology/fullarticle/10.100… -
JAMA Neurology
@JAMANeuro
Among patients with chronic #stroke and severe contralesional impairment, targeted ipsilesional arm training supported significant and sustained improvements in ipsilesional motor performance vs best practice therapy.
jamanetwork.com/journals/jamaneurology/fullarticle/10.100… -
JAMA Neurology
@JAMANeuro
Editorial: Robust evidence links chronic air pollution exposure to increased risk and accelerated progression of #als. jamanetwork.com/journals/jamaneurology/fullarticle/10.100…
-
JAMA Neurology
@JAMANeuro
Among adults with newly diagnosed focal #epilepsy, suicidality at diagnosis was associated with more than double the risk of future drug resistance vs mood or anxiety disorders alone. jamanetwork.com/journals/jamaneurology/fullarticle/10.100…
-
JAMA Neurology
@JAMANeuro
Long-term residential exposure to fine particulate matter and nitrogen dioxide is associated with increased risk, faster progression, and greater mortality in #motorneurondisease. jamanetwork.com/journals/jamaneurology/fullarticle/10.100…
-
JAMA Neurology
@JAMANeuro
Interview with Hannes Vietzen, PhD, author Epstein-Barr Virus Antibodies to Differentiate Multiple Sclerosis From Other Neuroinflammatory Diseases. Hosted by Cynthia E. Armand, MD. edhub.ama-assn.org/jn-learning/audio-player/10.1001/jaman…
-
JAMA Neurology
@JAMANeuro
Persistently high Epstein-Barr nuclear antigen 1 antibody titers distinguished #multiplesclerosis from #mogad and #nmosd, supporting use as a noninvasive diagnostic biomarker. jamanetwork.com/journals/jamaneurology/fullarticle/10.100…
-
JAMA Neurology
@JAMANeuro
In patients with #atrialfibrillation and recent #stroke, adding catheter ablation to oral anticoagulation did not significantly reduce recurrent stroke, systemic embolism, death, or hospitalization for heart failure compared to standard therapy.
jamanetwork.com/journals/jamaneurology/fullarticle/10.100… -
JAMA Neurology
@JAMANeuro
Among older adults with mild cognitive impairment, low-dose lithium did not significantly delay cognitive decline or affect neuroimaging and plasma biomarker outcomes over 2 years. Treatment was safe and well tolerated.
jamanetwork.com/journals/jamaneurology/fullarticle/10.100… -
JAMA Neurology
@JAMANeuro
In patients with atrial fibrillation and recent stroke, adding catheter ablation to oral anticoagulation did not significantly reduce recurrent stroke, systemic embolism, death, or hospitalization for heart failure compared to standard therapy.
jamanetwork.com/journals/jamaneurology/fullarticle/10.100… -
JAMA Neurology
@JAMANeuro
Among older adults with mild cognitive impairment, low-dose lithium did not significantly delay cognitive decline or affect neuroimaging and plasma biomarker outcomes over 2 years. Treatment was safe and well tolerated.
jamanetwork.com/journals/jamaneurology/fullarticle/10.100… -
JAMA Neurology
@JAMANeuro
In patients with atrial fibrillation and recent stroke, adding catheter ablation to oral anticoagulation did not significantly reduce recurrent stroke, systemic embolism, death, or hospitalization for heart failure compared to standard therapy.
jamanetwork.com/journals/jamaneurology/fullarticle/10.100… -
JAMA Neurology
@JAMANeuro
Among older adults with mild cognitive impairment, low-dose lithium did not significantly delay cognitive decline or affect neuroimaging and plasma biomarker outcomes over 2 years. Treatment was safe and well tolerated.
jamanetwork.com/journals/jamaneurology/fullarticle/10.100… -
JAMA Neurology
@JAMANeuro
In patients with atrial fibrillation and recent stroke, adding catheter ablation to oral anticoagulation did not significantly reduce recurrent stroke, systemic embolism, death, or hospitalization for heart failure compared to standard therapy.
jamanetwork.com/journals/jamaneurology/fullarticle/10.100… -
JAMA Neurology
@JAMANeuro
Among older adults with mild cognitive impairment, low-dose lithium did not significantly delay cognitive decline or affect neuroimaging and plasma biomarker outcomes over 2 years. Treatment was safe and well tolerated.
jamanetwork.com/journals/jamaneurology/fullarticle/10.100… -
JAMA Neurology
@JAMANeuro
Greater adherence to the #dash diet, plant-based dietary patterns, or diets with lower hyperinsulinemia and inflammation was associated with lower risk of subjective cognitive decline and better cognitive function in adults.
jamanetwork.com/journals/jamaneurology/fullarticle/10.100… -
JAMA Neurology
@JAMANeuro
Female sex, APOE ε4 allele, race, and African ancestry were jointly associated with amyloid pathology severity, supporting the need for sex- and ancestry-informed approaches in #alzheimerdisease biomarker thresholds and clinical trial design.
jamanetwork.com/journals/jamaneurology/fullarticle/10.100… -
JAMA Neurology
@JAMANeuro
Greater adherence to the #dash diet, plant-based dietary patterns, or diets with lower hyperinsulinemia and inflammation was associated with lower risk of subjective cognitive decline and better cognitive function in adults.
jamanetwork.com/journals/jamaneurology/fullarticle/10.100… -
JAMA Neurology
@JAMANeuro
💬 Viewpoint: Routine brain health screening, interdisciplinary teams, and policy reforms addressing neurotoxic exposures may shift neurology toward primary prevention—reducing disease burden across populations.
jamanetwork.com/journals/jamaneurology/fullarticle/10.100… -
JAMA Neurology
@JAMANeuro
Female sex, APOE ε4 allele, race, and African ancestry were jointly associated with amyloid pathology severity, supporting the need for sex- and ancestry-informed approaches in #alzheimerdisease biomarker thresholds and clinical trial design.
jamanetwork.com/journals/jamaneurology/fullarticle/10.100… -
JAMA Neurology
@JAMANeuro
💬 Viewpoint: The updated 2024 McDonald criteria enable MS diagnosis in asymptomatic individuals by incorporating imaging and CSF biomarkers, such as CVS and κ-FLC index, while promoting a single standardized framework.
jamanetwork.com/journals/jamaneurology/fullarticle/10.100… -
JAMA Neurology
@JAMANeuro
Early relapse is common in #pcnsv, with normal cerebrospinal fluid associated with increased recurrence, suggesting current monitoring and treatment strategies may need adjustment.
jamanetwork.com/journals/jamaneurology/fullarticle/10.100… -
JAMA Neurology
@JAMANeuro
In preclinical #alzheimerdisease, women exhibited higher plasma phosphorylated tau 217 at greater amyloid-β burden and faster tau accumulation and cognitive decline compared with men.
jamanetwork.com/journals/jamaneurology/fullarticle/10.100… -
JAMA Neurology
@JAMANeuro
Five years of ublituximab treatment in #multiplesclerosis demonstrated sustained reduction in relapse rates and confirmed disability progression, with safety profile consistent over time.
jamanetwork.com/journals/jamaneurology/fullarticle/10.100… -
JAMA Neurology
@JAMANeuro
Rising costs for #multiplesclerosis care are largely attributed to disease-modifying therapies, increasing patient financial burden over time. jamanetwork.com/journals/jamaneurology/fullarticle/10.100…
-
JAMA Neurology
@JAMANeuro
Case report: a patient with X-linked FHL1-related myofibrillar myopathy and Charcot-Marie-Tooth disease type 1A, a dual pathology revealed by imaging and genetic testing. jamanetwork.com/journals/jamaneurology/fullarticle/10.100…
-
JAMA Neurology
@JAMANeuro
In patients with post-dural puncture headache who do not respond to conventional treatment, iatrogenic CSF-venous fistula should be considered as it may necessitate different treatment. jamanetwork.com/journals/jamaneurology/fullarticle/10.100…
-
JAMA Neurology
@JAMANeuro
In preclinical #alzheimerdisease, women exhibited higher plasma phosphorylated tau 217 at greater amyloid-β burden and faster tau accumulation and cognitive decline compared with men.
jamanetwork.com/journals/jamaneurology/fullarticle/10.100… -
JAMA Neurology
@JAMANeuro
Clinicians and administrators encounter significant time burden and burnout due to prior authorization for neurologic medications. Specialty pharmacy integration may help reduce barriers. jamanetwork.com/journals/jamaneurology/fullarticle/10.100…
-
JAMA Neurology
@JAMANeuro
Five years of ublituximab treatment in #multiplesclerosis demonstrated sustained reduction in relapse rates and confirmed disability progression, with safety profile consistent over time.
jamanetwork.com/journals/jamaneurology/fullarticle/10.100… -
JAMA Neurology
@JAMANeuro
#epilepsy incidence among US #medicare beneficiaries aged 65 and older varied tenfold across regions and was associated with insufficient sleep, lack of vehicle access, heat index, physical inactivity, and uninsured rate. jamanetwork.com/journals/jamaneurology/fullarticle/10.100…
-
JAMA Neurology
@JAMANeuro
Following out-of-hospital cardiac arrest, targeted hypothermia did not affect societal participation or cognitive function at 24 months compared with normothermia; most recovery occurred within 6 months.
jamanetwork.com/journals/jamaneurology/fullarticle/10.100… -
JAMA Neurology
@JAMANeuro
Among offspring born in Norway between 1967 and 1989, exposure to maternal diabetes and being born large for gestational age were associated with increased risk of adult-onset #multiplesclerosis.
jamanetwork.com/journals/jamaneurology/fullarticle/10.100… -
JAMA Neurology
@JAMANeuro
Oveporexton produced significant improvements in sustained attention, memory, and executive function among adults with #narcolepsytype1. jamanetwork.com/journals/jamaneurology/fullarticle/10.100…
-
JAMA Neurology
@JAMANeuro
In adults with drug-resistant #focalepilepsy, cenobamate was associated with greater seizure reduction and seizure freedom vs brivaracetam, lacosamide, and perampanel, but with more adverse effects.
jamanetwork.com/journals/jamaneurology/fullarticle/10.100… -
JAMA Neurology
@JAMANeuro
From @JAMA_current: Moderate consumption of caffeinated coffee or tea was linked to reduced #dementia risk and modest improvements in cognitive outcomes; no benefit was seen for decaffeinated coffee in an observational study of US adults.
jamanetwork.com/journals/jama/fullarticle/10.1001/jama.20… -
JAMA Neurology
@JAMANeuro
Among patients with #preeclampsia, postpartum blood pressure self-management was linked to larger putamen, accumbens and pallidum volumes vs usual care.
jamanetwork.com/journals/jamaneurology/fullarticle/10.100… -
JAMA Neurology
@JAMANeuro
💬 Editorial: Plasma tau biomarkers such as p-tau217 are robust predictors of #alzheimerdisease pathology, but their use as interchangeable substitutes for tau PET imaging may be limited, especially for disease stage and anti-amyloid treatment.
jamanetwork.com/journals/jamaneurology/fullarticle/10.100… -
JAMA Neurology
@JAMANeuro
Individuals with #alzheimerdisease showing greater clinical impairment than predicted by tau burden are more likely to have copathology, including #tdp43 and #alphasynuclein, and experience faster decline.
jamanetwork.com/journals/jamaneurology/fullarticle/10.100… -
JAMA Neurology
@JAMANeuro
💬 Editorial: Tofersen slowed functional decline and reduced risk of death for patients with SOD1-related #als, especially with early treatment, and showed durable biomarker improvements over 148 weeks.
jamanetwork.com/journals/jamaneurology/fullarticle/10.100… -
JAMA Neurology
@JAMANeuro
Earlier initiation of tofersen slowed clinical decline, sustained biomarker improvement, and extended survival for SOD1-related #als, with no new long-term safety concerns. jamanetwork.com/journals/jamaneurology/fullarticle/10.100…
-
JAMA Neurology
@JAMANeuro
Among patients <70 years with acute #basilararteryocclusion, endovascular thrombectomy doubled the rate of ambulatory and self-care capable outcomes at 3 years vs medical treatment.
jamanetwork.com/journals/jamaneurology/fullarticle/10.100… -
JAMA Neurology
@JAMANeuro
#epilepsy treatment continues to evolve with real-world comparative data on newer anti-seizure medications.
Emanuele Cerulli Irelli, MD, and Cynthia Armand, MD, discuss the implications for individualized epilepsy management.
🎧 Listen now: edhub.ama-assn.org/jn-learning/audio-player/19036820?link… -
JAMA Neurology
@JAMANeuro
In adults with drug-resistant #focalepilepsy, cenobamate was associated with greater seizure reduction and seizure freedom vs brivaracetam, lacosamide, and perampanel, but with more adverse effects.
jamanetwork.com/journals/jamaneurology/fullarticle/10.100… -
JAMA Neurology
@JAMANeuro
Biologically informed plasma #ptau217 thresholds improved diagnostic accuracy for amyloid PET positivity in patients with #ckd and #anemia vs a standard single cutoff, supporting cost-efficient biomarker implementation in #alzheimerdisease screening.
jamanetwork.com/journals/jamaneurology/fullarticle/10.100… -
JAMA Neurology
@JAMANeuro
Higher circulating serum #klotho concentrations moderated the adverse association between brain atrophy and cognition in older adults at risk for #alzheimerdisease but not in younger individuals.
jamanetwork.com/journals/jamaneurology/fullarticle/10.100… -
JAMA Neurology
@JAMANeuro
Higher circulating serum #klotho concentrations moderated the adverse association between brain atrophy and cognition in older adults at risk for #alzheimerdisease but not in younger individuals.
jamanetwork.com/journals/jamaneurology/fullarticle/10.100… -
JAMA Neurology
@JAMANeuro
Biologically informed plasma #ptau217 thresholds improved diagnostic accuracy for amyloid PET positivity in patients with #ckd and #anemia vs a standard single cutoff, supporting cost-efficient biomarker implementation in #alzheimerdisease screening.
jamanetwork.com/journals/jamaneurology/fullarticle/10.100… -
JAMA Neurology
@JAMANeuro
Among patients with #stroke and #patentforamenovale, the PASCAL classification system identified those likely to benefit from closure and those at risk of increased atrial fibrillation. jamanetwork.com/journals/jamaneurology/fullarticle/10.100…
-
JAMA Neurology
@JAMANeuro
Among patients with chronic #stroke and severe contralesional impairment, targeted ipsilesional arm training supported significant and sustained improvements in ipsilesional motor performance vs best practice therapy. jamanetwork.com/journals/jamaneurology/fullarticle/10.100…
-
JAMA Neurology reposted
JAMA Cardiology
@JAMACardio
Today we welcome Barbara Casadei, MD, DPhil, from @ImperialNHLI, as Editor in Chief.
An internationally recognized clinician‑scientist, Dr Casadei brings extensive experience in global cardiovascular research. 🧵 -
JAMA Neurology reposted
NM Neurology
@NMNeurology
An 81 year old woman presenting with #memoryloss, #gaitinstability, #vertigo and #focalseizures was ultimately diagnosed with Kelch like protein 11 autoimmune encephalitis associated with metastatic Merkel cell carcinoma.
Her case highlights the importance of antibody testing in seronegative presentations, early seizure recognition and thorough malignancy workup in suspected #paraneoplasticsyndromes.
Read the full case published in @JAMANeuro: breakthroughsforphysicians.nm.org/neurosciences-clinical-… -
JAMA Neurology
@JAMANeuro
Autopsy findings in individuals with chronic traumatic encephalopathy (#cte) show frequent spinal tau and protein pathologies after repetitive head impacts, indicating spinal involvement in neurodegeneration. jamanetwork.com/journals/jamaneurology/fullarticle/10.100…
-
JAMA Neurology
@JAMANeuro
In #radiologicallyisolatedsyndrome, greater paramagnetic rim lesion burden on MRI was associated with increased risk and earlier development of clinical #multiplesclerosis. jamanetwork.com/journals/jamaneurology/fullarticle/10.100…
-
JAMA Neurology
@JAMANeuro
Among patients with #stroke and #patentforamenovale, the PASCAL classification system identified those likely to benefit from closure and those at risk of increased atrial fibrillation. jamanetwork.com/journals/jamaneurology/fullarticle/10.100…
-
JAMA Neurology
@JAMANeuro
Autopsy findings in individuals with chronic traumatic encephalopathy (#cte) show frequent spinal tau and protein pathologies after repetitive head impacts, indicating spinal involvement in neurodegeneration. jamanetwork.com/journals/jamaneurology/fullarticle/10.100…
-
JAMA Neurology
@JAMANeuro
In #radiologicallyisolatedsyndrome, greater paramagnetic rim lesion burden on MRI was associated with increased risk and earlier development of clinical #multiplesclerosis. jamanetwork.com/journals/jamaneurology/fullarticle/10.100…
-
JAMA Neurology
@JAMANeuro
Long-term residential exposure to fine particulate matter and nitrogen dioxide is associated with increased risk, faster progression, and greater mortality in #motorneurondisease.
jamanetwork.com/journals/jamaneurology/fullarticle/10.100… -
JAMA Neurology
@JAMANeuro
Patients with detectable virus-specific T cells before checkpoint inhibitor therapy in #pml demonstrated better survival rates and functional recovery than those without. jamanetwork.com/journals/jamaneurology/fullarticle/10.100…
-
JAMA Neurology
@JAMANeuro
Among patients with AF, surgical occlusion of the left atrial appendage was associated with lower rates of #stroke-related disability and mortality and a decreased proportion of cardioembolic #stroke.
jamanetwork.com/journals/jamaneurology/fullarticle/10.100… -
JAMA Neurology
@JAMANeuro
💬 Viewpoint: As neurologic disorders remain a leading cause of disability and death, community-engaged research offers a promising approach to close the “know-do gap” between discovery and real-world impact.
jamanetwork.com/journals/jamaneurology/fullarticle/10.100… -
JAMA Neurology
@JAMANeuro
Long-term residential exposure to fine particulate matter and nitrogen dioxide is associated with increased risk, faster progression, and greater mortality in #motorneurondisease.
jamanetwork.com/journals/jamaneurology/fullarticle/10.100… -
JAMA Neurology
@JAMANeuro
A 12-week remote, automated gamification intervention increased daily steps by 28% among US veterans with #parkinson disease, according to unadjusted analyses. jamanetwork.com/journals/jamaneurology/fullarticle/10.100…
-
JAMA Neurology
@JAMANeuro
Uniform amyloid PET cutoffs are supported for diverse older adult populations in #alzheimerdisease clinical practice. jamanetwork.com/journals/jamaneurology/fullarticle/10.100…
-
JAMA Neurology
@JAMANeuro
💬 Viewpoint: Empowering primary care practitioners to manage common neurological conditions may improve access, reduce delays, and enhance care quality.
jamanetwork.com/journals/jamaneurology/fullarticle/10.100… -
JAMA Neurology
@JAMANeuro
Abdominal clonus can occur in patients with thoracic spinal cord injury, expanding recognized patterns of upper motor neuron lesion-induced rhythmic contractions.
jamanetwork.com/journals/jamaneurology/fullarticle/10.100… -
JAMA Neurology
@JAMANeuro
Long-term residential exposure to fine particulate matter and nitrogen dioxide is associated with increased risk, faster progression, and greater mortality in #motorneurondisease.
jamanetwork.com/journals/jamaneurology/fullarticle/10.100… -
JAMA Neurology
@JAMANeuro
Among offspring born in Norway between 1967 and 1989, exposure to maternal diabetes and being born large for gestational age were associated with increased risk of adult-onset #multiplesclerosis.
jamanetwork.com/journals/jamaneurology/fullarticle/10.100… -
JAMA Neurology
@JAMANeuro
Case report: a man who self-diagnosed rapid-eye-movement (REM) sleep behavior disorder using a sleep-tracking wearable device, later confirmed by a sleep evaluation. jamanetwork.com/journals/jamaneurology/fullarticle/10.100…
-
JAMA Neurology
@JAMANeuro
Patients with detectable virus-specific T cells before checkpoint inhibitor therapy in #pml demonstrated better survival rates and functional recovery than those without. jamanetwork.com/journals/jamaneurology/fullarticle/10.100…
-
JAMA Neurology
@JAMANeuro
Case report: the appearance of autosomal recessive limb-girdle muscular dystrophy in a 30-year-old man with lower limb weakness, asymmetric atrophy of thigh muscles, and wasting of calf muscles. jamanetwork.com/journals/jamaneurology/fullarticle/10.100…
-
JAMA Neurology
@JAMANeuro
💬 Editorial: Robust evidence links chronic air pollution exposure to increased risk and accelerated progression of #als.
jamanetwork.com/journals/jamaneurology/fullarticle/10.100… -
JAMA Neurology
@JAMANeuro
Long-term residential exposure to fine particulate matter and nitrogen dioxide is associated with increased risk, faster progression, and greater mortality in #motorneurondisease.
jamanetwork.com/journals/jamaneurology/fullarticle/10.100… -
JAMA Neurology
@JAMANeuro
Among patients with AF, surgical occlusion of the left atrial appendage was associated with lower rates of #stroke-related disability and mortality and a decreased proportion of cardioembolic #stroke.
jamanetwork.com/journals/jamaneurology/fullarticle/10.100… -
JAMA Neurology
@JAMANeuro
Among offspring born in Norway between 1967 and 1989, exposure to maternal diabetes and being born large for gestational age were associated with increased risk of adult-onset #multiplesclerosis.
jamanetwork.com/journals/jamaneurology/fullarticle/10.100… -
JAMA Neurology
@JAMANeuro
Early relapse is common in #pcnsv, with normal cerebrospinal fluid associated with increased recurrence, suggesting current monitoring and treatment strategies may need adjustment.
jamanetwork.com/journals/jamaneurology/fullarticle/10.100… -
JAMA Neurology
@JAMANeuro
Late-window #ivt before transfer for #evt improved 3-month outcomes and recanalization rates without added safety risk in #aislvo patients. jamanetwork.com/journals/jamaneurology/fullarticle/10.100…
-
JAMA Neurology
@JAMANeuro
Obstructive sleep apnea (OSA) was associated with increased risk of incident #parkinsondisease among US veterans, and early CPAP treatment reduced this risk, supporting OSA management as a modifiable midlife factor.
jamanetwork.com/journals/jamaneurology/fullarticle/10.100… -
JAMA Neurology
@JAMANeuro
Among offspring born in Norway between 1967 and 1989, exposure to maternal diabetes and being born large for gestational age were associated with increased risk of adult-onset #multiplesclerosis.
jamanetwork.com/journals/jamaneurology/fullarticle/10.100… -
JAMA Neurology
@JAMANeuro
RCT: Online cognitive training, rehabilitation, and tDCS did not produce superior cognitive or neuropsychological improvements in #longcovid compared to active comparator arms.
jamanetwork.com/journals/jamaneurology/fullarticle/10.100… -
JAMA Neurology
@JAMANeuro
While incidence rates for central nervous system cancer remained stable from 1990 to 2021, both mortality and disability-adjusted life-years (DALYs) declined. jamanetwork.com/journals/jamaneurology/fullarticle/10.100…
-
JAMA Neurology
@JAMANeuro
💬 Editorial: Direct-to-consumer #alzheimer blood tests risk misuse and misinformation; regulation and clinician-led implementation are critical for safe adoption.
jamanetwork.com/journals/jamaneurology/fullarticle/10.100… -
JAMA Neurology
@JAMANeuro
Meta-analysis confirms plasma p-tau217 as a strong candidate for early #alzheimer screening, pending preventive therapies and regulatory guidance. jamanetwork.com/journals/jamaneurology/fullarticle/10.100…
-
JAMA Neurology
@JAMANeuro
In 2021, nervous system disorders impacted >180 million Americans and were the leading cause of disability, with #stroke, Alzheimer disease, #migraine, and diabetic neuropathy causing the largest health losses. jamanetwork.com/journals/jamaneurology/fullarticle/10.100…
-
JAMA Neurology
@JAMANeuro
Adults with #downsyndrome and amyloid-positive #alzheimerdisease had higher alignment between clinical and biological staging compared to sporadic cases. jamanetwork.com/journals/jamaneurology/fullarticle/10.100…
-
JAMA Neurology
@JAMANeuro
Among offspring born in Norway between 1967 and 1989, exposure to maternal diabetes and being born large for gestational age were associated with increased risk of adult-onset #multiplesclerosis. jamanetwork.com/journals/jamaneurology/fullarticle/10.100…
-
JAMA Neurology
@JAMANeuro
Early relapse is common in #pcnsv, with normal cerebrospinal fluid associated with increased recurrence, suggesting current monitoring and treatment strategies may need adjustment. jamanetwork.com/journals/jamaneurology/fullarticle/10.100…
-
JAMA Neurology
@JAMANeuro
HHV-6 was identified as a rare cause of fulminant acute hemorrhagic leukoencephalitis in an immunocompetent adult.
jamanetwork.com/journals/jamaneurology/fullarticle/10.100… -
JAMA Neurology
@JAMANeuro
Case report: a 23-year-old pregnant woman presented with seizures and chronic hepatitis B, with hyperintense lesions discovered in the left caudate nucleus on magnetic resonance imaging.
jamanetwork.com/journals/jamaneurology/fullarticle/10.100… -
JAMA Neurology
@JAMANeuro
Early relapse is common in #pcnsv, with normal cerebrospinal fluid associated with increased recurrence, suggesting current monitoring and treatment strategies may need adjustment. jamanetwork.com/journals/jamaneurology/fullarticle/10.100…
-
JAMA Neurology
@JAMANeuro
General anesthesia improved 90-day disability outcomes and increased the rate of successful reperfusion compared with moderate sedation in patients undergoing endovascular thrombectomy for acute ischemic stroke.
jamanetwork.com/journals/jamaneurology/fullarticle/10.100… -
JAMA Neurology
@JAMANeuro
In a patient with #mma, new-onset dystonic posturing, blepharospasm, and abnormal gait were associated with structural lesions in the globus pallidus and bilateral defects in dopamine transporter function on PET imaging. jamanetwork.com/journals/jamaneurology/fullarticle/10.100…
-
JAMA Neurology
@JAMANeuro
Among patients with #preeclampsia, postpartum blood pressure self-management was linked to larger putamen, accumbens and pallidum volumes vs usual care.
jamanetwork.com/journals/jamaneurology/fullarticle/10.100… -
JAMA Neurology
@JAMANeuro
Frontotemporal #dementia is comparable in frequency to dementia with Lewy bodies and occurs at higher rates than progressive supranuclear palsy, corticobasal syndrome, and amyotrophic lateral sclerosis.
jamanetwork.com/journals/jamaneurology/fullarticle/10.100… -
JAMA Neurology
@JAMANeuro
In patients with ischemic stroke and concurrent nonvalvular atrial fibrillation and ASCVD, adding an antiplatelet agent to anticoagulant therapy offered no net clinical benefit over anticoagulant monotherapy.
jamanetwork.com/journals/jamaneurology/fullarticle/10.100… -
JAMA Neurology
@JAMANeuro
Among patients <70 years with acute #basilararteryocclusion, endovascular thrombectomy doubled the rate of ambulatory and self-care capable outcomes at 3 years vs medical treatment.
jamanetwork.com/journals/jamaneurology/fullarticle/10.100… -
JAMA Neurology
@JAMANeuro
A secondary analysis of the TEMPO-2 RCT found no significant improvement in outcomes for minor ischemic stroke patients treated with intravenous tenecteplase, regardless of the presence of disabling deficits.
jamanetwork.com/journals/jamaneurology/fullarticle/10.100… -
JAMA Neurology
@JAMANeuro
💬 Viewpoint: Chronic immune-mediated peripheral nerve myelinopathies (CIPNM) require precise diagnosis and updated nomenclature due to diverse clinical presentations.
jamanetwork.com/journals/jamaneurology/fullarticle/10.100… -
JAMA Neurology
@JAMANeuro
Among patients <70 years with acute #basilararteryocclusion, endovascular thrombectomy doubled the rate of ambulatory and self-care capable outcomes at 3 years vs medical treatment.
jamanetwork.com/journals/jamaneurology/fullarticle/10.100… -
JAMA Neurology
@JAMANeuro
Among patients <70 years with acute #basilararteryocclusion, endovascular thrombectomy doubled the rate of ambulatory and self-care capable outcomes at 3 years vs medical treatment.
jamanetwork.com/journals/jamaneurology/fullarticle/10.100… -
JAMA Neurology
@JAMANeuro
In patients with ischemic stroke and concurrent nonvalvular atrial fibrillation and ASCVD, adding an antiplatelet agent to anticoagulant therapy offered no net clinical benefit over anticoagulant monotherapy. jamanetwork.com/journals/jamaneurology/fullarticle/10.100…
-
JAMA Neurology
@JAMANeuro
Earlier initiation of tofersen slowed clinical decline, sustained biomarker improvement, and extended survival for SOD1-related #als, with no new long-term safety concerns.
jamanetwork.com/journals/jamaneurology/fullarticle/10.100… -
JAMA Neurology
@JAMANeuro
Earlier initiation of tofersen slowed clinical decline, sustained biomarker improvement, and extended survival for SOD1-related #als, with no new long-term safety concerns.
jamanetwork.com/journals/jamaneurology/fullarticle/10.100… -
JAMA Neurology
@JAMANeuro
A 62-year-old man presented with progressive limb weakness and involuntary movements. Take the Clinical Challenge.
What is your diagnosis?
jamanetwork.com/journals/jamaneurology/fullarticle/10.100… -
JAMA Neurology
@JAMANeuro
The numbers are in.
This year's most popular JAMA Network content spans a range of topics, from #fluoride to #parkinson disease to #glp-1s. What was your favorite article in 2025—and did other readers agree?
🔗 jamanetwork.com/pages/most-viewed-articles?linkId=892306924 -
JAMA Neurology
@JAMANeuro
This case report describes a man presenting with amnestic seizure events manifesting with a wind swirl pattern on density spectral array, resulting in a diagnosis of anti–γ-aminobutyric acid B (GABAB) receptor antibody–associated encephalitis.
jamanetwork.com/journals/jamaneurology/fullarticle/10.100… -
JAMA Neurology
@JAMANeuro
Case report: a 58-year-old patient presenting with seizures and undergoing craniotomy, during which a live parasitic worm was discovered.
jamanetwork.com/journals/jamaneurology/fullarticle/10.100… -
JAMA Neurology
@JAMANeuro
Editorial: Tofersen slowed functional decline and reduced risk of death for patients with SOD1-related #als, especially with early treatment, and showed durable biomarker improvements over 148 weeks.
jamanetwork.com/journals/jamaneurology/fullarticle/10.100… -
JAMA Neurology
@JAMANeuro
Earlier initiation of tofersen slowed clinical decline, sustained biomarker improvement, and extended survival for SOD1-related #als, with no new long-term safety concerns.
jamanetwork.com/journals/jamaneurology/fullarticle/10.100… -
JAMA Neurology
@JAMANeuro
Case report: A 73-year-old woman presented with dysarthria and right-sided hemiparesis (NIH-Stroke Scale score of 9). jamanetwork.com/journals/jamaneurology/fullarticle/10.100…
-
JAMA Neurology
@JAMANeuro
The annual rate of first intracranial hemorrhage from unruptured brain AVMs was 1.4% in a multinational cohort, lower than commonly cited estimates. jamanetwork.com/journals/jamaneurology/fullarticle/10.100…
-
JAMA Neurology
@JAMANeuro
From @JAMA_current: Valacyclovir was associated with greater cognitive decline and did not improve disease markers in patients with symptomatic #alzheimerdisease and HSV seropositivity.
jamanetwork.com/journals/jama/fullarticle/10.1001/jama.20… -
JAMA Neurology
@JAMANeuro
General anesthesia improved 90-day disability outcomes and increased the rate of successful reperfusion compared with moderate sedation in patients undergoing endovascular thrombectomy for acute ischemic stroke.
jamanetwork.com/journals/jamaneurology/fullarticle/10.100… -
JAMA Neurology
@JAMANeuro
Among patients with focal treatment-resistant epilepsy, seizure frequency often decreases over time regardless of changes in medication or neuromodulation device use. jamanetwork.com/journals/jamaneurology/fullarticle/10.100…
-
JAMA Neurology
@JAMANeuro
Lower posttreatment amyloid plaque after donanemab was correlated with slower clinical decline and reduced AD-related plasma biomarkers in TRAILBLAZER-ALZ 2. jamanetwork.com/journals/jamaneurology/fullarticle/10.100…
-
JAMA Neurology
@JAMANeuro
A secondary analysis of the TEMPO-2 RCT found no significant improvement in outcomes for minor ischemic stroke patients treated with intravenous tenecteplase, regardless of the presence of disabling deficits. jamanetwork.com/journals/jamaneurology/fullarticle/10.100…
-
JAMA Neurology
@JAMANeuro
AI-driven TPNS device improved daily activity scores for #essentialtremor at 90 days versus sham in a multicenter RCT. Device may offer a new noninvasive option for ET; mild skin irritation was most common adverse event.
jamanetwork.com/journals/jamaneurology/fullarticle/10.100… -
JAMA Neurology
@JAMANeuro
Editorial: Plasma tau biomarkers such as p-tau217 are robust predictors of #alzheimerdisease pathology, but their use as interchangeable substitutes for tau PET imaging may be limited. jamanetwork.com/journals/jamaneurology/fullarticle/10.100…
-
JAMA Neurology
@JAMANeuro
Individuals with #alzheimerdisease showing greater clinical impairment than predicted by tau burden are more likely to have copathology, including #tdp43 and #alphasynuclein, and experience faster decline. jamanetwork.com/journals/jamaneurology/fullarticle/10.100…
-
JAMA Neurology
@JAMANeuro
In patients with ischemic stroke and concurrent nonvalvular atrial fibrillation and ASCVD, adding an antiplatelet agent to anticoagulant therapy offered no net clinical benefit over anticoagulant monotherapy. jamanetwork.com/journals/jamaneurology/fullarticle/10.100…
-
JAMA Neurology
@JAMANeuro
#menopause was not associated with increased risk of disability progression or secondary progressive MS in women with relapse-onset MS. jamanetwork.com/journals/jamaneurology/fullarticle/10.100…
-
JAMA Neurology
@JAMANeuro
💬 Editorial: Recent trials show intravenous thrombolysis provides no clear benefit for patients presenting to the emergency department with mild stroke (NIHSS 0–5), highlighting the need for highly individualized treatment decisions. jamanetwork.com/journals/jamaneurology/fullarticle/10.100…
-
JAMA Neurology
@JAMANeuro
Editorial: Recent trials of wearable nerve stimulators for #essentialtremor offer limited benefit over placebo. Noninvasive therapies may expand options for ET, but more evidence is needed before these devices achieve widespread uptake. jamanetwork.com/journals/jamaneurology/fullarticle/10.100…
-
JAMA Neurology
@JAMANeuro
Editorial: The ATIS-NVAF trial shows adding antiplatelet therapy to OAC in stroke patients with AF and atherosclerotic disease increases major bleeding without significant reduction in ischemic events. jamanetwork.com/journals/jamaneurology/fullarticle/10.100…
-
JAMA Neurology
@JAMANeuro
"The book is not closed on a more expansive view of the entire menopausal transition." Learn more in this Editorial. jamanetwork.com/journals/jamaneurology/fullarticle/10.100…
-
JAMA Neurology
@JAMANeuro
Viewpoint: Chronic immune-mediated peripheral nerve myelinopathies (CIPNM) require precise diagnosis and updated nomenclature due to diverse clinical presentations. jamanetwork.com/journals/jamaneurology/fullarticle/10.100…
-
JAMA Neurology
@JAMANeuro
Viewpoint: Recent trials challenge the efficacy of endovascular thrombectomy for distal and medium vessel occlusions, necessitating refined patient selection and exploring alternative treatments. jamanetwork.com/journals/jamaneurology/fullarticle/10.100…
-
JAMA Neurology
@JAMANeuro
Rising costs for #multiplesclerosis care are largely attributed to disease-modifying therapies, increasing patient financial burden over time. jamanetwork.com/journals/jamaneurology/fullarticle/10.100…
-
JAMA Neurology
@JAMANeuro
#opticalcoherencetomography reveals detailed thrombus composition and vessel wall pathology in carotid free-floating thrombus, guiding stent placement and clarifying stroke etiology. jamanetwork.com/journals/jamaneurology/fullarticle/10.100…
-
JAMA Neurology
@JAMANeuro
Clinicians and administrators encounter significant time burden and burnout due to prior authorization for neurologic medications. Specialty pharmacy integration may help reduce barriers. jamanetwork.com/journals/jamaneurology/fullarticle/10.100…
-
JAMA Neurology
@JAMANeuro
Oveporexton produced significant improvements in sustained attention, memory, and executive function among adults with #narcolepsytype1. jamanetwork.com/journals/jamaneurology/fullarticle/10.100…
-
JAMA Neurology
@JAMANeuro
Viewpoint: By removing conventional academic benchmarks, medical education has inadvertently increased student stress, underscoring the need for balanced assessment methods. jamanetwork.com/journals/jamaneurology/fullarticle/10.100…
-
JAMA Neurology
@JAMANeuro
This case report describes a unique presentation of Kelch-like protein 11 antibody-associated paraneoplastic encephalitis in an 81-year-old woman with a high-grade neuroendocrine carcinoma consistent with metastatic Merkel cell carcinoma. jamanetwork.com/journals/jamaneurology/fullarticle/10.100…
-
JAMA Neurology
@JAMANeuro
"An early and reliable 4R-tau biomarker might help guide the timing of disease-modifying therapies."
Read more about copathology in atypical Parkinsonism in this Viewpoint. jamanetwork.com/journals/jamaneurology/fullarticle/10.100… -
JAMA Neurology
@JAMANeuro
In patients with AIS-LVO admitted to non-thrombectomy centers after 4.5 hours, IVT before transfer for endovascular therapy was associated with improved 3-month functional outcomes and higher rates of recanalization during transfer.
jamanetwork.com/journals/jamaneurology/fullarticle/10.100… -
JAMA Neurology
@JAMANeuro
Editorial: In a meta-analysis, Malek-Ahmadi and colleagues show that plasma p-tau217 reliably distinguishes biomarker-positive from biomarker-negative individuals without cognitive impairment.
jamanetwork.com/journals/jamaneurology/fullarticle/10.100… -
JAMA Neurology
@JAMANeuro
Among published studies involving older adults without cognitive impairment, plasma p-tau217 was shown to reliably differentiate amyloid-positive from amyloid-negative individuals, with a large effect size and high diagnostic accuracy.
jamanetwork.com/journals/jamaneurology/fullarticle/10.100… -
JAMA Neurology
@JAMANeuro
More than half of the US population experienced health loss due to neurological, neurodevelopmental, metabolic, or infectious disorders in 2021, with #stroke and #dementia ranking among the top causes of disability and death.
jamanetwork.com/journals/jamaneurology/fullarticle/10.100… -
JAMA Neurology
@JAMANeuro
Among US veterans, obstructive sleep apnea was independently associated with an increased risk of developing #parkinson disease, even after accounting for potential confounders and competing risks.
jamanetwork.com/journals/jamaneurology/fullarticle/10.100… -
JAMA Neurology
@JAMANeuro
In #pediatric patients with #multiplesclerosis, chronic lesion development begins early in the disease course, even with effective treatment.
jamanetwork.com/journals/jamaneurology/fullarticle/10.100… -
JAMA Neurology
@JAMANeuro
More than half of the US population experienced health loss due to neurological, neurodevelopmental, metabolic, or infectious disorders in 2021, with #stroke and #dementia ranking among the top causes of disability and death.
jamanetwork.com/journals/jamaneurology/fullarticle/10.100… -
JAMA Neurology
@JAMANeuro
Participants with hearing loss who used hearing aids showed reduced risk for #dementia among those younger than 70 years at the time of hearing evaluation, when followed up for up to 20 years.
jamanetwork.com/journals/jamaneurology/fullarticle/10.100… -
JAMA Neurology
@JAMANeuro
On December 1 at 10 AM ET, JAMA Editor in Chief Kirsten Bibbins-Domingo, PhD, MD, MAS, will co-chair a public, live-streamed webinar discussing a new @WHO guideline concerning #glp-1 therapy and adults with #obesity.
Register for the webinar: www.who.int/news-room/events/detail/2025/12/01/default-ca… -
JAMA Neurology
@JAMANeuro
Case report: a false-negative result of the aquaporin-4–immunoglobulin G (AQP4-IgG) test due to the prozone effect in a woman with neuromyelitis optica spectrum disorder (NMOSD). jamanetwork.com/journals/jamaneurology/fullarticle/10.100…
-
JAMA Neurology
@JAMANeuro
More than half of the US population experienced health loss due to neurological, neurodevelopmental, metabolic, or infectious disorders in 2021, with #stroke and #dementia ranking among the top causes of disability and death.
jamanetwork.com/journals/jamaneurology/fullarticle/10.100… -
JAMA Neurology
@JAMANeuro
This case report describes a patient with a back-and-forth interhemispheric migration along a bullet’s own trajectory.
jamanetwork.com/journals/jamaneurology/fullarticle/10.100… -
JAMA Neurology
@JAMANeuro
Case report: a 61-year-old man with alcohol use disorder presented with altered consciousness and vision loss after ceasing alcohol consumption. jamanetwork.com/journals/jamaneurology/fullarticle/10.100…
-
JAMA Neurology
@JAMANeuro
On December 1 at 10 AM ET, JAMA Editor in Chief Kirsten Bibbins-Domingo, PhD, MD, MAS, will co-chair a public, live-streamed webinar discussing a new WHO guideline concerning #glp-1 therapy and adults with #obesity.
Register for the webinar: www.who.int/news-room/events/detail/2025/12/01/default-ca… -
JAMA Neurology
@JAMANeuro
Among US veterans, obstructive sleep apnea was independently associated with an increased risk of developing #parkinson disease, even after accounting for potential confounders and competing risks.
jamanetwork.com/journals/jamaneurology/fullarticle/10.100… -
JAMA Neurology
@JAMANeuro
Among US veterans, obstructive sleep apnea was independently associated with an increased risk of developing #parkinson disease, even after accounting for potential confounders and competing risks.
jamanetwork.com/journals/jamaneurology/fullarticle/10.100… -
JAMA Neurology
@JAMANeuro
Adults with acute #dengue virus infection had higher odds of developing neurological events—including memory loss, movement disorders, and fatigue—within 90 days compared to uninfected peers.
jamanetwork.com/journals/jamaneurology/fullarticle/10.100… -
JAMA Neurology
@JAMANeuro
📢 Are you an early-career neurologist with an interest in publishing?
Join the @JAMANeuro editorial team for a fellowship starting Feb. 2026. Learn the editorial process, contribute to the journal, grow your academic career. Apply by Dec. 1.
🔗 jamanetwork.com/pages/jama-neurology-editorial-fellowship -
JAMA Neurology
@JAMANeuro
Among US veterans, obstructive sleep apnea was independently associated with an increased risk of developing #parkinson disease, even after accounting for potential confounders and competing risks.
jamanetwork.com/journals/jamaneurology/fullarticle/10.100… -
JAMA Neurology
@JAMANeuro
Interview with John P. Ney, MD, MPH, author of US Burden of Disorders Affecting the Nervous System: From the Global Burden of Disease 2021 Study. Hosted by Cynthia E. Armand, MD. edhub.ama-assn.org/jn-learning/audio-player/10.1001/jaman…
-
JAMA Neurology
@JAMANeuro
More than half of the US population experienced health loss due to neurological, neurodevelopmental, metabolic, or infectious disorders in 2021, with #stroke and #dementia ranking among the top causes of disability and death.
jamanetwork.com/journals/jamaneurology/fullarticle/10.100… -
JAMA Neurology
@JAMANeuro
Subthalamic nucleus deep brain stimulation may improve motor function, activities of daily living, and reduces dyskinesia and medication needs in #parkinson patients. jamanetwork.com/journals/jamaneurology/fullarticle/10.100…
-
JAMA Neurology
@JAMANeuro
Long-term adaptive deep brain stimulation (aDBS) provided tolerable, effective, and safe therapy in persons with Parkinson disease whose symptoms were previously stable while receiving continuous DBS. jamanetwork.com/journals/jamaneurology/fullarticle/10.100…
-
JAMA Neurology
@JAMANeuro
Are you interested in receiving hands-on editorial training with an international peer-reviewed medical journal?
@JAMANeuro is accepting applications from early-career faculty for its editorial fellowship program starting in Feb. 2026.
Apply by Dec. 1: jamanetwork.com/pages/jama-neurology-editorial-fellowship… -
JAMA Neurology
@JAMANeuro
Home high-intensity aerobic training improved ataxia symptoms, fatigue, and aerobic fitness more effectively than dose-matched home balance training among individuals with cerebellar ataxias. jamanetwork.com/journals/jamaneurology/fullarticle/10.100…
-
JAMA Neurology
@JAMANeuro
Higher levels of fine particulate matter air pollution was associated with increased #dementia severity and increased #alzheimer disease neuropathologic change. jamanetwork.com/journals/jamaneurology/fullarticle/10.100…
-
JAMA Neurology
@JAMANeuro
JAMA Neurology is accepting applications for its 2026 Editorial Fellowship.
This 1-year opportunity offers early-career neurologists hands-on publishing experience, mentorship & a chance to contribute to a leading journal.
🔗Apply by December 1: jamanetwork.com/pages/jama-neurology-editorial-fellowship… -
JAMA Neurology
@JAMANeuro
From @JAMA_current: Peripheral neuropathy, defined as damage to the peripheral nerves, affects approximately 1% of adults worldwide.
This Review summarizes the clinical presentation, diagnosis, and treatment of length-dependent peripheral neuropathy.
jamanetwork.com/journals/jama/fullarticle/10.1001/jama.20… -
JAMA Neurology
@JAMANeuro
Viewpoint: Routine brain health screening, interdisciplinary teams, and policy reforms addressing neurotoxic exposures may shift neurology toward primary prevention—reducing disease burden across populations. jamanetwork.com/journals/jamaneurology/fullarticle/10.100…
-
JAMA Neurology
@JAMANeuro
Among patients with AF, surgical occlusion of the left atrial appendage was associated with lower rates of #stroke-related disability and mortality and a decreased proportion of cardioembolic #stroke. jamanetwork.com/journals/jamaneurology/fullarticle/10.100…
-
JAMA Neurology
@JAMANeuro
Frontotemporal #dementia is comparable in frequency to dementia with Lewy bodies and occurs at higher rates than progressive supranuclear palsy, corticobasal syndrome, and amyotrophic lateral sclerosis. jamanetwork.com/journals/jamaneurology/fullarticle/10.100…
-
JAMA Neurology
@JAMANeuro
Aneurysm wall enhancement on MRI, particularly circumferential AWE, may be used to predict the risk of instability in unruptured intracranial aneurysms over a four-year period. jamanetwork.com/journals/jamaneurology/fullarticle/10.100…
-
JAMA Neurology
@JAMANeuro
Plasma p-tau217 is a useful stand-alone marker and, when combined with confirmatory PET or CSF testing, may enhance precision in identifying cognitively unimpaired individuals with amyloid β pathology for preclinical #alzheimer disease trials. jamanetwork.com/journals/jamaneurology/fullarticle/10.100…
-
JAMA Neurology
@JAMANeuro
📢 Are you an early-career neurologist with an interest in publishing?
Join the @JAMANeuro editorial team for a 1-year fellowship starting Feb. 2026. Learn the editorial process, contribute to the journal, & grow your academic career. Apply by Dec. 1.
🔗jamanetwork.com/pages/jama-neurology-editorial-fellowship -
JAMA Neurology
@JAMANeuro
Viewpoint: The updated 2024 McDonald criteria enable MS diagnosis in asymptomatic individuals by incorporating imaging and CSF biomarkers, such as CVS and κ-FLC index, while promoting a single standardized framework. jamanetwork.com/journals/jamaneurology/fullarticle/10.100…
-
JAMA Neurology
@JAMANeuro
In patients with supratentorial intracerebral hemorrhage, minimally invasive surgery within 72 hours did not significantly reduce 30-day mortality or improve 180-day disability. @PenNeuro jamanetwork.com/journals/jamaneurology/fullarticle/10.100…
-
JAMA Neurology
@JAMANeuro
This case report describes a patient with left-sided weakness following transient ischemic attacks who underwent external carotid angioplasty based on findings from ultrahigh-resolution photon-counting computed tomographic angiography (CTA). jamanetwork.com/journals/jamaneurology/fullarticle/10.100…
-
JAMA Neurology
@JAMANeuro
Editorial: A probabilistic approach to explicate the role of atherosclerotic and arteriolosclerotic CVD would represent the broader clinical-biological construct more accurately. jamanetwork.com/journals/jamaneurology/fullarticle/10.100…
-
JAMA Neurology
@JAMANeuro
The VasCog-2-WSO criteria provide updated international guidelines for diagnosing vascular cognitive impairment and #dementia, incorporating recent biomarker advancements. jamanetwork.com/journals/jamaneurology/fullarticle/10.100…
-
JAMA Neurology
@JAMANeuro
Editorial: The risk of meningiomas increases with progestogen use such as depot medroxyprogesterone acetate (dMPA), especially with prolonged exposure, but overall incidence remains low. jamanetwork.com/journals/jamaneurology/fullarticle/10.100…
-
JAMA Neurology
@JAMANeuro
Depot medroxyprogesterone acetate use is associated with an increased risk of meningioma diagnosis, particularly with prolonged exposure and older age at initiation, though the overall clinical risk remains low. jamanetwork.com/journals/jamaneurology/fullarticle/10.100…
-
JAMA Neurology
@JAMANeuro
Epilepsy incidence among US Medicare beneficiaries aged 65 and older varied tenfold across regions and was associated with insufficient sleep, lack of vehicle access, heat index, physical inactivity, and uninsured rate. jamanetwork.com/journals/jamaneurology/fullarticle/10.100…
-
JAMA Neurology
@JAMANeuro
RCT: Online cognitive training, rehabilitation, and tDCS did not produce superior cognitive or neuropsychological improvements in long #covid compared to active comparator arms. jamanetwork.com/journals/jamaneurology/fullarticle/10.100…
-
JAMA Neurology
@JAMANeuro
📢 Calling all early-career neurologists!
Looking to learn about medical publishing, receive mentorship from senior editors, and gain hands-on editorial training? We invite you to apply to the 2026 @JAMANeuro Editorial Fellowship.
🔗 Apply by December 1: jamanetwork.com/pages/jama-neurology-editorial-fellowship -
JAMA Neurology
@JAMANeuro
The JAMA Network invites research submissions on #ai in clinical settings, prioritizing rigorous methodologies and validation for informed medical practice.
🔗 See the full submission criteria: jamanetwork.com/journals/jama/fullarticle/10.1001/jama.20… -
JAMA Neurology
@JAMANeuro
Viewpoint: As neurologic disorders remain a leading cause of disability and death, community-engaged research offers a promising approach to close the “know-do gap” between discovery and real-world impact. jamanetwork.com/journals/jamaneurology/fullarticle/10.100…
-
JAMA Neurology
@JAMANeuro
This case report describes a 73-year-old man with a type B aortic dissection and quadriplegia.
jamanetwork.com/journals/jamaneurology/fullarticle/10.100… -
JAMA Neurology
@JAMANeuro
📢 Are you an early-career neurologist with an interest in publishing?
Join the @JAMANeuro editorial team for a 1-year fellowship starting Feb. 2026. Learn the editorial process, contribute to the journal, & grow your academic career. Apply by Dec. 1.
🔗 jamanetwork.com/pages/jama-neurology-editorial-fellowship -
JAMA Neurology
@JAMANeuro
A 12-week remote, automated gamification intervention increased daily steps by 28% among US veterans with Parkinson disease, according to unadjusted analyses. jamanetwork.com/journals/jamaneurology/fullarticle/10.100…
-
JAMA Neurology
@JAMANeuro
While incidence rates for central nervous system cancer remained stable from 1990 to 2021, both mortality and disability-adjusted life-years (DALYs) declined. jamanetwork.com/journals/jamaneurology/fullarticle/10.100…
-
JAMA Neurology
@JAMANeuro
Case report: a 65-year-old man with a mobile filling defect detected in his middle cerebral artery during mechanical thrombectomy. jamanetwork.com/journals/jamaneurology/fullarticle/10.100…
-
JAMA Neurology
@JAMANeuro
Case report: a 23-year-old pregnant woman presented with seizures and chronic hepatitis B, with hyperintense lesions discovered in the left caudate nucleus on magnetic resonance imaging. jamanetwork.com/journals/jamaneurology/fullarticle/10.100…
-
JAMA Neurology
@JAMANeuro
While the advent of general AI promises broader access to health care, it also introduces risks. This Viewpoint discusses the integration of artificial intelligence in neurology. jamanetwork.com/journals/jamaneurology/fullarticle/10.100…
-
JAMA Neurology
@JAMANeuro
Viewpoint: Advances in epilepsy research, including disease-modifying therapies and genomic newborn screening, promise a shift from symptomatic treatment to proactive disease prevention. jamanetwork.com/journals/jamaneurology/fullarticle/10.100…
-
JAMA Neurology
@JAMANeuro
This individual-patient study validated the results of previous studies showing that treatment effect on disability in progressive multiple sclerosis is limited to patients with inflammatory activity at baseline. jamanetwork.com/journals/jamaneurology/fullarticle/10.100…
-
JAMA Neurology
@JAMANeuro
The JAMA Network is committed to providing clinicians & policymakers with the evidence they need to make informed decisions in an evolving technology landscape.
We seek original research on the clinical application of #ai in medicine.
🔗 Learn more: jamanetwork.com/journals/jama/fullarticle/10.1001/jama.20… -
JAMA Neurology
@JAMANeuro
This case report discusses a patient with vertebral pseudoaneurysm that spontaneously ruptured and led to vertebro-vertebral arteriovenous fistula requiring endovascular therapy. jamanetwork.com/journals/jamaneurology/fullarticle/10.100…
-
JAMA Neurology
@JAMANeuro
Patients with sporadic Creutzfeldt-Jakob Disease have a brief, age-dependent life expectancy, typically lasting 12 weeks, unchanged despite rising incidence over 30 years. jamanetwork.com/journals/jamaneurology/fullarticle/10.100…
-
JAMA Neurology
@JAMANeuro
Editorial: Recent trials show intravenous thrombolysis provides no clear benefit for patients presenting to the emergency department with mild stroke (NIHSS 0–5), highlighting the need for highly individualized treatment decisions. jamanetwork.com/journals/jamaneurology/fullarticle/10.100…
-
JAMA Neurology
@JAMANeuro
A secondary analysis of the TEMPO-2 RCT found no significant improvement in outcomes for minor ischemic stroke patients treated with intravenous tenecteplase, regardless of the presence of disabling deficits. jamanetwork.com/journals/jamaneurology/fullarticle/10.100…
-
JAMA Neurology
@JAMANeuro
Prenatal exposure to chlorpyrifos is associated with long-term alterations in brain structure, function, metabolism, and poor motor performance in children aged 6 to 14 years. jamanetwork.com/journals/jamaneurology/fullarticle/10.100…
-
JAMA Neurology
@JAMANeuro
Male patients with #dementia have higher mortality rates and greater use of health care services, particularly hospitalizations, compared to female patients. jamanetwork.com/journals/jamaneurology/fullarticle/10.100…
-
JAMA Neurology
@JAMANeuro
Early initiation of intravenous immunoglobulin treatment within the first year of onset is associated with improved long-term outcomes and survival in patients with anti-IgLON5 disease. jamanetwork.com/journals/jamaneurology/fullarticle/10.100…
-
JAMA Neurology
@JAMANeuro
Compared with endovascular treatment (EVT) alone, intravenous thrombolysis plus EVT modestly increased the risk of intracranial hemorrhage, notably any parenchymal hematoma. jamanetwork.com/journals/jamaneurology/fullarticle/10.100…
-
JAMA Neurology
@JAMANeuro
This case report describes a patient who presented with a 2-day history of dizziness, unsteady gait, and confusion. In the past month, he had experienced 2 cerebral infarctions and fungal infection in his left armpit. jamanetwork.com/journals/jamaneurology/fullarticle/10.100…
-
JAMA Neurology
@JAMANeuro
In the Human Epilepsy Project multicenter cohort study, most individuals with newly diagnosed focal #epilepsy required over a year and multiple antiseizure medications to become seizure free. jamanetwork.com/journals/jamaneurology/fullarticle/10.100…
-
JAMA Neurology
@JAMANeuro
Among patients with focal treatment-resistant epilepsy, seizure frequency often decreases over time regardless of changes in medication or neuromodulation device use.
jamanetwork.com/journals/jamaneurology/fullarticle/10.100… -
JAMA Neurology
@JAMANeuro
Oseltamivir treatment during influenza episodes was associated with a reduced risk of serious neuropsychiatric events in children and adolescents enrolled in Tennessee Medicaid. jamanetwork.com/journals/jamaneurology/fullarticle/10.100…
-
JAMA Neurology
@JAMANeuro
Editorial: Recent trials of wearable nerve stimulators for #essentialtremor offer limited benefit over placebo. Noninvasive therapies may expand options for ET, but more evidence is needed before these devices achieve widespread uptake. jamanetwork.com/journals/jamaneurology/fullarticle/10.100…
-
JAMA Neurology
@JAMANeuro
AI-driven TPNS device improved daily activity scores for #essentialtremor at 90 days versus sham in a multicenter RCT. Device may offer a new noninvasive option for ET; mild skin irritation was most common adverse event. jamanetwork.com/journals/jamaneurology/fullarticle/10.100…
-
JAMA Neurology
@JAMANeuro
Adding argatroban or eptifibatide to intravenous thrombolysis did not improve reperfusion rates or clinical outcomes in endovascular thrombectomy for acute ischemic stroke. jamanetwork.com/journals/jamaneurology/fullarticle/10.100…
-
JAMA Neurology
@JAMANeuro
In women with multiple sclerosis, disease-modifying therapy management during pregnancy increased relapse risk, particularly in patients receiving natalizumab with prolonged interruption or fingolimod. jamanetwork.com/journals/jamaneurology/fullarticle/10.100…
-
JAMA Neurology
@JAMANeuro
Editorial: Plasma p-tau217 is a promising yet complementary #alzheimer biomarker, aiding diagnosis and trial efficiency but not fully replacing CSF and PET, especially in those without cognitive impairment.
jamanetwork.com/journals/jamaneurology/fullarticle/10.100… -
JAMA Neurology
@JAMANeuro
Across the JAMA Network, we seek submission of manuscripts describing original research that examines the application of #ai in clinical settings.
🔗 Learn more about submission criteria: jamanetwork.com/journals/jama/fullarticle/10.1001/jama.20… -
JAMA Neurology
@JAMANeuro
Using tau PET and plasma p-tau217 biomarkers may refine #alzheimer trials by tracking disease progression in real-time and anticipating cognitive changes prior to impairment.
jamanetwork.com/journals/jamaneurology/fullarticle/10.100… -
JAMA Neurology
@JAMANeuro
From @JAMA_current: #microplastics are increasingly detected in human tissues, with potential links to cognitive, cardiovascular, and inflammatory outcomes.
📌 Learn more: jamanetwork.com/journals/jama/fullarticle/10.1001/jama.20… -
JAMA Neurology
@JAMANeuro
HHV-6 was identified as a rare cause of fulminant acute hemorrhagic leukoencephalitis in an immunocompetent adult.
jamanetwork.com/journals/jamaneurology/fullarticle/10.100… -
JAMA Neurology
@JAMANeuro
Lower posttreatment amyloid plaque after donanemab was correlated with slower clinical decline and reduced AD-related plasma biomarkers in TRAILBLAZER-ALZ 2. jamanetwork.com/journals/jamaneurology/fullarticle/10.100…
-
JAMA Neurology
@JAMANeuro
From @JAMA_current: After mechanical thrombectomy for acute LVO stroke, intra-arterial alteplase increased the rate of excellent 90-day functional outcomes without raising symptomatic intracranial hemorrhage.
jamanetwork.com/journals/jama/fullarticle/10.1001/jama.20… -
JAMA Neurology
@JAMANeuro
General anesthesia improved 90-day disability outcomes and increased the rate of successful reperfusion compared with moderate sedation in patients undergoing endovascular thrombectomy for acute ischemic stroke. jamanetwork.com/journals/jamaneurology/fullarticle/10.100…
-
JAMA Neurology
@JAMANeuro
Viewpoint: The APOE4 allele is associated with an increased risk of #alzheimer disease and earlier onset, but more longitudinal studies with diverse populations are needed to accurately estimate this risk.
jamanetwork.com/journals/jamaneurology/fullarticle/10.100… -
JAMA Neurology
@JAMANeuro
In patients with post-dural puncture headache who do not respond to conventional treatment, iatrogenic CSF-venous fistula should be considered as it may necessitate different treatment.
jamanetwork.com/journals/jamaneurology/fullarticle/10.100… -
JAMA Neurology
@JAMANeuro
Brain arteriovenous malformations are high flow cerebrovascular lesions with great potential to cause intracranial hemorrhage and epilepsy.
Learn more in this episode with author Helen Kim, PhD, and JAMA Neurology Web Editor Cynthia Armand.
edhub.ama-assn.org/jn-learning/audio-player/19008008?link… -
JAMA Neurology
@JAMANeuro
The annual rate of first intracranial hemorrhage from unruptured brain AVMs was 1.4% in a multinational cohort, lower than commonly cited estimates.
jamanetwork.com/journals/jamaneurology/fullarticle/10.100… -
JAMA Neurology
@JAMANeuro
Editorial: The ATIS-NVAF trial shows adding antiplatelet therapy to OAC in stroke patients with AF and atherosclerotic disease increases major bleeding without significant reduction in ischemic events.
jamanetwork.com/journals/jamaneurology/fullarticle/10.100… -
JAMA Neurology
@JAMANeuro
In patients with ischemic stroke and concurrent nonvalvular atrial fibrillation and ASCVD, adding an antiplatelet agent to anticoagulant therapy offered no net clinical benefit over anticoagulant monotherapy.
jamanetwork.com/journals/jamaneurology/fullarticle/10.100… -
JAMA Neurology
@JAMANeuro
The VasCog-2-WSO criteria provide updated international guidelines for diagnosing vascular cognitive impairment and #dementia, incorporating recent biomarker advancements. jamanetwork.com/journals/jamaneurology/fullarticle/10.100…
-
JAMA Neurology
@JAMANeuro
"Neurologists should take the same caution and consideration as psychiatrists in their code of ethics for public persons."
This Viewpoint discusses the ethical considerations of commenting on the neurological health of public figures. jamanetwork.com/journals/jamaneurology/fullarticle/10.100… -
JAMA Neurology
@JAMANeuro
Case report: brain imaging of 2 patients with a disease course suggestive of autoimmune glial fibrillary acidic protein astrocytopathy. jamanetwork.com/journals/jamaneurology/fullarticle/10.100…
-
JAMA Neurology
@JAMANeuro
Case report: an atypical postvaccinal encephalitis in a 60-year-old man, with radial perivascular enhancement consistent with inflammation of glial fibrillary acidic protein–rich white matter loci. jamanetwork.com/journals/jamaneurology/fullarticle/10.100…
-
JAMA Neurology
@JAMANeuro
Case report: a patient with X-linked FHL1-related myofibrillar myopathy and Charcot-Marie-Tooth disease type 1A, a dual pathology revealed by imaging and genetic testing. jamanetwork.com/journals/jamaneurology/fullarticle/10.100…
-
JAMA Neurology
@JAMANeuro
"The book is not closed on a more expansive view of the entire menopausal transition."
Learn more in this Editorial. jamanetwork.com/journals/jamaneurology/fullarticle/10.100… -
JAMA Neurology
@JAMANeuro
In this study, menopause was not the primary driver of multiple sclerosis clinical progression in women at midlife.
jamanetwork.com/journals/jamaneurology/fullarticle/10.100… -
JAMA Neurology
@JAMANeuro
OTOF gene therapy (GT) offers rapid improvements in auditory and speech performance, outperforming cochlear implantation (CI) in speech in noise and music perception.
jamanetwork.com/journals/jamaneurology/fullarticle/10.100… -
JAMA Neurology
@JAMANeuro
OTOF gene therapy (GT) offers rapid improvements in auditory and speech performance, outperforming cochlear implantation (CI) in speech in noise and music perception.
jamanetwork.com/journals/jamaneurology/fullarticle/10.100… -
JAMA Neurology
@JAMANeuro
Local visual interpretations of clinical amyloid-PET scans closely matched central quantitative assessments, supporting the reliability of visual reads in real-world clinical settings. jamanetwork.com/journals/jamaneurology/fullarticle/10.100…
-
JAMA Neurology
@JAMANeuro
Behavioral therapy is noninferior to drug therapy in improving overactive bladder symptoms in #parkinson disease. jamanetwork.com/journals/jamaneurology/fullarticle/10.100… @baldheadted
-
JAMA Neurology
@JAMANeuro
Case report: a man who self-diagnosed rapid-eye-movement (REM) sleep behavior disorder using a sleep-tracking wearable device, later confirmed by a sleep evaluation. jamanetwork.com/journals/jamaneurology/fullarticle/10.100…
-
JAMA Neurology
@JAMANeuro
Long-term adaptive deep brain stimulation (aDBS) provided tolerable, effective, and safe therapy in persons with Parkinson disease whose symptoms were previously stable while receiving continuous DBS. jamanetwork.com/journals/jamaneurology/fullarticle/10.100…
-
JAMA Neurology
@JAMANeuro
Laser interstitial thermal therapy may be considered as a treatment option for durable seizure control and quality of life improvements in patients with mesial temporal lobe epilepsy. jamanetwork.com/journals/jamaneurology/fullarticle/10.100…
-
JAMA Neurology
@JAMANeuro
Editorial: A probabilistic approach to explicate the role of atherosclerotic and arteriolosclerotic CVD would represent the broader clinical-biological construct more accurately. jamanetwork.com/journals/jamaneurology/fullarticle/10.100…
-
JAMA Neurology
@JAMANeuro
The VasCog-2-WSO criteria provide updated international guidelines for diagnosing vascular cognitive impairment and #dementia, incorporating recent biomarker advancements. jamanetwork.com/journals/jamaneurology/fullarticle/10.100…
-
JAMA Neurology
@JAMANeuro
Zero-degree head positioning for acute LVO patients is a protective maneuver to maintain clinical stability in the pre-thrombectomy phase while awaiting definitive treatment. jamanetwork.com/journals/jamaneurology/fullarticle/10.100…
-
JAMA Neurology
@JAMANeuro
Case report: the appearance of autosomal recessive limb-girdle muscular dystrophy in a 30-year-old man with lower limb weakness, asymmetric atrophy of thigh muscles, and wasting of calf muscles. jamanetwork.com/journals/jamaneurology/fullarticle/10.100… @atabisneuro
-
JAMA Neurology
@JAMANeuro
A 62-year-old man presented with progressive limb weakness and involuntary movements. Take the Clinical Challenge. What is your diagnosis? jamanetwork.com/journals/jamaneurology/fullarticle/10.100…
-
JAMA Neurology
@JAMANeuro
Subthalamic nucleus deep brain stimulation may improve motor function, activities of daily living, and reduces dyskinesia and medication needs in #parkinson patients. jamanetwork.com/journals/jamaneurology/fullarticle/10.100…
-
JAMA Neurology
@JAMANeuro
Viewpoint: Empowering primary care practitioners to manage common neurological conditions may improve access, reduce delays, and enhance care quality. jamanetwork.com/journals/jamaneurology/fullarticle/10.100… @ShuvroRoy
-
JAMA Neurology
@JAMANeuro
Plasma p-tau217 is a useful stand-alone marker and, when combined with confirmatory PET or CSF testing, may enhance precision in identifying cognitively unimpaired individuals with amyloid β pathology for preclinical #alzheimer disease trials. jamanetwork.com/journals/jamaneurology/fullarticle/10.100…
-
JAMA Neurology
@JAMANeuro
Home high-intensity aerobic training improved ataxia symptoms, fatigue, and aerobic fitness more effectively than dose-matched home balance training among individuals with cerebellar ataxias.
#ana2025 @TheNewANA1
jamanetwork.com/journals/jamaneurology/fullarticle/10.100… -
JAMA Neurology
@JAMANeuro
At #ana2025? 🩺 Don't miss these timely articles from JAMA Neurology, selected to enhance your conference takeaways: 👇
MRI aneurysm wall imaging may be used for predicting the risk of aneurysm instability.
jamanetwork.com/journals/jamaneurology/fullarticle/10.100…Post not available here, view on X
JAMA Neurology
@JAMANeuro
Frontotemporal #dementia is comparable in frequency to dementia with Lewy bodies and occurs at higher rates than progressive supranuclear palsy, corticobasal syndrome, and amyotrophic lateral sclerosis.
#ana2025
jamanetwork.com/journals/jamaneurology/fullarticle/10.100…
JAMA Neurology
@JAMANeuro
Higher levels of fine particulate matter air pollution was associated with increased #dementia severity and increased #alzheimer disease neuropathologic change.
#ana2025
jamanetwork.com/journals/jamaneurology/fullarticle/10.100… -
JAMA Neurology
@JAMANeuro
In anterior circulation stroke patients post-thrombectomy, low and medium doses of intra-arterial tenecteplase demonstrated adequate safety to warrant larger trials to investigate their therapeutic potential. jamanetwork.com/journals/jamaneurology/fullarticle/10.100…
-
JAMA Neurology
@JAMANeuro
Frontotemporal #dementia is comparable in frequency to dementia with Lewy bodies and occurs at higher rates than progressive supranuclear palsy, corticobasal syndrome, and amyotrophic lateral sclerosis. jamanetwork.com/journals/jamaneurology/fullarticle/10.100…
-
JAMA Neurology
@JAMANeuro
Higher levels of fine particulate matter air pollution was associated with increased #dementia severity and increased #alzheimer disease neuropathologic change. jamanetwork.com/journals/jamaneurology/fullarticle/10.100…
-
JAMA Neurology
@JAMANeuro
#glp-1 RA therapy may offer an alternative management strategy for idiopathic intracranial #hypertension. jamanetwork.com/journals/jamaneurology/fullarticle/10.100…
-
JAMA Neurology
@JAMANeuro
Higher levels of fine particulate matter air pollution was associated with increased #dementia severity and increased #alzheimer disease neuropathologic change. jamanetwork.com/journals/jamaneurology/fullarticle/10.100…
-
JAMA Neurology
@JAMANeuro
Frontotemporal #dementia is comparable in frequency to dementia with Lewy bodies and occurs at higher rates than progressive supranuclear palsy, corticobasal syndrome, and amyotrophic lateral sclerosis. jamanetwork.com/journals/jamaneurology/fullarticle/10.100…
-
JAMA Neurology
@JAMANeuro
Case report: a 58-year-old patient presenting with seizures and undergoing craniotomy, during which a live parasitic worm was discovered. jamanetwork.com/journals/jamaneurology/fullarticle/10.100…
-
JAMA Neurology
@JAMANeuro
Higher levels of fine particulate matter air pollution was associated with increased #dementia severity and increased #alzheimer disease neuropathologic change.
jamanetwork.com/journals/jamaneurology/fullarticle/10.100… -
JAMA Neurology
@JAMANeuro
Frontotemporal #dementia is comparable in frequency to dementia with Lewy bodies and occurs at higher rates than progressive supranuclear palsy, corticobasal syndrome, and amyotrophic lateral sclerosis.
jamanetwork.com/journals/jamaneurology/fullarticle/10.100… -
JAMA Neurology
@JAMANeuro
Aneurysm wall enhancement on MRI, particularly circumferential AWE, may be used to predict the risk of instability in unruptured intracranial aneurysms over a four-year period. jamanetwork.com/journals/jamaneurology/fullarticle/10.100…
-
JAMA Neurology reposted
Michael Okun
@MichaelOkun
What is the 2025 update on antibody therapies for Alzheimer’s? Experientia docet – experience teaches. Spoiler alert: think EAC or effectiveness, access and cost. Rita Rubin tackles this critically important topic in a recent piece in JAMA. The real world rollout of anti-amyloid antibody therapies like lecanemab and donanemab has revealed both promise and challenges. Early adopters are enthusiastic, safety signals remain consistent w/ trials, and yet questions remain on effectiveness, access and cost.
Key Points:
- Real world experience shows high person w/ disease and caregiver satisfaction, w/ safety rates similar to clinical trials.
- Lecanemab and donanemab both slow disease progression, however longer term evidence supporting true disease modification remains debated.
- Access is limited and marked by racial, ethnic and socioeconomic disparities.
My take: I think this is an interesting time in therapies for neurodegenerative diseases, and I hope we are just starting to see the 'tip of the iceberg' for more effective therapies specifically for Alzheimer's. I am focused squarely on EAC or effectiveness, access and cost. Here are 5 points that resonated w/ me from the piece in JAMA. 1 These drugs target amyloid plaque, a hallmark of Alzheimer’s, and seem to 'mildly' slow decline. 2- Safety risks like brain swelling or bleeding exist, however remain mostly manageable under proper monitoring. 3- Choosing between therapies depends on factors like genetic risk, infusion schedule and side effect profile. 4- Many persons w/ Alzheimer's may be ineligible if disease is too advanced when first diagnosed. 5- Cost, access and equity remain major barriers that we as a community must together urgently address.
jamanetwork.com/journals/jama/fullarticle/2838092 @JAMA_current @JAMANeuro @ParkinsonDotOrg @alzassociation @alzheimerssoc @AlzResearchUK #alzheimer @NEJM -
JAMA Neurology reposted
Eric Topol
@EricTopol
Air pollution (particulate matter, PM 2.5) and worsened Alzheimer's neuropathology @JAMANeuro
jamanetwork.com/journals/jamaneurology/fullarticle/2838665
Eric Topol
@EricTopol
The impact of air pollution particulate matter 2.5 (PM 2.5) on the brain and lung
1. What is PM 2.5 and its constituents?
www.jci.org/articles/view/194312 -
JAMA Neurology
@JAMANeuro
Higher levels of fine particulate matter air pollution was associated with increased #dementia severity and increased #alzheimer disease neuropathologic change. jamanetwork.com/journals/jamaneurology/fullarticle/10.100…
-
JAMA Neurology
@JAMANeuro
Frontotemporal #dementia is comparable in frequency to dementia with Lewy bodies and occurs at higher rates than progressive supranuclear palsy, corticobasal syndrome, and amyotrophic lateral sclerosis. jamanetwork.com/journals/jamaneurology/fullarticle/10.100…
-
JAMA Neurology
@JAMANeuro
Viewpoint: Clinical metagenomic next-generation sequencing (mNGS) testing shows promise for diagnosing central nervous system infections, but its widespread clinical use is hampered by regulatory challenges. jamanetwork.com/journals/jamaneurology/fullarticle/10.100…
-
JAMA Neurology
@JAMANeuro
Newborns of insured Hispanic mothers had a lower prevalence of perinatal hypoxic-ischemic encephalopathy in this cross-sectional study. jamanetwork.com/journals/jamaneurology/fullarticle/10.100…
-
JAMA Neurology
@JAMANeuro
📌 Most viewed this week from JAMA Neurology: In patients with supratentorial intracerebral hemorrhage, minimally invasive surgery within 72 hours did not significantly reduce 30-day mortality or improve 180-day disability.
jamanetwork.com/journals/jamaneurology/fullarticle/283820… -
JAMA Neurology
@JAMANeuro
Case report: A 73-year-old woman presented with dysarthria and right-sided hemiparesis (NIH-Stroke Scale score of 9). jamanetwork.com/journals/jamaneurology/fullarticle/10.100…
-
JAMA Neurology
@JAMANeuro
In patients with supratentorial intracerebral hemorrhage, minimally invasive surgery within 72 hours did not significantly reduce 30-day mortality or improve 180-day disability compared to medical management alone. jamanetwork.com/journals/jamaneurology/fullarticle/10.100…
-
JAMA Neurology
@JAMANeuro
Editorial: the dMPA associated meningioma risk remains very low but provides health care professionals with data to counsel women taking these medications that meningioma may be a risk to consider. jamanetwork.com/journals/jamaneurology/fullarticle/10.100…
-
JAMA Neurology
@JAMANeuro
Women receiving depot medroxyprogesterone acetate had a greater relative risk of subsequent meningioma diagnosis especially with prolonged exposures and starting the medication at older ages. jamanetwork.com/journals/jamaneurology/fullarticle/10.100…
-
JAMA Neurology
@JAMANeuro
Higher educational attainment is linked to slower tau accumulation in amyloid β-negative individuals but accelerates tau accumulation and spread in amyloid β-positive stages. #alzheimer jamanetwork.com/journals/jamaneurology/fullarticle/10.100… @tengfei_guo
-
JAMA Neurology
@JAMANeuro
Amyloid-beta accumulation in centenarians is associated with reduced cognitive performance and is not a benign aspect of aging. jamanetwork.com/journals/jamaneurology/fullarticle/10.100…
-
JAMA Neurology
@JAMANeuro
White matter microstructural changes were associated with cognitive decline, emphasizing their role in aging and Alzheimer disease assessment. jamanetwork.com/journals/jamaneurology/fullarticle/10.100… @MRIatIIT, @ModHabes
-
JAMA Neurology
@JAMANeuro
Regional differences in dementia incidence were found among older US veterans, with the highest rates in the Southeast, Northwest, and Rocky Mountains compared to the Mid-Atlantic. jamanetwork.com/journals/jamaneurology/fullarticle/10.100…
-
JAMA Neurology
@JAMANeuro
APOE epsilon ε4 is a significant risk factor for intracranial hemorrhage in patients with atrial fibrillation on apixaban. jamanetwork.com/journals/jamaneurology/fullarticle/10.100… @sheth_kevin
-
JAMA Neurology
@JAMANeuro
Case report: a false-negative result of the aquaporin-4–immunoglobulin G (AQP4-IgG) test due to the prozone effect in a woman with neuromyelitis optica spectrum disorder (NMOSD). jamanetwork.com/journals/jamaneurology/fullarticle/10.100…
-
JAMA Neurology
@JAMANeuro
In the Human Epilepsy Project multicenter cohort study, most individuals with newly diagnosed focal #epilepsy required over a year and multiple antiseizure medications to become seizure free.
jamanetwork.com/journals/jamaneurology/fullarticle/10.100… -
JAMA Neurology
@JAMANeuro
Editorial: Plasma p-tau217 is a promising yet complementary #alzheimer biomarker, aiding diagnosis and trial efficiency but not fully replacing CSF and PET, especially in those without cognitive impairment.
jamanetwork.com/journals/jamaneurology/fullarticle/10.100… -
JAMA Neurology
@JAMANeuro
Using tau PET and plasma p-tau217 biomarkers may refine #alzheimer trials by tracking disease progression in real-time and anticipating cognitive changes prior to impairment.
jamanetwork.com/journals/jamaneurology/fullarticle/10.100… -
JAMA Neurology
@JAMANeuro
Most viewed this week from @JAMANeuro:
Participants with hearing loss who used hearing aids showed reduced risk for #dementia among those younger than 70 years at the time of hearing evaluation, when followed up for up to 20 years.
jamanetwork.com/journals/jamaneurology/fullarticle/283771… -
JAMA Neurology
@JAMANeuro
Viewpoint: Neurologists must ensure 100% accuracy in brain death determinations to uphold public trust and avoid grave consequences by strictly following guidelines and enhancing training. jamanetwork.com/journals/jamaneurology/fullarticle/10.100…
-
JAMA Neurology
@JAMANeuro
Meningitis may sometimes be an early sign of meningoencephalitis or parenchymal disease, with lesions not yet visible due to radiologic delay. jamanetwork.com/journals/jamaneurology/fullarticle/10.100… @EoinFlanagan14, @albertaboseif, @marignierro
-
JAMA Neurology
@JAMANeuro
Most viewed this week from @JAMANeuro:
Participants with hearing loss who used hearing aids showed reduced risk for #dementia among those younger than 70 years at the time of hearing evaluation, when followed up for up to 20 years.
jamanetwork.com/journals/jamaneurology/fullarticle/283771… -
JAMA Neurology
@JAMANeuro
Ambroxol was deemed safe and well-tolerated in patients with Parkinson disease dementia. jamanetwork.com/journals/jamaneurology/fullarticle/10.100…
-
JAMA Neurology
@JAMANeuro
Case report: a 36-year-old male patient with Wilson disease and opposite muscle tone manifestations in his upper and lower limbs. jamanetwork.com/journals/jamaneurology/fullarticle/10.100…
-
JAMA Neurology
@JAMANeuro
Viewpoint: Chronic immune-mediated peripheral nerve myelinopathies (CIPNM) require precise diagnosis and updated nomenclature due to diverse clinical presentations. jamanetwork.com/journals/jamaneurology/fullarticle/10.100…
-
JAMA Neurology
@JAMANeuro
Participants with hearing loss who used hearing aids showed reduced risk for #dementia among those younger than 70 years at the time of hearing evaluation, when followed up for up to 20 years. jamanetwork.com/journals/jamaneurology/fullarticle/10.100…
-
JAMA Neurology
@JAMANeuro
Prenatal exposure to chlorpyrifos is associated with long-term alterations in brain structure, function, metabolism, and poor motor performance in children aged 6 to 14 years. jamanetwork.com/journals/jamaneurology/fullarticle/10.100…
-
JAMA Neurology
@JAMANeuro
📢 In this podcast episode, author Colin Derdeyn, MD, of @MedicineUVA discusses treatment of acute ischemic stroke and more, with JAMA Neurology Web Editor Cynthia Armand.
🔗 Listen now on @AMAEdHub: edhub.ama-assn.org/jn-learning/audio-player/18995216?link… -
JAMA Neurology
@JAMANeuro
Adding argatroban or eptifibatide to intravenous thrombolysis did not improve reperfusion rates or clinical outcomes in endovascular thrombectomy for acute ischemic stroke. jamanetwork.com/journals/jamaneurology/fullarticle/10.100…
-
JAMA Neurology
@JAMANeuro
Most viewed this week from @JAMANeuro:
Compared with endovascular treatment (EVT) alone, intravenous thrombolysis plus EVT modestly increased the risk of intracranial hemorrhage, notably any parenchymal hematoma.
jamanetwork.com/journals/jamaneurology/fullarticle/283758… -
JAMA Neurology
@JAMANeuro
Images in Neurology: An eight-year-old girl was seen in a clinic for cerebrospinal fluid (CSF) rhinorrhea, orthostatic headaches, and an acquired Chiari malformation. jamanetwork.com/journals/jamaneurology/fullarticle/10.100…
-
JAMA Neurology
@JAMANeuro
No evidence was found for a new neurological disease in New Brunswick, Canada, as previously misdiagnosed well-known conditions were responsible for the symptoms.
jamanetwork.com/journals/jamaneurology/fullarticle/10.100…
@sarahlidstone -
JAMA Neurology
@JAMANeuro
Most viewed this week from @JAMANeuro:
Compared with endovascular treatment (EVT) alone, intravenous thrombolysis plus EVT modestly increased the risk of intracranial hemorrhage, notably any parenchymal hematoma.
jamanetwork.com/journals/jamaneurology/fullarticle/283758… -
JAMA Neurology
@JAMANeuro
Despite a decrease in age-standardized rates, subarachnoid hemorrhage remains one of the most common cardiovascular and neurological causes of death and disability globally. jamanetwork.com/journals/jamaneurology/fullarticle/10.100…
-
JAMA Neurology
@JAMANeuro
Viewpoint: Recent trials challenge the efficacy of endovascular thrombectomy for distal and medium vessel occlusions, necessitating refined patient selection and exploring alternative treatments.
jamanetwork.com/journals/jamaneurology/fullarticle/10.100… -
JAMA Neurology
@JAMANeuro
In #pediatric patients with #multiplesclerosis, chronic lesion development begins early in the disease course, even with effective treatment.
jamanetwork.com/journals/jamaneurology/fullarticle/10.100… -
JAMA Neurology
@JAMANeuro
Case report: a 61-year-old man with alcohol use disorder presented with altered consciousness and vision loss after ceasing alcohol consumption. jamanetwork.com/journals/jamaneurology/fullarticle/10.100…
-
JAMA Neurology
@JAMANeuro
Despite a decrease in age-standardized rates, subarachnoid hemorrhage remains one of the most common cardiovascular and neurological causes of death and disability globally. jamanetwork.com/journals/jamaneurology/fullarticle/10.100…
-
JAMA Neurology
@JAMANeuro
Male patients with #dementia have higher mortality rates and greater use of health care services, particularly hospitalizations, compared to female patients. jamanetwork.com/journals/jamaneurology/fullarticle/10.100…
-
JAMA Neurology
@JAMANeuro
Despite a decrease in age-standardized rates, subarachnoid hemorrhage remains one of the most common cardiovascular and neurological causes of death and disability globally. jamanetwork.com/journals/jamaneurology/fullarticle/10.100…
-
JAMA Neurology
@JAMANeuro
Compared with endovascular treatment (EVT) alone, intravenous thrombolysis plus EVT modestly increased the risk of intracranial hemorrhage, notably any parenchymal hematoma. jamanetwork.com/journals/jamaneurology/fullarticle/10.100…
-
JAMA Neurology
@JAMANeuro
Most viewed this week from @JAMANeuro:
Oseltamivir treatment during #influenza episodes was associated with a reduced risk of serious neuropsychiatric events in children and adolescents enrolled in Tennessee #medicaid.
jamanetwork.com/journals/jamaneurology/fullarticle/283716… -
JAMA Neurology
@JAMANeuro
Stridor is a common and presenting feature of IgLON5-antibody disease. This Research Letter describes an additional inspiratory noise distinct from stridor, in three patients, observed independently across two centers. jamanetwork.com/journals/jamaneurology/fullarticle/10.100…
-
JAMA Neurology
@JAMANeuro
Most viewed this week from @JAMANeuro:
Oseltamivir treatment during #influenza episodes was associated with a reduced risk of serious neuropsychiatric events in children and adolescents enrolled in Tennessee #medicaid.
jamanetwork.com/journals/jamaneurology/fullarticle/283716… -
JAMA Neurology
@JAMANeuro
Oseltamivir treatment during influenza episodes was associated with a reduced risk of serious neuropsychiatric events in children and adolescents enrolled in Tennessee Medicaid. jamanetwork.com/journals/jamaneurology/fullarticle/10.100… @AntoonMD
-
JAMA Neurology
@JAMANeuro
From @JAMA_current : A recent study showed that newborns have high levels of p-tau, a biomarker for #alzheimer disease. Understanding how infants clear the protein could help prevent aggregation, which leads to #neurodegeneration in adults. jamanetwork.com/journals/jama/fullarticle/10.1001/jama.20…
-
JAMA Neurology
@JAMANeuro
Antithrombotic therapy (AT) did not increase chronic subdural hematoma recurrence risk after burr hole surgery, and perioperative AT pause did not raise thromboembolic event risk. jamanetwork.com/journals/jamaneurology/fullarticle/10.100… @aeschack
-
JAMA Neurology
@JAMANeuro
In patients with Duchenne muscular dystrophy, delandistrogene moxeparvovec demonstrated efficacy in reducing muscle fat accumulation and slowing disease progression compared to placebo. jamanetwork.com/journals/jamaneurology/fullarticle/10.100…
-
JAMA Neurology
@JAMANeuro
Oseltamivir treatment during influenza episodes was associated with a reduced risk of serious neuropsychiatric events in children and adolescents enrolled in Tennessee Medicaid. jamanetwork.com/journals/jamaneurology/fullarticle/10.100… @AntoonMD
-
JAMA Neurology
@JAMANeuro
Key biomarkers identified in individuals with radiologically isolated syndrome are associated with the development of multiple sclerosis symptoms.
jamanetwork.com/journals/jamaneurology/fullarticle/10.100…
@garinho29 @eefst @Enric_Monreal -
JAMA Neurology
@JAMANeuro
Early initiation of intravenous immunoglobulin treatment within the first year of onset is associated with improved long-term outcomes and survival in patients with anti-IgLON5 disease.
jamanetwork.com/journals/jamaneurology/fullarticle/10.100… -
JAMA Neurology reposted
AMA Ed Hub™
@AMAEdHub
A 31-year-old woman was evaluated for generalized dystonia, dysarthria, dysphagia, severe scoliosis and motor development disorder that began in her childhood. Read more about this case and test your diagnostic skills with @JAMANeuro.
amaedhub.org/4lI3Ziy -
JAMA Neurology reposted
Susan Rohde
@SusanRohde_
I was enjoying the discussion on the @alzassociation and IWG criteria for AD at #aaic2025 when Reisa Sperling cited our latest @JAMANeuro paper on Amyloid pathology in centenarians! "If I were to become 100, I would want be in the yellow group". 💯🧠 What a special moment!
-
JAMA Neurology reposted
NM Neurology
@NMNeurology
A study published in @JamaNeuro and co-authored by Rizwan Akhtar, MD, found that AI-based imaging may effectively help physicians differentiate patients with Parkinson's disease from those with similar conditions. Learn more:
news.feinberg.northwestern.edu/2025/06/25/ai-imaging-appr… -
JAMA Neurology
@JAMANeuro
In women with multiple sclerosis, disease-modifying therapy management during pregnancy increased relapse risk, particularly in patients receiving natalizumab with prolonged interruption or fingolimod. jamanetwork.com/journals/jamaneurology/fullarticle/10.100… @XtineLebrunF
-
JAMA Neurology
@JAMANeuro
An #ai imaging tool was found to be over 96% accurate at diagnosing Parkinson disease using MRI scans.
➡ Read the full study in JAMA Neurology: jamanetwork.com/journals/jamaneurology/fullarticle/10.100… -
JAMA Neurology
@JAMANeuro
Oseltamivir treatment during influenza episodes was associated with a reduced risk of serious neuropsychiatric events in children and adolescents enrolled in Tennessee Medicaid. jamanetwork.com/journals/jamaneurology/fullarticle/10.100… @AntoonMD
-
JAMA Neurology
@JAMANeuro
Epilepsy is more prevalent in patients with frontotemporal dementia compared to healthy controls and those with #alzheimer disease. jamanetwork.com/journals/jamaneurology/fullarticle/10.100… @esolje
-
JAMA Neurology
@JAMANeuro
Among adults with episodic cluster #headache, eptinezumab did not significantly reduce the frequency of episodic cluster headache attacks compared to placebo. jamanetwork.com/journals/jamaneurology/fullarticle/10.100…
-
JAMA Neurology
@JAMANeuro
This systematic review and meta-analysis found a high residual risk of recurrent stroke in patients with atrial fibrillation despite anticoagulation. jamanetwork.com/journals/jamaneurology/fullarticle/10.100… @ronancollins7
-
JAMA Neurology
@JAMANeuro
Autism spectrum disorder was associated with increased risk of #parkinson disease, even after adjusting for depression or antidepressant use and antipsychotic exposure. jamanetwork.com/journals/jamaneurology/fullarticle/10.100… @szlevine
-
JAMA Neurology
@JAMANeuro
This individual-patient study validated the results of previous studies showing that treatment effect on disability in progressive multiple sclerosis is limited to patients with inflammatory activity at baseline. jamanetwork.com/journals/jamaneurology/fullarticle/10.100…
-
JAMA Neurology
@JAMANeuro
Patients with sporadic Creutzfeldt-Jakob Disease have a brief, age-dependent life expectancy, typically lasting 12 weeks, unchanged despite rising incidence over 30 years. jamanetwork.com/journals/jamaneurology/fullarticle/10.100…
-
JAMA Neurology
@JAMANeuro
Editorial from @JAMA_current: The US POINTER study suggests that modest lifestyle interventions can enhance cognitive health in aging populations, offering a practical and cost-effective approach to dementia prevention.
jamanetwork.com/journals/jama/fullarticle/10.1001/jama.20…
#aaic2025 -
JAMA Neurology
@JAMANeuro
From @JAMA_current: In older adults at risk of cognitive decline and dementia, a structured lifestyle intervention yielded greater benefit than a lower-intensity self-guided intervention.
jamanetwork.com/journals/jama/fullarticle/10.1001/jama.20…
#aaic2025 -
JAMA Neurology
@JAMANeuro
Local visual interpretations of clinical amyloid-PET scans closely matched central quantitative assessments, supporting the reliability of visual reads in real-world clinical settings. jamanetwork.com/journals/jamaneurology/fullarticle/10.100…
-
JAMA Neurology
@JAMANeuro
Most viewed this week from @JAMANeuro:
GLP-1 RA therapy may offer an alternative management strategy for idiopathic intracranial #hypertension.
jamanetwork.com/journals/jamaneurology/fullarticle/283606… -
JAMA Neurology
@JAMANeuro
Viewpoint: Assessing frailty in patients with multiple sclerosis enhances neurologists’ ability to understand the variability in health status within this highly heterogeneous disease. jamanetwork.com/journals/jamaneurology/fullarticle/10.100…
-
JAMA Neurology
@JAMANeuro
Case report: a 4-year-old child presented with jerky movements of all 4 limbs, recurrent falls, and progressive cognitive impairment over a 6-month period. jamanetwork.com/journals/jamaneurology/fullarticle/10.100… @arunkoulneuro
-
JAMA Neurology
@JAMANeuro
Most viewed this week from @JAMANeuro:
GLP-1 RA therapy may offer an alternative management strategy for idiopathic intracranial #hypertension.
jamanetwork.com/journals/jamaneurology/fullarticle/283606… -
JAMA Neurology
@JAMANeuro
RCT: Rizatriptan provided limited benefits for headache-related symptoms but not vertigo in treating vestibular #migraine attacks. jamanetwork.com/journals/jamaneurology/fullarticle/10.100…
-
JAMA Neurology
@JAMANeuro
Individuals with more severe clinical #alzheimer disease symptoms than their biological stage often have additional pathologies, suggesting the need to evaluate non-AD biomarkers for accurate diagnosis. jamanetwork.com/journals/jamaneurology/fullarticle/10.100…
-
JAMA Neurology
@JAMANeuro
Viewpoint: By removing conventional academic benchmarks, medical education has inadvertently increased student stress, underscoring the need for balanced assessment methods. jamanetwork.com/journals/jamaneurology/fullarticle/10.100…
-
JAMA Neurology
@JAMANeuro
Case report: a 65-year-old man with a mobile filling defect detected in his middle cerebral artery during mechanical thrombectomy. jamanetwork.com/journals/jamaneurology/fullarticle/10.100…
-
JAMA Neurology
@JAMANeuro
OTOF gene therapy (GT) offers rapid improvements in auditory and speech performance, outperforming cochlear implantation (CI) in speech in noise and music perception.
jamanetwork.com/journals/jamaneurology/fullarticle/10.100… -
JAMA Neurology
@JAMANeuro
Most viewed this week from @JAMANeuro:
GLP-1 RA therapy may offer an alternative management strategy for idiopathic intracranial hypertension.
jamanetwork.com/journals/jamaneurology/fullarticle/283606… -
JAMA Neurology
@JAMANeuro
Viewpoint: Screening for α-synuclein abnormalities in research can improve understanding of disease progression, refine selection of participants for clinical trials, and lead to more accurate and applicable results. jamanetwork.com/journals/jamaneurology/fullarticle/10.100…
-
JAMA Neurology
@JAMANeuro
Images in Neurology: A 52-year-old woman suddenly collapsed in a public place and was brought to a hospital by ambulance, presenting with a decreased level of consciousness. jamanetwork.com/journals/jamaneurology/fullarticle/10.100…
-
JAMA Neurology
@JAMANeuro
Most viewed this week from @JAMANeuro:
GLP-1 RA therapy may offer an alternative management strategy for idiopathic intracranial hypertension.
jamanetwork.com/journals/jamaneurology/fullarticle/283606… -
JAMA Neurology
@JAMANeuro
Behavioral therapy is noninferior to drug therapy in improving overactive bladder symptoms in #parkinson disease. jamanetwork.com/journals/jamaneurology/fullarticle/10.100… @baldheadted
-
JAMA Neurology
@JAMANeuro
In a specialty memory clinic, patients treated with lecanemab over 14 months experienced manageable adverse events. jamanetwork.com/journals/jamaneurology/fullarticle/10.100… @ErikMusiek
-
JAMA Neurology
@JAMANeuro
Behavioral therapy is noninferior to drug therapy in improving overactive bladder symptoms in #parkinson disease. jamanetwork.com/journals/jamaneurology/fullarticle/10.100… @baldheadted
-
JAMA Neurology
@JAMANeuro
Between 22% and 44% of #dementia cases by age 80 are attributed to midlife and late-life vascular risk factors, according to this cohort study. jamanetwork.com/journals/jamaneurology/fullarticle/10.100…
-
JAMA Neurology reposted
Eric Topol
@EricTopol
GLP-1 drugs may provide benefit for idiopathic intracranial hypertension
jamanetwork.com/journals/jamaneurology/fullarticle/2836065
jamanetwork.com/journals/jamaneurology/fullarticle/2836068 -
JAMA Neurology
@JAMANeuro
Authors @rivetdj and @WilliamMualem discuss "GLP-1 Receptor Agonists in Idiopathic Intracranial Hypertension" with JAMA Neurology Web Editor Cynthia Armand. edhub.ama-assn.org/jn-learning/audio-player/10.1001/jaman…
-
JAMA Neurology
@JAMANeuro
Behavioral therapy is noninferior to drug therapy in improving overactive bladder symptoms in #parkinson disease. jamanetwork.com/journals/jamaneurology/fullarticle/10.100… @baldheadted
-
JAMA Neurology
@JAMANeuro
GLP-1 RA therapy may offer an alternative management strategy for idiopathic intracranial hypertension. jamanetwork.com/journals/jamaneurology/fullarticle/10.100… @rivetdj @WilliamMualem
-
JAMA Neurology
@JAMANeuro
Most viewed this week from @JAMANeuro:
Higher educational attainment is linked to slower tau accumulation in amyloid β-negative individuals but accelerates tau accumulation and spread in amyloid β-positive stages. #alzheimer
jamanetwork.com/journals/jamaneurology/fullarticle/283585… -
JAMA Neurology
@JAMANeuro
Most viewed this week from @JAMANeuro:
Higher educational attainment is linked to slower tau accumulation in amyloid β-negative individuals but accelerates tau accumulation and spread in amyloid β-positive stages. #alzheimer
jamanetwork.com/journals/jamaneurology/fullarticle/283585… -
JAMA Neurology
@JAMANeuro
Case report: a 23-year-old pregnant woman presented with seizures and chronic hepatitis B, with hyperintense lesions discovered in the left caudate nucleus on magnetic resonance imaging. jamanetwork.com/journals/jamaneurology/fullarticle/10.100…
-
JAMA Neurology
@JAMANeuro
Laser interstitial thermal therapy may be considered as a treatment option for durable seizure control and quality of life improvements in patients with mesial temporal lobe epilepsy. jamanetwork.com/journals/jamaneurology/fullarticle/10.100…
-
JAMA Neurology
@JAMANeuro
Higher educational attainment is linked to slower tau accumulation in amyloid β-negative individuals but accelerates tau accumulation and spread in amyloid β-positive stages.
jamanetwork.com/journals/jamaneurology/fullarticle/10.100…
@tengfei_guo #alzheimer -
JAMA Neurology
@JAMANeuro
In anterior circulation stroke patients post-thrombectomy, low and medium doses of intra-arterial tenecteplase demonstrated adequate safety to warrant larger trials to investigate their therapeutic potential. jamanetwork.com/journals/jamaneurology/fullarticle/10.100…
JAMA Neurology
@JAMANeuro
Published in @JAMA_current:
In patients with acute large vessel occlusion (LVO), intra-arterial tenecteplase after successful thrombectomy improved 90-day neurological outcomes without increasing hemorrhage or mortality.
jamanetwork.com/journals/jama/fullarticle/10.1001/jama.20… -
JAMA Neurology
@JAMANeuro
Amyloid-beta accumulation in centenarians is associated with reduced cognitive performance and is not a benign aspect of aging. jamanetwork.com/journals/jamaneurology/fullarticle/10.100…
-
JAMA Neurology
@JAMANeuro
Ambroxol was deemed safe and well-tolerated in patients with Parkinson disease dementia. jamanetwork.com/journals/jamaneurology/fullarticle/10.100…
-
JAMA Neurology
@JAMANeuro
Most viewed this week from @JAMANeuro:
APOE epsilon ε4 is a significant risk factor for intracranial hemorrhage in patients with atrial fibrillation on apixaban.
jamanetwork.com/journals/jamaneurology/fullarticle/283566… -
JAMA Neurology
@JAMANeuro
Most viewed this week from @JAMANeuro:
APOE epsilon ε4 is a significant risk factor for intracranial hemorrhage in patients with atrial fibrillation on apixaban.
jamanetwork.com/journals/jamaneurology/fullarticle/283566… -
JAMA Neurology
@JAMANeuro
Case report: brain imaging of 2 patients with a disease course suggestive of autoimmune glial fibrillary acidic protein astrocytopathy. jamanetwork.com/journals/jamaneurology/fullarticle/10.100…
-
JAMA Neurology
@JAMANeuro
Case report: an atypical postvaccinal encephalitis in a 60-year-old man, with radial perivascular enhancement consistent with inflammation of glial fibrillary acidic protein–rich white matter loci. jamanetwork.com/journals/jamaneurology/fullarticle/10.100…
-
JAMA Neurology
@JAMANeuro
Today, the JAMA Neurology Editorial Board met to discuss plans for the journal, which is dedicated to publishing scientific information for physicians who care for people with neurologic disorders and for those interested in the structure and function of the human nervous system.
-
JAMA Neurology reposted
Eric Topol
@EricTopol
Having an APOε4 allele may be risk factor for brain hemorrhage with apixiban, a commonly used blood thinner for atrial fibrillation
jamanetwork.com/journals/jamaneurology/fullarticle/2835665 -
JAMA Neurology
@JAMANeuro
APOE epsilon ε4 is a significant risk factor for intracranial hemorrhage in patients with atrial fibrillation on apixaban. jamanetwork.com/journals/jamaneurology/fullarticle/10.100… @sheth_kevin @MrDisability
-
JAMA Neurology
@JAMANeuro
Case report: a 61-year-old man with myasthenia gravis initially diagnosed with blepharospasm who was later found to have the nonparalytic disorder apraxia of eyelid opening. jamanetwork.com/journals/jamaneurology/fullarticle/10.100…
-
JAMA Neurology
@JAMANeuro
This Viewpoint discusses the potential to transform ALS care, drive innovation in ALS therapeutic development, and pave the way for breakthroughs in other neurodegenerative diseases. jamanetwork.com/journals/jamaneurology/fullarticle/10.100…
-
JAMA Neurology
@JAMANeuro
Case report: a man who tested positive for IgLON5-IgG antibody after intermittent episodes of paresthetic feeling involving the throat and jaw, associated with subtle dysarthria & dysphagia, & upper-extremity paresthesia with piloerection of the forearms. jamanetwork.com/journals/jamaneurology/fullarticle/10.100…
-
JAMA Neurology
@JAMANeuro
From @JAMANeuro: Tau PET positivity is detectable in a small but nonnegligible proportion of individuals in the preclinical stages of #alzheimer disease, with increasing frequency in symptomatic stages of the disease.
jamanetwork.com/journals/jama/fullarticle/10.1001/jama.20… -
JAMA Neurology
@JAMANeuro
Viewpoint: Bridging the gap between the widespread understanding of Alzheimer disease (AD) as a syndrome and the biological understanding of AD as a chronic condition will require change in at least 3 areas. jamanetwork.com/journals/jamaneurology/fullarticle/10.100…
-
JAMA Neurology
@JAMANeuro
Meningitis may sometimes be an early sign of meningoencephalitis or parenchymal disease, with lesions not yet visible due to radiologic delay. jamanetwork.com/journals/jamaneurology/fullarticle/10.100…
-
JAMA Neurology
@JAMANeuro
Newborns of insured Hispanic mothers had a lower prevalence of perinatal hypoxic-ischemic encephalopathy in this cross-sectional study. jamanetwork.com/journals/jamaneurology/fullarticle/10.100…
-
JAMA Neurology
@JAMANeuro
Secondary analysis of MR CLEAN-LATE showed that penumbra size, but not core volume or mismatch ratio, modified treatment effect, with a trend towards potential harm in patients with the smallest penumbras. jamanetwork.com/journals/jamaneurology/fullarticle/10.100…
-
JAMA Neurology
@JAMANeuro
SECA RCT: Discontinuing acetylsalicylic acid treatment did not reduce recurrence rate of surgically treated chronic subdural hematoma within 6 months. jamanetwork.com/journals/jamaneurology/fullarticle/10.100…
-
JAMA Neurology
@JAMANeuro
The risk of poststroke epilepsy (PSE) in young adults is relatively low, and existing risk scores are applicable for identifying high-risk individuals in this age group, according to this cohort study. jamanetwork.com/journals/jamaneurology/fullarticle/10.100…
-
JAMA Neurology
@JAMANeuro
Variability in the used definitions of progression independent of relapse activity (PIRA) in multiple sclerosis clinical trials, registries, and cohorts results in variability in the reported incidence and persistence of PIRA. jamanetwork.com/journals/jamaneurology/fullarticle/10.100…
-
JAMA Neurology
@JAMANeuro
Belly dancer’s dyskinesia (BDD) is a rare movement disorder involving involuntary abdominal muscle contractions, potentially linked to central nervous system issues.
Learn more in this case report: jamanetwork.com/journals/jamaneurology/fullarticle/10.100… -
JAMA Neurology reposted
JAMA
@JAMA_current
From @JAMANeuro: CT perfusion and CT angiography showed less than optimal accuracy for confirming death by neurologic criteria.
#ccr25 @CritCareReviews
jamanetwork.com/journals/jamaneurology/fullarticle/10.100… -
JAMA Neurology reposted
JAMA
@JAMA_current
📢 #ccr25 Highlights: We've compiled the JAMA and @JAMANeuro papers presented at this year’s meeting. Explore the thread! 👇
Augmenting enteral protein did not improve outcomes for critically ill patients compared with standard protein levels in the intensive care setting. -
JAMA Neurology reposted
AMA Ed Hub™
@AMAEdHub
A 63-year-old male developed intermittent episodes of paresthetic feeling involving the throat spreading to the jaw, associated with subtle dysarthria and dysphagia. Learn more about this case and earn #cme credit with @JAMANeuro.
amaedhub.org/43FsgPK -
JAMA Neurology
@JAMANeuro
CT perfusion and CT angiography showed less than optimal accuracy for confirming death by neurologic criteria.
#ccr25 @CritCareReviews
jamanetwork.com/journals/jamaneurology/fullarticle/10.100… -
JAMA Neurology
@JAMANeuro
Certain genetic, cognitive, cerebrovascular, and neurologic factors are associated with late-onset epilepsy in people with cognitive decline. jamanetwork.com/journals/jamaneurology/fullarticle/10.100…
-
JAMA Neurology
@JAMANeuro
An early and reliable 4R-tau biomarker might help guide the timing of disease-modifying therapies. Read more about copathology in atypical Parkinsonism in this Viewpoint. jamanetwork.com/journals/jamaneurology/fullarticle/10.100…
-
JAMA Neurology
@JAMANeuro
Alzheimer disease biomarkers are present in various dementia types, with the strongest correlations between cerebrospinal fluid biomarkers and cognitive function seen in patients with early and late onset Alzheimer disease. jamanetwork.com/journals/jamaneurology/fullarticle/10.100…
-
JAMA Neurology
@JAMANeuro
Case report: a 36-year-old male patient with Wilson disease and opposite muscle tone manifestations in his upper and lower limbs. jamanetwork.com/journals/jamaneurology/fullarticle/10.100…
-
JAMA Neurology
@JAMANeuro
Individuals with cannabis use severe enough to require emergency department or hospital care may be at increased risk of being diagnosed with dementia. jamanetwork.com/journals/jamaneurology/fullarticle/10.100…
-
JAMA Neurology
@JAMANeuro
White matter microstructural changes were associated with cognitive decline, emphasizing their role in aging and Alzheimer disease assessment. jamanetwork.com/journals/jamaneurology/fullarticle/10.100…
-
JAMA Neurology
@JAMANeuro
Fremanezumab compared with placebo significantly reduced the mean number of monthly migraine days and depressive symptoms in patients with migraine and comorbid major depressive disorder. jamanetwork.com/journals/jamaneurology/fullarticle/10.100…
-
JAMA Neurology
@JAMANeuro
Can GLP-1 agonists and SGLT-2 inhibitors decrease dementia risk?
Two recent JAMA Neurology studies examined the association. 🧵This media couldn't be displayed. See it on the original post.Post not available here, view on X
JAMA Neurology
@JAMANeuro
Read the Original Investigation “GLP-1RA and SGLT2i Medications for Type 2 Diabetes and Alzheimer Disease and Related Dementias.” jamanetwork.com/journals/jamaneurology/fullarticle/10.100…
JAMA Neurology
@JAMANeuro
Read the accompanying Editorial “GLP-1 Receptor Agonists—From Breakthroughs in Cardiometabolic Treatment to Emerging Neuroprotective Potential.” jamanetwork.com/journals/jamaneurology/fullarticle/10.100…
-
JAMA Neurology
@JAMANeuro
Regional differences in dementia incidence were found among older US veterans, with the highest rates in the Southeast, Northwest, and Rocky Mountains compared to the Mid-Atlantic. jamanetwork.com/journals/jamaneurology/fullarticle/10.100…
-
JAMA Neurology
@JAMANeuro
Diffusion-weighted imaging lesion frequency and volume were unaffected by intensive antihypertensive therapy in patients with sub-acute intracerebral hemorrhage. jamanetwork.com/journals/jamaneurology/fullarticle/10.100…
-
JAMA Neurology
@JAMANeuro
Most viewed this week from @JAMANeuro:
Between 22% and 44% of dementia cases by age 80 are attributed to midlife and late-life vascular risk factors, according to this cohort study.
jamanetwork.com/journals/jamaneurology/fullarticle/283460… -
JAMA Neurology
@JAMANeuro
This case report describes a patient with spontaneous, arrhythmic, spasmodic contractions of the abdominal muscles whose imaging confirmed involvement of the genu, body, and splenium of the corpus callosum. jamanetwork.com/journals/jamaneurology/fullarticle/10.100…
-
JAMA Neurology
@JAMANeuro
Differentiating between MCI subtypes in individuals attending memory clinics was associated with the diagnostic performance of blood p-tau217 models to determine brain amyloidosis in patients’ clinical management.
jamanetwork.com/journals/jamaneurology/fullarticle/283127… -
JAMA Neurology
@JAMANeuro
Reldesemtiv, a fast skeletal troponin activator, was not effective in slowing progression in amyotrophic lateral sclerosis (ALS).
jamanetwork.com/journals/jamaneurology/fullarticle/10.100… -
JAMA Neurology
@JAMANeuro
Stridor is a common and presenting feature of IgLON5-antibody disease. This Research Letter describes an additional inspiratory noise distinct from stridor, in three patients, observed independently across two centers. jamanetwork.com/journals/jamaneurology/fullarticle/10.100…
-
JAMA Neurology reposted
Michael Okun
@MichaelOkun
From Autism to Parkinson’s? A link we didn’t see coming: but maybe should have? A groundbreaking new study out of Sweden, just published in JAMA Neurology, raises eyebrows, and important questions about an unexpected link between autism spectrum disorder and Parkinson’s disease. While these two conditions seem worlds apart, they may actually share more in common than we thought, especially when it comes to dopamine and to genetics.
Key Points:
- Autism was linked to a 4.5-fold increased risk of developing Parkinson's compared to the general population.
- This link held even after adjusting for depression, antipsychotic use, socioeconomic status, and family history.
- Dopaminergic and genetic pathways, including PARK2 mutations, may in some cases underlie this connection however the exact link(s) are unclear.
- Antipsychotics, commonly used in autism, increased Parkinson's risk, however only explained half of the association that was uncovered.
- The study used a nationwide Swedish cohort of over 2.2 million people and there was an incredible 30 years of follow-up available.
My take: Here are my 5 key takeaways from this article linking Parkinson's and autism. 1- It’s time to rethink old boundaries. Neurodevelopment and neurodegeneration could very well be two ends of the same spectrum. 2- Don’t ignore dopamine’s dual role. Both autism and Parkinson's have been associated w/ dopaminergic dysfunction. There is obvious evidence: social behavior in one, movement in the other. 3- Watch this space in the future autism care models. As more individuals with autism age, we will likely need strategies to identify and manage early signs of Parkinson's. 4- This isn’t just about medication. Even without antipsychotic use, autism still independently raised the Parkinson's risk. 5- Neurologists must stay alert. Subtle signs of parkinsonism in those with autism should not be dismissed. Could these actually be the early whispers of Parkinson's disease?
jamanetwork.com/journals/jamaneurology/fullarticle/2834684 #autismandparkinsons #neurodevelopmenttoneurodegeneration #dopaminedisorders @JAMANeuro @FixelInstitute @ParkinsonDotOrg @alzassociation @autismawarness2 @autismspeaks @AutismSociety @NationalAutism -
JAMA Neurology reposted
JAMA+ AI
@JAMAplusAI
"While the advent of general AI promises broader access to health care, it also introduces risks."
This @JAMANeuro Viewpoint discusses the integration of artificial intelligence in neurology.
jamanetwork.com/journals/jamaneurology/fullarticle/283345… -
JAMA Neurology
@JAMANeuro
Most viewed this week from @JAMANeuro:
Between 22% and 44% of dementia cases by age 80 are attributed to midlife and late-life vascular risk factors, according to this cohort study.
jamanetwork.com/journals/jamaneurology/fullarticle/283460… -
JAMA Neurology
@JAMANeuro
From @JAMA_current: Middle meningeal artery embolization did not significantly reduce chronic subdural hematoma recurrence at 6 months compared to standard care.
jamanetwork.com/journals/jama/fullarticle/10.1001/jama.20… -
JAMA Neurology
@JAMANeuro
Antithrombotic therapy (AT) did not increase chronic subdural hematoma recurrence risk after burr hole surgery, and perioperative AT pause did not raise thromboembolic event risk. jamanetwork.com/journals/jamaneurology/fullarticle/10.100…
-
JAMA Neurology
@JAMANeuro
Epilepsy is more prevalent in patients with frontotemporal dementia compared to healthy controls and those with Alzheimer disease. jamanetwork.com/journals/jamaneurology/fullarticle/10.100…
-
JAMA Neurology
@JAMANeuro
Zero-degree head positioning for acute LVO patients is a protective maneuver to maintain clinical stability in the pre-thrombectomy phase while awaiting definitive treatment. jamanetwork.com/journals/jamaneurology/fullarticle/10.100…
-
JAMA Neurology
@JAMANeuro
Between 22% and 44% of dementia cases by age 80 are attributed to midlife and late-life vascular risk factors, according to this cohort study. jamanetwork.com/journals/jamaneurology/fullarticle/10.100…
-
JAMA Neurology
@JAMANeuro
Author Manuel Comabella discusses Prognostic Factors for Multiple Sclerosis Symptoms in Radiologically Isolated Syndrome with JAMA Neurology Web Editor Cynthia Armand. Listen now: edhub.ama-assn.org/jn-learning/audio-player/10.1001/jaman…
-
JAMA Neurology
@JAMANeuro
Key biomarkers identified in individuals with radiologically isolated syndrome are associated with the development of multiple sclerosis symptoms. jamanetwork.com/journals/jamaneurology/fullarticle/10.100…
-
JAMA Neurology
@JAMANeuro
Most viewed this week from @JAMANeuro:
Autism spectrum disorder was associated with increased risk of Parkinson disease, even after adjusting for depression or antidepressant use and antipsychotic exposure.
jamanetwork.com/journals/jamaneurology/fullarticle/283468… -
JAMA Neurology
@JAMANeuro
This study demonstrated the feasibility and safety of using the new RATIONAL robot-assisted thrombectomy system for treating acute ischemic stroke. jamanetwork.com/journals/jamaneurology/fullarticle/10.100…
-
JAMA Neurology
@JAMANeuro
Autism spectrum disorder was associated with increased risk of Parkinson disease, even after adjusting for depression or antidepressant use and antipsychotic exposure.
jamanetwork.com/journals/jamaneurology/fullarticle/10.100… -
JAMA Neurology
@JAMANeuro
Although a clearly superior day to initiate direct oral anticoagulant treatment after atrial fibrillation-related stroke was not identified, the evidence suggests that earlier initiation within the first 2 weeks is better than later. jamanetwork.com/journals/jamaneurology/fullarticle/10.100…
-
JAMA Neurology
@JAMANeuro
The successful testing and validation of Automated Imaging Differentiation for Parkinsonism suggest its integration within the diagnostic workup of 3 commonly encountered neurodegenerative parkinsonian disorders.
jamanetwork.com/journals/jamaneurology/fullarticle/10.100… -
JAMA Neurology
@JAMANeuro
Most viewed this week from @JAMANeuro:
Autism spectrum disorder was associated with increased risk of Parkinson disease, even after adjusting for depression or antidepressant use and antipsychotic exposure.
jamanetwork.com/journals/jamaneurology/fullarticle/283468… -
JAMA Neurology
@JAMANeuro
Despite a decrease in age-standardized rates, subarachnoid hemorrhage remains one of the most common cardiovascular and neurological causes of death and disability globally.
jamanetwork.com/journals/jamaneurology/fullarticle/10.100… -
JAMA Neurology
@JAMANeuro
Donanemab treatment increased amyloid-related imaging abnormalities risk compared with placebo in patients with early symptomatic Alzheimer disease and elevated amyloid levels. jamanetwork.com/journals/jamaneurology/fullarticle/10.100…
-
JAMA Neurology
@JAMANeuro
Autism spectrum disorder was associated with increased risk of Parkinson disease, even after adjusting for depression or antidepressant use and antipsychotic exposure. jamanetwork.com/journals/jamaneurology/fullarticle/10.100…
-
JAMA Neurology
@JAMANeuro
Despite a decrease in age-standardized rates, subarachnoid hemorrhage remains one of the most common cardiovascular and neurological causes of death and disability globally.
jamanetwork.com/journals/jamaneurology/fullarticle/10.100… -
JAMA Neurology
@JAMANeuro
Images in Neurology: An eight-year-old girl was seen in a clinic for cerebrospinal fluid (CSF) rhinorrhea, orthostatic headaches, and an acquired Chiari malformation. jamanetwork.com/journals/jamaneurology/fullarticle/283381…
-
JAMA Neurology
@JAMANeuro
Autism spectrum disorder was associated with increased risk of Parkinson disease, even after adjusting for depression or antidepressant use and antipsychotic exposure. jamanetwork.com/journals/jamaneurology/fullarticle/10.100…
-
JAMA Neurology
@JAMANeuro
Glucose-lowering therapy with GLP1-RAs, but not SGLT2 inhibitors, was associated with a statistically significant reduction in dementia or cognitive impairment. jamanetwork.com/journals/jamaneurology/fullarticle/10.100…
-
JAMA Neurology
@JAMANeuro
Most viewed this week from @JAMANeuro:
Individuals with more severe clinical Alzheimer disease symptoms than their biological stage often have additional pathologies, suggesting the need to evaluate non-AD biomarkers for accurate diagnosis.
jamanetwork.com/journals/jamaneurology/fullarticle/283381… -
JAMA Neurology
@JAMANeuro
The ImmunoWELL JCV IgG test for detecting John Cunningham virus antibodies in natalizumab-treated multiple sclerosis patients yielded more positive results compared to the second-generation STRATIFY JCV DxSelect assay. jamanetwork.com/journals/jamaneurology/fullarticle/10.100… @eefst
-
JAMA Neurology
@JAMANeuro
In this Viewpoint, @juliaehbrown, Winston Chiong, and Nora Hutchinson explore how current ethical challenges of N-of-1 trials for serious neurological diseases could be addressed by integrating current approaches into learning healthcare systems. jamanetwork.com/journals/jamaneurology/fullarticle/10.100…
-
JAMA Neurology
@JAMANeuro
This phase 2a clinical trial found that high-dose N-acetylcysteine (NAC) was safe, well tolerated, and reduced disease-associated biomarkers in patients with hereditary cystatin C amyloid angiopathy (HCCAA). jamanetwork.com/journals/jamaneurology/fullarticle/10.100…
-
JAMA Neurology
@JAMANeuro
This case report describes cerebral white matter abnormalities from encephalitis caused by Angiostrongylus cantonensis in a 60-year-old woman. jamanetwork.com/journals/jamaneurology/fullarticle/10.100…
-
JAMA Neurology
@JAMANeuro
Most viewed this week from @JAMANeuro:
Individuals with more severe clinical Alzheimer disease symptoms than their biological stage often have additional pathologies, suggesting the need to evaluate non-AD biomarkers for accurate diagnosis.
jamanetwork.com/journals/jamaneurology/fullarticle/283381… -
JAMA Neurology
@JAMANeuro
In people with type 2 diabetes, both GLP-1RAs and SGLT2is were associated with decreased risk of Alzheimer disease and related dementias vs other glucose-lowering drugs, and no difference was observed between both drugs. jamanetwork.com/journals/jamaneurology/fullarticle/10.100…
-
JAMA Neurology
@JAMANeuro
Despite a decrease in age-standardized rates, subarachnoid hemorrhage remains one of the most common cardiovascular and neurological causes of death and disability globally.
#esoc2025 @ESOstroke
jamanetwork.com/journals/jamaneurology/fullarticle/10.100… -
JAMA Neurology
@JAMANeuro
Individuals with more severe clinical Alzheimer disease symptoms than their biological stage often have additional pathologies, suggesting the need to evaluate non-AD biomarkers for accurate diagnosis. jamanetwork.com/journals/jamaneurology/fullarticle/10.100…
-
JAMA Neurology
@JAMANeuro
Individuals with more severe clinical Alzheimer disease symptoms than their biological stage often have additional pathologies, suggesting the need to evaluate non-AD biomarkers for accurate diagnosis.
jamanetwork.com/journals/jamaneurology/fullarticle/10.100… -
JAMA Neurology
@JAMANeuro
Images in Neurology: A 52-year-old woman suddenly collapsed in a public place and was brought to a hospital by ambulance, presenting with a decreased level of consciousness.
jamanetwork.com/journals/jamaneurology/fullarticle/10.100… -
JAMA Neurology reposted
UCD Medicine
@UCDMedicine
Are blood thinners doing enough to prevent stroke in high-risk patients? Research explores the residual risk of recurrent stroke in patients with AF & suggests that treatment strategies are insufficient. www.ucd.ie/medicine/news/2025/arebloodthinnersdoingenough… @jamaneuro and @esostroke #stroke #afib #esoc25
-
JAMA Neurology
@JAMANeuro
This systematic review and meta-analysis found a high residual risk of recurrent stroke in patients with atrial fibrillation despite anticoagulation.
jamanetwork.com/journals/jamaneurology/fullarticle/10.100… @ronancollins7
JAMA Neurology
@JAMANeuro
-
JAMA Neurology
@JAMANeuro
Among adults with episodic cluster headache, eptinezumab did not significantly reduce the frequency of episodic cluster headache attacks compared to placebo.
jamanetwork.com/journals/jamaneurology/fullarticle/10.100… -
JAMA Neurology
@JAMANeuro
Individuals with more severe clinical Alzheimer disease symptoms than their biological stage often have additional pathologies. jamanetwork.com/journals/jamaneurology/fullarticle/10.100…
-
JAMA Neurology
@JAMANeuro
Most viewed this week from @JAMANeuro:
In a specialty memory clinic, patients treated with lecanemab over 14 months experienced manageable adverse events.
jamanetwork.com/journals/jamaneurology/fullarticle/283345… -
JAMA Neurology
@JAMANeuro
This case report describes a diagnosis of muscle infiltration of mycosis fungoides in a female aged 36 years with initial disease manifesting as pigmented skin patches. jamanetwork.com/journals/jamaneurology/fullarticle/10.100…
-
JAMA Neurology
@JAMANeuro
Viewpoint: Although genetic therapies have shown significant promise, a centralized registry for systematic data sharing could enhance patient safety and improve therapeutic outcomes. jamanetwork.com/journals/jamaneurology/fullarticle/10.100…
-
JAMA Neurology
@JAMANeuro
Venture capital investment in neurology companies has grown from 2000 to 2023, primarily focusing on pharmaceuticals and drug discovery. jamanetwork.com/journals/jamaneurology/fullarticle/10.100…
-
JAMA Neurology
@JAMANeuro
In this Editorial, JAMA Neurology Editor in Chief S Andrew Josephson reflects on 2024 accomplishments of the journal, discusses future plans, and acknowledges the contributions of the editorial team. jamanetwork.com/journals/jamaneurology/fullarticle/10.100…
-
JAMA Neurology
@JAMANeuro
Most viewed this week from @JAMANeuro:
In a specialty memory clinic, patients treated with lecanemab over 14 months experienced manageable adverse events.
jamanetwork.com/journals/jamaneurology/fullarticle/283345… -
JAMA Neurology
@JAMANeuro
In a specialty memory clinic, patients treated with lecanemab over 14 months experienced manageable adverse events. jamanetwork.com/journals/jamaneurology/fullarticle/10.100… @ErikMusiek
-
JAMA Neurology reposted
Michael Okun
@MichaelOkun
Is the "New Brunswick Neurological Syndrome of Unknown Cause" actually a new disease? The data out today strongly suggest the answer is NO. We must carefully study and share data on clusters of 'unknown' cases, and especially those cases that draw intense attention from the media. All of these recent Canadian cases hailed from New Brunswick, Canada. Bendahan, Lang and colleagues take a deeper dive by using both in person examinations and neuropathology.
Key Points:
- This was a cross-sectional study.
- 14 persons had second independent clinical evaluations.
- 11 persons had neuropathological diagnoses and the tissue revealed "no evidence of a new disease."
- The authors uncovered that there was "well-known, previously misdiagnosed neurological conditions."
My take: Neurology is not easy, and these cases remind me of the famous Canadian doctor William Osler, who was (perhaps) one of the best 'diagnosticians' of all time. He said, “Medicine is learned by the bedside and not in the classroom. Let not your conceptions of disease come from the words heard in the lecture room or read from the book. See and then reason and compare and control. But see first.” The recent publication in JAMA Neurology by Bendahan, Lang and colleagues underscores the critical importance of systematic data collection and objective evaluation (seeing) in cases of neurological syndromes w/ unknown causes. Their study, focused on a cluster of people initially diagnosed with the New Brunswick neurological syndrome of unknown cause, and their data critically used 'subsequent comprehensive in-person assessments' and in some cases neuropathology. The data revealed alternative diagnoses in each case. I completely agree with the authors that these types of unknown 'neuro' cases are "complex neurological disorders that 'always' will benefit from a second, independent and/or subspecialist evaluation...these cases require multidisciplinary support throughout the diagnostic journey." Always ask yourself, do you see what you want to see? Are you being rigorous and as unbiased as possible. Are you open to revising your initial impressions? Can a second look enhance diagnostic accuracy and outcomes? When we work together to understand unknown human diseases, remember, absit invidia – let there be no ill will. These authors are sharing hard data to help us to understand a phenomenon. We must always seek clarity. BRAVO.
tiny.cc/2r8j001 @JAMANeuro @ParkinsonDotOrg @FixelInstitute #nsuc #neurologicalsyndrome #neuromystery #neuroscience -
JAMA Neurology reposted
Alina Ivaniuk 🇺🇦
@AlinaIvaniuk
Thrilled to see our small projection into the future of #epilepsy precision medicine seeing light in @JAMANeuro. 🧬
So many exciting developments on the horizon - we need to make sure awareness and education are lining up for upcoming advances! 💪
@yesILAE @MayoFL_NeuroRes
Dennis Lal
@LalDennis
Thrilled to share our new Viewpoint just out in JAMA Neurology—“Epilepsy at the Precision Medicine Crossroads—Disease Modification, Presymptomatic Treatment, and Early Screening.”
Congratulations @AlinaIvaniuk, Elia & @a_brunklaus
Link: doi.org/10.1001/jamaneurol.2025.1179 -
JAMA Neurology
@JAMANeuro
RCT: Rizatriptan provided limited benefits for headache-related symptoms but not vertigo in treating vestibular migraine attacks. jamanetwork.com/journals/jamaneurology/fullarticle/10.100…
-
JAMA Neurology
@JAMANeuro
In a specialty memory clinic, patients treated with lecanemab over 14 months experienced manageable adverse events. jamanetwork.com/journals/jamaneurology/fullarticle/10.100… @ErikMusiek
-
JAMA Neurology
@JAMANeuro
Viewpoint: Advances in epilepsy research, including disease-modifying therapies and genomic newborn screening, promise a shift from symptomatic treatment to proactive disease prevention. jamanetwork.com/journals/jamaneurology/fullarticle/10.100… @AlinaIvaniuk
-
JAMA Neurology
@JAMANeuro
RCT: Rizatriptan provided limited benefits for headache-related symptoms but not vertigo in treating vestibular migraine attacks. jamanetwork.com/journals/jamaneurology/fullarticle/10.100…
-
JAMA Neurology
@JAMANeuro
In patients with Duchenne muscular dystrophy, delandistrogene moxeparvovec demonstrated efficacy in reducing muscle fat accumulation and slowing disease progression compared to placebo. jamanetwork.com/journals/jamaneurology/fullarticle/10.100…
-
JAMA Neurology
@JAMANeuro
RCT: Rizatriptan provided limited benefits for headache-related symptoms but not vertigo in treating vestibular migraine attacks. jamanetwork.com/journals/jamaneurology/fullarticle/10.100…
-
JAMA Neurology
@JAMANeuro
In a specialty memory clinic, patients treated with lecanemab over 14 months experienced manageable adverse events.
jamanetwork.com/journals/jamaneurology/fullarticle/10.100… @ErikMusiek -
JAMA Neurology
@JAMANeuro
No evidence was found for a new neurological disease in New Brunswick, Canada, as previously misdiagnosed well-known conditions were responsible for the symptoms. jamanetwork.com/journals/jamaneurology/fullarticle/10.100… @sarahlidstone
-
JAMA Neurology
@JAMANeuro
In this Viewpoint, @DrISubramanian and Ali Saad discuss strategies for people with neurodegenerative diseases to manage their health and safety during a heat wave. jamanetwork.com/journals/jamaneurology/fullarticle/10.100…
-
JAMA Neurology
@JAMANeuro
EMGs and MRIs for peripheral neuropathy remain overused while AAN-recommended tests like SPEP and GTT are underused, with diagnostic test use largely unchanged from 2007 to 2019. jamanetwork.com/journals/jamaneurology/fullarticle/10.100…
-
JAMA Neurology
@JAMANeuro
No evidence was found for a new neurological disease in New Brunswick, Canada, as previously misdiagnosed well-known conditions were responsible for the symptoms. jamanetwork.com/journals/jamaneurology/fullarticle/10.100… @sarahlidstone
-
JAMA Neurology
@JAMANeuro
"While the advent of general AI promises broader access to health care, it also introduces risks." This Viewpoint discusses the integration of artificial intelligence in neurology. jamanetwork.com/journals/jamaneurology/fullarticle/10.100…
-
JAMA Neurology
@JAMANeuro
This narrative review outlines recent advances and challenges in technologies arising from computer vision, a branch of artificial intelligence (#ai). jamanetwork.com/journals/jamaneurology/fullarticle/10.100…
-
JAMA Neurology
@JAMANeuro
Case report: a 4-year-old child presented with jerky movements of all 4 limbs, recurrent falls, and progressive cognitive impairment over a 6-month period.
jamanetwork.com/journals/jamaneurology/fullarticle/10.100… @arunkoulneuro -
JAMA Neurology
@JAMANeuro
No evidence was found for a new neurological disease in New Brunswick, Canada, as previously misdiagnosed well-known conditions were responsible for the symptoms.
jamanetwork.com/journals/jamaneurology/fullarticle/10.100… @sarahlidstone -
JAMA Neurology
@JAMANeuro
Secondary analysis of MR CLEAN-LATE showed that penumbra size, but not core volume or mismatch ratio, modified treatment effect, with a trend towards potential harm in patients with the smallest penumbras.
jamanetwork.com/journals/jamaneurology/fullarticle/10.100… -
JAMA Neurology
@JAMANeuro
Author Richard Lipton discusses "Fremanezumab for the Treatment of Patients With Migraine and Comorbid Major Depressive Disorder" with JAMA Neurology Web Editor Cynthia Armand. edhub.ama-assn.org/jn-learning/audio-player/10.1001/jaman…
-
JAMA Neurology
@JAMANeuro
Fremanezumab compared with placebo significantly reduced the mean number of monthly migraine days and depressive symptoms in patients with migraine and comorbid major depressive disorder.
jamanetwork.com/journals/jamaneurology/fullarticle/10.100… -
JAMA Neurology
@JAMANeuro
Most viewed this week from @JAMANeuro:
SECA RCT: Discontinuing acetylsalicylic acid treatment did not reduce recurrence rate of surgically treated chronic subdural hematoma within 6 months.
jamanetwork.com/journals/jamaneurology/fullarticle/283285… -
JAMA Neurology
@JAMANeuro
Viewpoint: Electronic health records and patient portals have improved patient access and communication but has also increased workload and burnout among physicians. jamanetwork.com/journals/jamaneurology/fullarticle/10.100…
-
JAMA Neurology
@JAMANeuro
The MELD Graph, a graph neural network for detecting focal cortical dysplasia (FCD) on MRI scans, demonstrated improved performance and interpretability compared to existing methods. jamanetwork.com/journals/jamaneurology/fullarticle/10.100… @ECondeBlanco
-
JAMA Neurology
@JAMANeuro
Most viewed this week from @JAMANeuro:
SECA RCT: Discontinuing acetylsalicylic acid treatment did not reduce recurrence rate of surgically treated chronic subdural hematoma within 6 months.
jamanetwork.com/journals/jamaneurology/fullarticle/283285… -
JAMA Neurology
@JAMANeuro
Most viewed in the last 7 days from @JAMANeuro:
Individuals with cannabis use severe enough to require hospital-based care were at increased risk of a new dementia diagnosis compared with those with all-cause hospital-based care or the general population. jamanetwork.com/journals/jamaneurology/fullarticle/283224… -
JAMA Neurology
@JAMANeuro
The mechanisms underlying the discordance between plasma biomarkers and PET reflective of Alzheimer disease pathologies may be heterogeneous. jamanetwork.com/journals/jamaneurology/fullarticle/10.100…
-
JAMA Neurology
@JAMANeuro
Teleneurorehabilitation was as effective as in-person rehabilitation in improving motor and non-motor symptoms and quality of life in Parkinson disease during the COVID-19 lockdown. jamanetwork.com/journals/jamaneurology/fullarticle/10.100…
-
JAMA Neurology
@JAMANeuro
Sex differences in the pathological progression of Alzheimer disease calls for sex-specific timing considerations when administrating anti-Aβ and anti-tau treatments. jamanetwork.com/journals/jamaneurology/fullarticle/10.100…
-
JAMA Neurology
@JAMANeuro
"Neurologists should take the same caution and consideration as psychiatrists in their code of ethics for public persons."
This Viewpoint discusses the ethical considerations of commenting on the neurological health of public figures.
jamanetwork.com/journals/jamaneurology/fullarticle/10.100… -
JAMA Neurology
@JAMANeuro
From @JAMA_current: The SPIRIT 2025 statement updates the guidelines for randomized trial protocols to enhance their completeness, transparency, and consistency, benefiting stakeholders involved in clinical research.
jamanetwork.com/journals/jama/fullarticle/10.1001/jama.20… -
JAMA Neurology
@JAMANeuro
Alzheimer disease biomarkers are present in various dementia types, with the strongest correlations between cerebrospinal fluid biomarkers and cognitive function seen in patients with early and late onset Alzheimer disease.
jamanetwork.com/journals/jamaneurology/fullarticle/10.100… -
JAMA Neurology
@JAMANeuro
SECA RCT: Discontinuing acetylsalicylic acid treatment did not reduce recurrence rate of surgically treated chronic subdural hematoma within 6 months.
jamanetwork.com/journals/jamaneurology/fullarticle/10.100… -
JAMA Neurology
@JAMANeuro
This case report describes a 35-year-old female patient experiencing chronic neuropsychiatric symptoms related to kambo, a secretion of the South American giant leaf frog.
jamanetwork.com/journals/jamaneurology/fullarticle/10.100… -
JAMA Neurology
@JAMANeuro
Most viewed in the last 7 days from @JAMANeuro:
Individuals with cannabis use severe enough to require hospital-based care were at increased risk of a new dementia diagnosis compared with those with all-cause hospital-based care or the general population. jamanetwork.com/journals/jamaneurology/fullarticle/283224… -
JAMA Neurology
@JAMANeuro
Recurrent intracerebral hemorrhage (ICH) adjacent to a previous ICH is a phenomenon associated with early recurrence and features of cerebral amyloid angiopathy. jamanetwork.com/journals/jamaneurology/fullarticle/10.100…
-
JAMA Neurology
@JAMANeuro
Plasma p-tau217 detected clinically relevant Alzheimer disease (AD) in frontotemporal lobar degeneration-related syndromes, while NfL and GFAP showed less diagnostic value. jamanetwork.com/journals/jamaneurology/fullarticle/10.100…
-
JAMA Neurology reposted
AMA Ed Hub™
@AMAEdHub
A 61-year-old man presented with chronic progressive weakness and gait dysfunction. Neurological examination revealed impaired short-term recall and a pseudobulbar affect. What is your diagnosis? @JAMANeuro amaedhub.org/4cjGIzx
-
JAMA Neurology reposted
UF Pharmacy
@UFPharmacy
A team of @UFHealth researchers led by Serena Jingchuan Guo, asst. prof. of pharmaceutical outcomes and policy in the @UF College of Pharmacy, found glucose-lowering meds like Ozempic may protect against Alzheimer’s. The study was published in @JAMANeuro. pharmacy.ufl.edu/2025/04/16/popular-diabetes-medications-…
-
JAMA Neurology reposted
AMA Ed Hub™
@AMAEdHub
Earn #cme and deepen your understanding of the presentation and progression of hyperacute active hemorrhage related to an intracranial metastatic tumor, as captured by MRI in this case from @JAMANeuro. Learn more. amaedhub.org/4cnCyXt
-
JAMA Neurology
@JAMANeuro
Treatment with verdiperstat was unlikely to alter disease progression in amyotrophic lateral sclerosis. jamanetwork.com/journals/jamaneurology/fullarticle/10.100…
-
JAMA Neurology
@JAMANeuro
Transient ischemic attack (TIA)-associated cognitive decline suggests a need to reevaluate post-TIA management and to screen regularly for cognitive change. jamanetwork.com/journals/jamaneurology/fullarticle/10.100…
-
JAMA Neurology
@JAMANeuro
Diffusion-weighted imaging lesion frequency and volume were unaffected by intensive antihypertensive therapy in patients with sub-acute intracerebral hemorrhage.
jamanetwork.com/journals/jamaneurology/fullarticle/10.100… -
JAMA Neurology
@JAMANeuro
Case report highlights a temporal relationship between the use of a glucagon-like peptide-1 receptor (GLP-1) agonist and the occurrence of central retinal artery occlusion. jamanetwork.com/journals/jamaneurology/fullarticle/10.100…
-
JAMA Neurology
@JAMANeuro
Viewpoint: The APOE4 allele is associated with an increased risk of Alzheimer's disease (AD) and earlier onset, but more longitudinal studies with diverse populations are needed to accurately estimate this risk. jamanetwork.com/journals/jamaneurology/fullarticle/10.100…
-
JAMA Neurology
@JAMANeuro
Certain genetic, cognitive, cerebrovascular, and neurologic factors are associated with late-onset epilepsy in people with cognitive decline.
jamanetwork.com/journals/jamaneurology/fullarticle/10.100… -
JAMA Neurology
@JAMANeuro
Case report: a man who tested positive for IgLON5-IgG antibody after intermittent episodes of paresthetic feeling involving the throat and jaw.
jamanetwork.com/journals/jamaneurology/fullarticle/10.100… -
JAMA Neurology
@JAMANeuro
Variability in the used definitions of progression independent of relapse activity (PIRA) in multiple sclerosis clinical trials, registries, and cohorts results in variability in the reported incidence and persistence of PIRA.
jamanetwork.com/journals/jamaneurology/fullarticle/10.100… -
JAMA Neurology
@JAMANeuro
Certain genetic, cognitive, cerebrovascular, and neurologic factors are associated with late-onset epilepsy in people with cognitive decline.
jamanetwork.com/journals/jamaneurology/fullarticle/10.100… -
JAMA Neurology
@JAMANeuro
Most viewed in the last 7 days from @JAMANeuro:
In people with type 2 diabetes, both GLP-1RAs and SGLT2is were associated with decreased risk of Alzheimer disease and related dementias vs other glucose-lowering drugs.
jamanetwork.com/journals/jamaneurology/fullarticle/283197… -
JAMA Neurology
@JAMANeuro
The risk of poststroke epilepsy (PSE) in young adults is relatively low, and existing risk scores are applicable for identifying high-risk individuals in this age group, according to this cohort study.
jamanetwork.com/journals/jamaneurology/fullarticle/10.100… -
JAMA Neurology
@JAMANeuro
Individuals with cannabis use severe enough to require emergency department or hospital care may be at increased risk of being diagnosed with dementia.
jamanetwork.com/journals/jamaneurology/fullarticle/10.100… -
JAMA Neurology reposted
JAMA
@JAMA_current
Authors, editors, reviewers, and other potential users should use CONSORT 2025 when writing and evaluating manuscripts of randomized trials to ensure that trial reports are clear and transparent.
Learn more in this Special Communication. jamanetwork.com/journals/jama/fullarticle/10.1001/jama.20… -
JAMA Neurology
@JAMANeuro
Certain genetic, cognitive, cerebrovascular, and neurologic factors are associated with late-onset epilepsy in people with cognitive decline.
jamanetwork.com/journals/jamaneurology/fullarticle/10.100… -
JAMA Neurology
@JAMANeuro
Glucose-lowering therapy with GLP1-RAs, but not SGLT2 inhibitors, was associated with a statistically significant reduction in dementia or cognitive impairment.
jamanetwork.com/journals/jamaneurology/fullarticle/10.100… -
JAMA Neurology
@JAMANeuro
In people with type 2 diabetes, both GLP-1RAs and SGLT2is were associated with decreased risk of Alzheimer disease and related dementias vs other glucose-lowering drugs.
jamanetwork.com/journals/jamaneurology/fullarticle/10.100… -
JAMA Neurology
@JAMANeuro
In this Viewpoint, child neurologist @schor_n advocates for inclusive AI training for use in outlier populations such as those that are common in clinical neurology practices.
jamanetwork.com/journals/jamaneurology/fullarticle/10.100… -
JAMA Neurology
@JAMANeuro
Viewpoint: Clinical metagenomic next-generation sequencing (mNGS) testing shows promise for diagnosing central nervous system infections, but its widespread clinical use is hampered by regulatory challenges. jamanetwork.com/journals/jamaneurology/fullarticle/10.100…
-
JAMA Neurology
@JAMANeuro
This case report describes a 75-year-old man who presented with sudden-onset right hemiplegia. jamanetwork.com/journals/jamaneurology/fullarticle/10.100…
-
JAMA Neurology
@JAMANeuro
Most viewed in the last 7 days from @JAMANeuro:
In people with type 2 diabetes, both GLP-1RAs and SGLT2is were associated with decreased risk of Alzheimer disease and related dementias vs other glucose-lowering drugs.
jamanetwork.com/journals/jamaneurology/fullarticle/283197… -
JAMA Neurology
@JAMANeuro
In people with type 2 diabetes, both GLP-1RAs and SGLT2is were associated with decreased risk of Alzheimer disease and related dementias vs other glucose-lowering drugs.
jamanetwork.com/journals/jamaneurology/fullarticle/10.100… -
JAMA Neurology
@JAMANeuro
Glucose-lowering therapy with GLP1-RAs, but not SGLT2 inhibitors, was associated with a statistically significant reduction in dementia or cognitive impairment.
jamanetwork.com/journals/jamaneurology/fullarticle/10.100… -
JAMA Neurology
@JAMANeuro
This Special Communication outlines some of the most pressing neuropalliative care research needs, the advancement of which will best serve patients of all ages living with serious neurologic diseases and their care partners.
jamanetwork.com/journals/jamaneurology/fullarticle/10.100… -
JAMA Neurology
@JAMANeuro
Images in Neurology: A 61-year-old man developed ptosis and occasional complete eyelid closure with difficulty opening them.
jamanetwork.com/journals/jamaneurology/fullarticle/10.100… -
JAMA Neurology
@JAMANeuro
Want to submit your #aanam research to @JAMA_current, @JAMANeuro, @JAMANetworkOpen or one of our other Network journals?
➡️ Learn what to expect from the submission and review process: www.youtube.com/watch?linkId=794442370&v=YQhpKdSfc_g -
JAMA Neurology
@JAMANeuro
Glucose-lowering therapy with GLP1-RAs, but not SGLT2 inhibitors, was associated with a statistically significant reduction in dementia or cognitive impairment. jamanetwork.com/journals/jamaneurology/fullarticle/10.100…
-
JAMA Neurology
@JAMANeuro
In people with type 2 diabetes, both GLP-1RAs and SGLT2is were associated with decreased risk of Alzheimer disease and related dementias vs other glucose-lowering drugs, and no difference was observed between both drugs. jamanetwork.com/journals/jamaneurology/fullarticle/10.100…
-
JAMA Neurology
@JAMANeuro
📣 Final day of exhibits at #aanam!
Find us at booth 1113 to get recent articles for your trip home and ask about submitting your research presented at the meeting to @JAMA_current, @JAMANeuro, @JAMANetworkOpen, or one of our other JAMA Network journals. -
JAMA Neurology
@JAMANeuro
Meet @JAMANeuro Editor S. Andrew Josephson at #aanam. He will be at booth 1113 in the exhibit hall today, April 8, 1:30 PM- 2:30 PM to answer questions and talk with you about your research and publishing opportunities with the JAMA Network
-
JAMA Neurology
@JAMANeuro
This study demonstrated the feasibility and safety of using the new RATIONAL robot-assisted thrombectomy system for treating acute ischemic stroke. jamanetwork.com/journals/jamaneurology/fullarticle/10.100…
-
JAMA Neurology reposted
Céline Gounder, MD, ScM, FIDSA 🇺🇦
@celinegounder
1/ Two new studies in JAMA Neurology explore whether GLP-1 diabetes & weight-loss drugs, like Ozempic & Mounjaro, might reduce dementia risk.
Here’s what they found & why we should interpret the results cautiously.This media couldn't be displayed. See it on the original post. -
JAMA Neurology
@JAMANeuro
Attending #aanam? Supplement your schedule with Predicting Individual Pain Sensitivity Using a Novel Cortical Biomarker Signature, from @JAMANeuro. Free to read online during the meeting jamanetwork.com/pages/conferences-aan?linkId=787749439
-
JAMA Neurology
@JAMANeuro
At #aanam? @JAMANeuro Editor S. Andrew Josephson will be at booth 1113 in the exhibit hall today, April 7, 1:00 PM– 2:00 PM. Stop by to ask questions and talk with him about your research and publishing opportunities with the JAMA Network
-
JAMA Neurology
@JAMANeuro
At #aanam? @JAMANeuro Editor S. Andrew Josephson will be at booth 1113 in the exhibit hall today, April 7, 1:00 PM– 2:00 PM. Stop by to ask questions and talk with him about your research and publishing opportunities with the JAMA Network
-
JAMA Neurology
@JAMANeuro
Glucose-lowering therapy with GLP1-RAs, but not SGLT2 inhibitors, was associated with a statistically significant reduction in dementia or cognitive impairment. jamanetwork.com/journals/jamaneurology/fullarticle/10.100…
-
JAMA Neurology
@JAMANeuro
In people with type 2 diabetes, both GLP-1RAs and SGLT2is were associated with decreased risk of Alzheimer disease and related dementias vs other glucose-lowering drugs, and no difference was observed between both drugs. jamanetwork.com/journals/jamaneurology/fullarticle/10.100…
-
JAMA Neurology
@JAMANeuro
Detection of Epileptogenic Focal Cortical Dysplasia Using Graph Neural Networks: A MELD Study, from JAMANeuro is free to read online during #aanam jamanetwork.com/pages/conferences-aan?linkId=787712788
-
JAMA Neurology
@JAMANeuro
Exhibits at #aanam are open. Find @JAMA_current, @JAMANeuro, and @JAMANetworkOpen at booth 1113. Get recent articles, find out when you can meet our editors, and ask us about publishing opportunities and submitting your work
-
JAMA Neurology
@JAMANeuro
Most viewed from @JAMANeuro:
A clearly superior day to initiate direct oral anticoagulant treatment after atrial fibrillation-related stroke was not identified, the evidence suggests that earlier initiation within the first 2 wks is better than later.
jamanetwork.com/journals/jamaneurology/fullarticle/283191… -
JAMA Neurology
@JAMANeuro
Heading to #aanam? Meet @JAMANeuro Editor S. Andrew Josephson at booth 1113 in the exhibit hall. See the schedule in the image or at our booth
-
JAMA Neurology
@JAMANeuro
Brain hypometabolism, detected by FDG-PET, begins in the prodromal stages of dementia with Lewy bodies (DLB) and progressively worsens. jamanetwork.com/journals/jamaneurology/fullarticle/10.100…
-
JAMA Neurology
@JAMANeuro
Most viewed from @JAMANeuro:
A clearly superior day to initiate direct oral anticoagulant treatment after atrial fibrillation-related stroke was not identified, the evidence suggests that earlier initiation within the first 2 wks is better than later.
jamanetwork.com/journals/jamaneurology/fullarticle/283191… -
JAMA Neurology
@JAMANeuro
Attending #aanam? Check out our page created for attendees. Find recent articles and podcasts, find out when you can meet our editors, and get information For Authors on @JAMA_current, @JAMANeuro, and @JAMANetworkOpen jamanetwork.com/pages/conferences-aan?linkId=787737879
-
JAMA Neurology
@JAMANeuro
Differentiating between MCI subtypes in individuals attending memory clinics was associated with the diagnostic performance of blood p-tau217 models to determine brain amyloidosis in patients’ clinical management. jamanetwork.com/journals/jamaneurology/fullarticle/10.100… @Rantes_
-
JAMA Neurology
@JAMANeuro
Most viewed from @JAMANeuro:
The successful testing & validation of Automated Imaging Differentiation for Parkinsonism suggest its integration within the diagnostic workup of 3 commonly encountered neurodegenerative parkinsonian disorders.
jamanetwork.com/journals/jamaneurology/fullarticle/283163… -
JAMA Neurology
@JAMANeuro
The ImmunoWELL JCV IgG test for detecting John Cunningham virus antibodies in natalizumab-treated multiple sclerosis patients yielded more positive results compared to the second-generation STRATIFY JCV DxSelect assay. jamanetwork.com/journals/jamaneurology/fullarticle/10.100…
-
JAMA Neurology
@JAMANeuro
This phase 2a clinical trial found that high-dose N-acetylcysteine (NAC) was safe, well tolerated, and reduced disease-associated biomarkers in patients with hereditary cystatin C amyloid angiopathy (HCCAA). jamanetwork.com/journals/jamaneurology/fullarticle/10.100…
-
JAMA Neurology
@JAMANeuro
Author Steven Warach discusses "Optimal Delay Time to Initiate Anticoagulation After Ischemic Stroke in Atrial Fibrillation: A Pragmatic, Response-Adaptive Randomized Clinical Trial" with JAMA Neurology Web Editor Cynthia Armand. edhub.ama-assn.org/jn-learning/audio-player/10.1001/jaman…
-
JAMA Neurology
@JAMANeuro
Although a clearly superior day to initiate direct oral anticoagulant treatment after atrial fibrillation-related stroke was not identified, the evidence suggests that earlier initiation within the first 2 weeks is better than later. jamanetwork.com/journals/jamaneurology/fullarticle/10.100…
-
JAMA Neurology
@JAMANeuro
Headache diagnoses were associated with increased risk of attempted and completed suicide after accounting for sociodemographic factors and baseline medical and psychiatric comorbidities. @ChFuglsang jamanetwork.com/journals/jamaneurology/fullarticle/10.100…
-
JAMA Neurology
@JAMANeuro
Most viewed from @JAMANeuro:
The successful testing & validation of Automated Imaging Differentiation for Parkinsonism suggest its integration within the diagnostic workup of 3 commonly encountered neurodegenerative parkinsonian disorders.
jamanetwork.com/journals/jamaneurology/fullarticle/283163… -
JAMA Neurology
@JAMANeuro
Patient-centered intensive motor learning programs could produce improvements in upper extremity function in children with perinatal stroke and unilateral cerebral palsy. @mihill68 jamanetwork.com/journals/jamaneurology/fullarticle/10.100…
-
JAMA Neurology
@JAMANeuro
Thrombolysis with prourokinase was not superior to standard care to improve the functional outcomes for patients with mild ischemic #stroke within 4.5 hours of symptom onset and had a similar safety profile. jamanetwork.com/journals/jamaneurology/fullarticle/10.100…
-
JAMA Neurology
@JAMANeuro
Most viewed in the last 7 days from @JAMANeuro:
Donanemab treatment increased amyloid-related imaging abnormalities risk compared with placebo in patients with early symptomatic Alzheimer disease and elevated amyloid levels.
jamanetwork.com/journals/jamaneurology/fullarticle/283114… -
JAMA Neurology
@JAMANeuro
A man aged 61 years presented with chronic progressive weakness and gait dysfunction over a 4-year period. Take the Clinical Challenge. What is your diagnosis? jamanetwork.com/journals/jamaneurology/fullarticle/10.100…
-
JAMA Neurology
@JAMANeuro
Most viewed in the last 7 days from @JAMANeuro:
Donanemab treatment increased amyloid-related imaging abnormalities risk compared with placebo in patients with early symptomatic Alzheimer disease and elevated amyloid levels.
jamanetwork.com/journals/jamaneurology/fullarticle/283114… -
JAMA Neurology
@JAMANeuro
Autoantibodies targeting the astrocytic intermediate filament protein vimentin were identified in patients with previously undifferentiated meningoencephalomyelitis. jamanetwork.com/journals/jamaneurology/fullarticle/10.100…
-
JAMA Neurology
@JAMANeuro
In this Editorial, JAMA Neurology Editor in Chief S Andrew Josephson reflects on 2024 accomplishments of the journal, discusses future plans, and acknowledges the contributions of the editorial team. jamanetwork.com/journals/jamaneurology/fullarticle/10.100…
-
JAMA Neurology reposted
Giulio Maria Pasinetti, MD, PhD
@IcahnCMIN
Researchers Gillian Coughlan, @bucklr01, et al examined whether female sex is assoc w/ faster tau accumulation in setting of high Aβ (as measured w/ PET) & the moderating influence of sex on assoc btwn APOEε4 carrier status & tau accumulation @JAMANeuro
jamanetwork.com/journals/jamaneurology/article-abstract/2… -
JAMA Neurology reposted
Michael Okun
@MichaelOkun
Are we letting our perspectives evolve on α-Synuclein testing for Parkinson's? Cameron Dietiker and Caroline Tanner challenge us to think deeper on the topic and consider all the factors in play. I also include Claudio Soto's great recent review on the actual test for nerds wanting to refresh.
Key Points:
- There has been an emergence of methods to detect 'abnormal' α-synuclein using something called an α-synuclein seed amplification assay (SAA).
- Also emerging has been the phosphorylated α-synuclein in the skin.
- The authors ponder the "many knowledge gaps" in testing.
- Which populations? What circumstances? How do you apply the test for clinical care vs. research?
- Do we risk health equity?
- Sensitivities and specificities for 'synucleinopathy' are ~85%.
- Still which synucleinopathy remains elusive, and also some folks w/ Parkinson's genes have been testing negative.
- Sensitivity for the LRRK2 was only ~68%.
- The authors point out that "a positive α-synuclein test result is not diagnostic of a pure synucleinopathy."
- Co-pathology is a key worry and challenge.
- Use in research populations has great promise (at-risk, prodromal, and manifest.)
- Clinical trials will open the door "to test new therapies before significant clinical disability is present."
My take: Parkinson's is not one disease. We have a way to go w/ biomarkers, however I am confident that scientists are figuring it out. Love the notion that we are (may be) using biomarkers to open the door to understanding the role of toxic chemicals, and the many opportunities for prevention. It is humbling to consider that "most people w/ PD live in low-income and middle-income countries, and do not have equitable access to neurological care or therapies." I think the authors nail it by choosing the word "evolving" in their title, as they ponder α-Synuclein testing. Mihi cura futuri – my concern is for the future, so I agree w/ the authors, tap the brakes and let the story 'evolve.'
jamanetwork.com/journals/jamaneurology/fullarticle/2830409 #parkinson @FixelInstitute @ParkinsonDotOrg @JAMANeuro
Nice Review in Trends in Biotechnology by Claudio Soto:
www.cell.com/trends/biotechnology/fulltext/S0167-7799(24)… -
JAMA Neurology reposted
AMA Ed Hub™
@AMAEdHub
A 61-year-old man presented with chronic progressive weakness and gait dysfunction. Neurological examination revealed impaired short-term recall and a pseudobulbar affect. What is your diagnosis? @JAMANeuro amaedhub.org/43IHgfP
-
JAMA Neurology reposted
Michael Okun
@MichaelOkun
Can a 3T MRI be used as a diagnostic tool to help clinicians differentiate Parkinson's, MSA and PSP? Yep. Welcome Automated Imaging Differentiation for Parkinsonism or AIDP to the toolbox. Brand new AI based technique just published by Vaillancourt and colleagues in JAMA Neurology.
Key Points:
- A 3T magnetic resonance imaging sequence paired w/ machine learning met primary end points for differentiating Parkinson's disease, MSA, and PSP.
- This was a NIH funded and PSG collaborative multi-center study and the technique was named Automated Imaging Differentiation of Parkinsonism.
- The study used 249 patients and also had a large retrospective cohort of 396 patients (to validate it).
- Excellent discrimination was uncovered for Parkinson's disease vs atypical parkinsonism.
- Excellent discrimination shown for MSA vs PSP.
- Excellent discrimination in Parkinson's disease vs MSA.
- Finally, excellent discrimination of Parkinson's disease vs PSP.
- The AIDP machine learning algorithm "predicted the postmortem neuropathology in 93.8% of autopsy cases."
My take: The day has arrived where MRI can be used as a diagnostic tool for helping clinicians to differentiate Parkinson's, MSA and PSP. This is really important, as most people will collect at least one MRI study anyway for workup of a potential neurodegenerative disease (and to exclude obvious causes such as tumors). 3T magnetic resonance imaging, when paired w/ machine learning proved powerful. Importantly, the study was conducted in many centers and on many different types of MRI scanners. The procedure was fast and took less than than 10-minute to obtain a diffusion MRI free water based imaging sequence. This was paired w/ an automated image processing and support vector machine learning diagnostic classification. Test-retest analysis was excellent. "DaT SPECT, skin biopsy, and synuclein seed aggregation assays (SAA) have all been proposed to aid in diagnosing Parkinson's." We can add a 3T MRI with AIDP to our toolbox. Could the combination of AIDP plus SAA, skin biopsy, or both "offer a more practical, affordable, and accessible potential approach to test for diagnosis and disease staging?" Thank you to all the 21 sites who participated and for disclosure, I was the senior author, so please take into account my natural bias. It is – mirabile dictu – wonderful to say, that we are moving closer to tools that have the potential to impact both care and research in the area of Parkinson's disease.
jamanetwork.com/journals/jamaneurology/fullarticle/2831631 @ParkinsonDotOrg @FixelInstitute #parkinsons @JAMANeuro -
JAMA Neurology
@JAMANeuro
This case report describes a patient with spontaneous, arrhythmic, spasmodic contractions of the abdominal muscles whose imaging confirmed involvement of the genu, body, and splenium of the corpus callosum. jamanetwork.com/journals/jamaneurology/fullarticle/10.100…
-
JAMA Neurology
@JAMANeuro
Venture capital investment in neurology companies has grown from 2000 to 2023, primarily focusing on pharmaceuticals and drug discovery. jamanetwork.com/journals/jamaneurology/fullarticle/10.100…
-
JAMA Neurology
@JAMANeuro
In this study, the successful testing and validation of Automated Imaging Differentiation for Parkinsonism suggest its integration within the diagnostic workup of 3 commonly encountered neurodegenerative parkinsonian disorders. jamanetwork.com/journals/jamaneurology/fullarticle/10.100…
-
JAMA Neurology
@JAMANeuro
Viewpoint from @SeanPauzauskie, @JaredGenser, and @yusterafa: Advances in neurotechnologies present significant ethical and privacy challenges surrounding neural data privacy. jamanetwork.com/journals/jamaneurology/fullarticle/10.100…
-
JAMA Neurology
@JAMANeuro
The Get With the Guidelines-Stroke program has improved stroke care quality since 2003, increasing the population-level value measured in quality-adjusted life-years. jamanetwork.com/journals/jamaneurology/fullarticle/10.100…
-
JAMA Neurology
@JAMANeuro
A novel cortical biomarker can accurately distinguish high and low pain-sensitive individuals and may predict the transition from acute to chronic pain. jamanetwork.com/journals/jamaneurology/fullarticle/10.100…
-
JAMA Neurology
@JAMANeuro
In patients with hereditary transthyretin amyloidosis with polyneuropathy, treatment with patisiran resulted in better outcomes and survival than those receiving placebo. jamanetwork.com/journals/jamaneurology/fullarticle/10.100…
-
JAMA Neurology
@JAMANeuro
Apixaban compared to aspirin was associated with fewer incident nonlacunar covert infarcts among patients with a recent cryptogenic ischemic stroke and atrial cardiopathy. jamanetwork.com/journals/jamaneurology/fullarticle/10.100…
-
JAMA Neurology
@JAMANeuro
This case report describes cerebral white matter abnormalities from encephalitis caused by Angiostrongylus cantonensis in a 60-year-old woman. jamanetwork.com/journals/jamaneurology/fullarticle/10.100…
-
JAMA Neurology
@JAMANeuro
Donanemab treatment increased amyloid-related imaging abnormalities risk compared with placebo in patients with early symptomatic Alzheimer disease and elevated amyloid levels. jamanetwork.com/journals/jamaneurology/fullarticle/10.100…
-
JAMA Neurology
@JAMANeuro
Mood alterations may be a common prodromal feature of sporadic Creutzfeldt-Jakob disease. jamanetwork.com/journals/jamaneurology/fullarticle/10.100…
-
JAMA Neurology
@JAMANeuro
Repeated Neurological Pupil Index measurements were insufficient to replace invasive monitoring in patients with subarachnoid hemorrhage, traumatic brain injury, and intracerebral hemorrhage. jamanetwork.com/journals/jamaneurology/fullarticle/10.100… @fabio_taccone
-
JAMA Neurology
@JAMANeuro
Most viewed in the last 7 days from @JAMANeuro:
Recurrence and features of cerebral amyloid angiopathy were associated with adjacent intracerebral hemorrhage.
jamanetwork.com/journals/jamaneurology/fullarticle/283085… -
JAMA Neurology
@JAMANeuro
Viewpoint: Assessing frailty in patients with multiple sclerosis enhances neurologists’ ability to understand the variability in health status within this highly heterogeneous disease. jamanetwork.com/journals/jamaneurology/fullarticle/10.100…
-
JAMA Neurology
@JAMANeuro
Optimizing serum glial fibrillary acidic protein and serum neurofilament light chain timing and demographic-adjusted cutoffs could improve accuracy in assessing neuromyelitis optica spectrum disorder disease activity. jamanetwork.com/journals/jamaneurology/fullarticle/10.100… @akproebstel
-
JAMA Neurology
@JAMANeuro
EMGs and MRIs for peripheral neuropathy remain overused while AAN-recommended tests like SPEP and GTT are underused, with diagnostic test use largely unchanged from 2007 to 2019. jamanetwork.com/journals/jamaneurology/fullarticle/10.100…
-
JAMA Neurology
@JAMANeuro
This case report describes a 35-year-old female patient experiencing chronic neuropsychiatric symptoms related to kambo, a secretion of the South American giant leaf frog. jamanetwork.com/journals/jamaneurology/fullarticle/10.100…
-
JAMA Neurology
@JAMANeuro
Sex differences in the pathological progression of Alzheimer disease calls for sex-specific timing considerations when administrating anti-Aβ and anti-tau treatments. jamanetwork.com/journals/jamaneurology/fullarticle/10.100…
-
JAMA Neurology
@JAMANeuro
Most viewed in the last 7 days from @JAMANeuro:
Can the diagnosis of epilepsy-causing focal cortical dysplasias (FCD) be improved using state-of-the-art artificial intelligence?
jamanetwork.com/journals/jamaneurology/fullarticle/283041… -
JAMA Neurology
@JAMANeuro
Author David Seiffge discusses "Location and Timing of Recurrent, Nontraumatic Intracerebral Hemorrhage" with JAMA Neurology Web Editor Cynthia Armand.
edhub.ama-assn.org/jn-learning/audio-player/18954577?link… -
JAMA Neurology
@JAMANeuro
Recurrent intracerebral hemorrhage (ICH) adjacent to a previous ICH is a phenomenon associated with early recurrence and features of cerebral amyloid angiopathy. jamanetwork.com/journals/jamaneurology/fullarticle/10.100…
-
JAMA Neurology
@JAMANeuro
IgG4-RD pachymeningitis often causes headache and cranial nerve problems, is best diagnosed with MRI and biopsy, and frequently relapses despite treatment. jamanetwork.com/journals/jamaneurology/fullarticle/10.100…
-
JAMA Neurology
@JAMANeuro
Viewpoint from @james_hillis, Edward Scheffer Cliff, and @KNVokinger: The FDA's recent authorization of an AI-powered medical device for dementia prognosis marks a step in the regulation and clinical implementation of #ai in healthcare. jamanetwork.com/journals/jamaneurology/fullarticle/10.100…
-
JAMA Neurology
@JAMANeuro
A restricted mean survival time-based analysis provided a clearer clinical meaning to 2 RCTs in progressive multiple sclerosis, which can be used to complement the standard hazard ratio. jamanetwork.com/journals/jamaneurology/fullarticle/10.100…
-
JAMA Neurology
@JAMANeuro
Most viewed in the last 7 days from @JAMANeuro:
Can the diagnosis of epilepsy-causing focal cortical dysplasias (FCD) be improved using state-of-the-art artificial intelligence?
jamanetwork.com/journals/jamaneurology/fullarticle/283041… -
JAMA Neurology
@JAMANeuro
Performance feedback provided through a dashboard used by local quality improvement teams reduced door-to–groin puncture time for endovascular thrombectomy. jamanetwork.com/journals/jamaneurology/fullarticle/10.100…
-
JAMA Neurology
@JAMANeuro
TAK-071, a novel acetylcholine M1 positive allosteric modulator, did not affect the primary outcome of gait but did improve a cognitive composite score in participants with #parkinson disease. jamanetwork.com/journals/jamaneurology/fullarticle/10.100…
-
JAMA Neurology
@JAMANeuro
Viewpoint: Screening for α-synuclein abnormalities in research can improve understanding of disease progression, refine selection of participants for clinical trials, and lead to more accurate and applicable results. jamanetwork.com/journals/jamaneurology/fullarticle/10.100…
-
JAMA Neurology
@JAMANeuro
Gestational hypertension, preeclampsia, and eclampsia were associated with an increased risk of new-onset migraine, headache, epilepsy, sleep disorder, or mental fatigue within months to years after giving birth. jamanetwork.com/journals/jamaneurology/fullarticle/10.100… @cathycluver
-
JAMA Neurology
@JAMANeuro
The MELD Graph, a graph neural network for detecting focal cortical dysplasia (FCD) on MRI scans, demonstrated improved performance and interpretability compared to existing methods. jamanetwork.com/journals/jamaneurology/fullarticle/10.100… @ECondeBlanco
-
JAMA Neurology
@JAMANeuro
Most viewed in the last 7 days from @JAMANeuro:
Results show that in ALS, the use of verdiperstat did not impact the progression of the disease.
jamanetwork.com/journals/jamaneurology/fullarticle/283024… -
JAMA Neurology
@JAMANeuro
Teleneurorehabilitation was as effective as in-person rehabilitation in improving motor and non-motor symptoms and quality of life in Parkinson disease during the COVID-19 lockdown #telepark trial. jamanetwork.com/journals/jamaneurology/fullarticle/10.100… @Divyani_garg
-
JAMA Neurology
@JAMANeuro
Viewpoint challenges conventional clinical practice that eschews pharmacological intervention for comatose patients with epileptiform abnormalities after cardiac arrest using evidence from the TELSTAR trial. jamanetwork.com/journals/jamaneurology/fullarticle/10.100…
-
JAMA Neurology
@JAMANeuro
Images in Neurology: The presentation and progression of hyperacute active hemorrhage related to an intracranial metastatic tumor as captured by magnetic resonance imaging (MRI). jamanetwork.com/journals/jamaneurology/fullarticle/10.100…
-
JAMA Neurology
@JAMANeuro
Most viewed in the last 7 days from @JAMANeuro:
Results show that in ALS, the use of verdiperstat did not impact the progression of the disease.
jamanetwork.com/journals/jamaneurology/fullarticle/283024… -
JAMA Neurology
@JAMANeuro
Anti-CGRP monoclonal antibodies were not associated with higher CVD risks compared to onabotulinumtoxinA in #medicare beneficiaries with migraine, a group who were predominantly older adults or disabled. jamanetwork.com/journals/jamaneurology/fullarticle/10.100…
-
JAMA Neurology
@JAMANeuro
In the DOT-MS trial, discontinuation of first-line disease-modifying therapy in patients aged 18 and older lead to recurrence of inflammation in ~20% of cases. jamanetwork.com/journals/jamaneurology/fullarticle/10.100… @eefst
-
JAMA Neurology
@JAMANeuro
From Editorial on Original Investigation into contact sport play and parkinsonism: "While much remains uncertain, the concerns about repetitive head impact-related parkinsonism, once confined to the boxing ring, have now reached other sports arenas." jamanetwork.com/journals/jamaneurology/fullarticle/10.100…
-
JAMA Neurology
@JAMANeuro
Study of deceased contact sports athletes with CTE reports that nearly 25% had parkinsonism during life. Most had an unusual pathology related to CTE and football play and not the typical Lewy body pathology found in most cases of Parkinson disease. jamanetwork.com/journals/jamaneurology/fullarticle/10.100…
-
JAMA Neurology
@JAMANeuro
In this study, the risk of 30-day stroke, death, or myocardial infarction or 1-year ipsilateral stroke was similar in patients undergoing transcarotid artery revascularization compared with those undergoing endarterectomy for carotid stenosis. jamanetwork.com/journals/jamaneurology/fullarticle/10.100…
-
JAMA Neurology
@JAMANeuro
An 18-month #meditation intervention had no effect on brain volume, marginal effects on perfusion, and improved composite scores of attention & emotion regulation relevant in #aging. jamanetwork.com/journals/jamaneurology/fullarticle/10.100… @SilverSanteEU @ChetelatLab #rct #research
-
JAMA Neurology
@JAMANeuro
Researchers turn to #smartphone #app and #machinelearning to develop an objective digital biomarker that tracks real-world symptom severity in those with #parkinsondisease jamanetwork.com/journals/jamaneurology/fullarticle/10.100…






































































































































































































































































































































































































































































































































































































































































































































